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Declaration 
From April 2001 until September 2005 1 worked as a Pilkington research fellow at the 
Department of Complementary Medicine, University of Exeter, which in 2002 was 
integrated as a unit of the Peninsula Medical School. All the publications presented here 
have been carried out during my time of employment in this post at the Complementary 
Medicine Unit of the Peninsula Medical School in Exeter, United Kingdom. 
During the first few months of my research post in 2001 1 recognized the importance of 
the Internet as a tool to obtain healthcare information. Under the supervision of 
Professor Edzard Ernst, director of CAM, I carried out five Internet surveys, of which I 
collected and summarized the data and drafted the first version of the manuscripts, 
which were then finalized by Professor Ernst's comments: 
* Health risks over the Internet: advice offered by'medical herbalists' to a pregnant 
woman. 
* Reflexologists' responses to a patient with abdominal pain -a survey on Internet 
advice. 
* Internet advice by acupuncturists -a risk factor for cardiovascular patients? 
* Are asthma sufferers at risk when consulting chiropractors over the Internet? 
* Aspects of MMR / MMR vaccination advice over the Internet. 
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In the years 2002 - 2005 1 co-authored systematic reviews, which aimed at assessing 
the efficacy and safety of various CAM for specific health conditions. This co-authorship 
involved acting as a second, independent data extractor and working on finalizing the 
manuscript: 
* Mistletoe for cancer? A systematic review of randomized clinical trials. 
* Efficacy of coenzyme Q1 0 for improved tolerability of cancer treatments: a systematic 
review. 
*A systematic review of guided imagery as an adjuvant cancer therapy. 
* Acupuncture for the relief of cancer-related pain -a systematic review. 
* Ukrain -a new cancer cure? A systematic review of randomized clinical trials. 
One systematic review I carried out as a first author, which meant I was first data 
extractor, summarized the data and drafted the first version of the manuscript. This 
project was carried out in 2002 and publication followed in 2004. Professor Ernst was 
the second author and thus second, independent data extractor. He also helped finalize 
the manuscript by commenting on it: 
* Music therapies for patients with cardiovascular diseases -a systematic review. 
Finally, I was lead researcher in an international, multischool survey assessing 
medical students' attitudes toward the concept of 'holism'. I conceptualized the project 
in that I identified a group of international collaborators, corresponded with the original 
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author of the instrument (which we then modified and validated), collected and entered 
data for one of the participating schools and drafted the first manuscript. Planning of this 
project began in 2001 and its finalization lasted 4 years; ending with its publication in 
2005: 
* Multischool, international survey of medical students' attitudes toward holism. 
e- 
35; 
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Abstract 
Katja Boehm 
Acquisition, Distribution and Perspectives of Healthcare Information In 
Complementary and Alternative Medicines (CAM) 
There is an underlying need to gather information for a better understanding of the 
mechanisms of action, safety, efficacy and cost-effectiveness of CAM. Once this 
information has been collected, the research needs to be distributed amongst 
healthcare professionals, the public and governing bodies. , 
In my work, I looked at the range of German and UK general practitioners' attitudes 
toward CAM and medical students' CAM attitudes in the UK, USA, Canada, New 
Zealand and Hong Kong. GPs' CAM attitudes did not differ across countries but a lack 
of information regarding safety and efficacy, as well as CAM training opportunities were 
criticized. CAM education was found to vary across countries due to different curricula 
and personal CAM use was a better predictor of CAM attitudes than was CAM exposure 
in the medical schools' curricula. 
I furthermore collected information on how CAM practitioners respond to specific patient 
and researcher health queries via e-mail. Medical herbalists, chiropractors, 
reflexologists, acupuncturists and homeopaths were contacted. It was found that 
response rates to a fictitious patient were significantly higher than those given to a 
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researcher. Some of the advice given online was interpreted as misleading or 
dangerous. Regulations for CAM practitioners dealing with potential clients' postal or 
online health queries should be put in place. 
I co-authored various systematic reviews, which summarize data from clinical trials and 
thus assessed the efficacy of mistletoe, co-enzyme Q1 0, guided imagery acupuncture 
and Ukrain for cancer care and music therapy for cardiovascular conditions. To 
summarize these reviews I conclude that some CAM modalities play an important role 
as an adjunct to conventional medicine in palliative cancer care and are based on a 
non-specific effect. Specific effects of CAM for certain health conditions are rather small. 
There is a need to regulate how CAM information is distributed. More rigorous clinical 
trials need to be financed and carried out independently to assess CAM efficacy and 
safety in those CAM modalities where a specific effect is suspected and in others with 
non-specific effects possibly CAM therapist evaluations should be carried out. Further 
international regulations should be put in place regarding CAM education in medical 
schools and CAM training for healthcare professionals. 
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Critical appraisal 
Nature of my work 
During last two decades, there has been a combination of growing interest in 
complementary and alternative medicine (CAM) by the public and also by researchers 
worldwide. "" 2 There has been a slow albeit noticeable fusion between public interest 
and clinical medicine. The general public of the 'modern' world has become increasingly 
health-oriented and thus is seeking alternative ways of taking care of their bodies and 
minds. CAM, in particular, can be of interest due to so called "push and pull factors". 
Pull factors are, for instance, congruence with the philosophy, which a specific health 
system is based on (i. e. Ayurveda) or the wish to take personal control over one's 
health and medical treatment. Push factors can be dissatisfaction with (some aspects 
of) the orthodox healthcare system, rejection of science and technology or sheer 
desperation. 
Conventional medicine on the other hand also strives to become more holistic and 
communicative. The press often likes to act as some sort of mediator between the two - 
at times to the disadvantage of both sides. Education about CAM in terms of teaching 
and learning of CAM is slowly being introduced in academic institutions due to a 
personal interest of academics, the increase noted in public CAM use and the 
employment of governing bodies (e. g. ministries, departments of education). Scientific 
evidence-based CAM research has so far explored the efficacy and safety of a variety 
of modalities when applied in specific health conditions by publication of systematic 
Kaýa Boehm 
Acquisition, distnbution and perspectives of healthcare information in complementary and alternative medicines (CAM) 
8 
reviews and meta-analyses. However, there have been suggestions that therapist 
evaluations as opposed to therapy efficacy and therapist training might be a better 
method of CAM assessment. 3 
CAM can be either of a diagnostic or a therapeutic nature and sometimes can act as 
both. As far as we can understand and rationally explain it, their mechanism of action is 
either on a physical, pharmacological or'undefined energies' level. For some CAM 
(mainly herbal medicines) a specific effect has been investigated and pinpointed. Other 
CAMs are still labeled 'nonspecific effect therapy, simply because no other effect than 
the placebo or meaning-specific effect has so far been identified. It is still not 
understood what the 'placebo effect' or the 'meaning response' fully entails but it has 
been shown that its effects are physiological and psychological. The 'meaning 
response' is described as the meaning in the treatment of an illness during which 
process the patient experiences knowledge, symbol and meaning and follows from the 
interaction with the context in which healing occurs, whilst the patient's attitude and 
understanding of medicine playa fundamental role in the healing process. 4 
Thus, there is a need to a) gather information as to the mechanism of action, safety, 
efficacy and cost-effectiveness of CAM, b) distribute that information to all healthcare 
professionals and governing bodies and c) inform the public. Currently, a mix of 
confusion, misinformation and lack of evidence still exists in the general public as well 
as in healthcare professionals. 
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Prior to my PhD-related work I carried out a survey using postal questionnaires and 
conducted additional interviews assessing what the range of German and UK general 
practitioners' (GPs) attitudes towards complementary and alternative medicines (CAM) 
are (Schmidt, Jacobs and Barton 2002). 5 It was of particular interest to identify cross- 
cultural differences and to assess for which health conditions GPs may apply or 
recommend CAM to their patients. The results showed that CAM attitudes varied, many 
of which were positive. The difference between UK and German GPs' CAM attitudes 
was not statistically significant although German GPs were slightly more positive. 
Favorite CAM modalities which GPs referred their patients to included acupuncture, 
chiropractic treatment, osteopathy and herbal medicine. The majority of practitioners 
noted a lack of clear information as to the safety and efficacy of CAM and a number of 
them requested more training and education about CAM. This piece of work was the 
first of its kind in assessing cross-culturally GPs' CAM attitudes. Personally, it lays for 
me the first stone for further CAM investigations. However, one aspect I did not assess 
with this study due to the chosen population that I studied was to inquire about the 
attitudes of medical students during the course of their curricula. Additionally, I had not 
used a validated and reliable instrument with which to measure CAM attitudes. 
This was achieved by a further international, multischool survey (Schmidt, Rees, 
Greenfield et al 2005). 6 The survey was carried out at locations in the UK, USA, New 
Zealand, Canada and Hong Kong and revealed that CAM education varied greatly 
according to different medical schools' curricula. Within the UK, differences were noted 
between 'traditional' medical schools that still teach according to 'content learning' as 
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opposed to the more currently adopted style of 'problem-based learning'. There was 
also the notion that prior CAM exposure and current personal consumption of CAM 
acted as a better predictor of the concept of 'holism', which is the core of what the CAM 
idea envelopes, than CAM exposure in the medical school's curriculum. 
After having shed some light on the extent of CAM healthcare information available to 
the medical profession and the range of attitudes toward holism the question remained 
as to what type of information about CAM the general population is being provided with. 
Specifically, I wanted to know how CAM practitioners respond to patients and 
researchers when being approached with a precise health-related problem. I therefore 
carried out 5 Intemet-based surveys of various natures. Apart from the first conducted 
survey the population was randomly divided into 2 groups, one of which was contacted 
via e-mail by a researcher and one of which was contacted by a (fictitious) patient. We 
involved medical herbalist, chiropractors, reflexologists, acupuncturists and 
homeopaths. The first study assessed the advice given to a pregnant woman when 
contacting medical herbadists regarding the problem of morning sickness. 7 Specifically, 
the woman asked about three herbs: ginger, raspberry and juniper. It was found that 
advice was readily available and its action ranged from misleading to dangerous. 
Respondents were, however, additionally giving general lifestyle advice. 
Similar results were found in another survey assessing UK reflexologists' responses to 
a patient with abdominal pain, weight loss and fatigue - presenting a potential case of 
8 liver cirrhosis or liver cancer. Here, the sample (all members of the 
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UK Association of Reflexologists who provided an email address) was randomly divided 
into 2 groups. The response rate was twice as high when the reflexologist was 
approached by a patient compared to a researcher and the respondents replied in a 
much more careful fashion regarding claims and diagnosis when approached by a 
researcher as opposed to a 'potential' client. The majority of reflexologists, however, 
responded in a responsible manner in that they advised the patient to seek help from a 
physician or other healthcare professional. 
A third Internet survey included all acupuncturists internationally whose email address 
was listed on a public directory. 9 The population was randomly divided into three 
groups: group A (fictitious patient), group B (fictitious patient 'living in therapist's area, 
i. e. potential client), and group C (researcher). All participants were asked to comment 
on the application of electroacupuncture for smoking cessation in a patient with a 
pacemaker. Concerns with administering electroacupuncture were issued by a third of 
all respondents but, again, acupuncturists in group C were more cautious in giving and 
the nature of their advice. 
Chiropractors approached over the Internet in a similar fashion showed a readiness to 
provide advice regarding asthma treatment, which is often not evidence-based. 10 The 
majority encouraged a patient with asthma, who had been treated with corticosteroids 
and thus may suffer from osteoporosis (as there is a link between higher doses of 
corticosteroids and osteoporosis)" to seek chiropractic treatment for their asthma relief. 
Finally, having joined a timely debate regarding vaccinations against measles, mumps 
and rubella (MMR) for a1 year old by approaching homeopaths, chiropractors and GPs, 
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it was found that a) GPs refused to give any advice whatsoever, b) very few 
homeopaths and chiropractors openly advised against the MMR vaccination and c) 
indirect advice to seek alternatives to the MMR was given. 12,13 
Systematic reviews (SRs) can be carried out when there are more than two clinical trials 
assessing one therapy for a treatment of a certain health condition. The randomized 
clinical trial (RCT) is seen as the 'gold standard' to draw any meaningful evidence- 
based conclusion. The SIR of mistletoe (Viscum album) for cancer included 10 
randomized clinical trials (RCTs) that met the predefined inclusion criteria. 14 This 
review concluded that although the studies of weaker trial design suggested benefits of 
mistletoe extracts in terms of quality of life, the stronger studies exhibited no efficacy in 
survival, quality of life and other outcome measures. 
In another systematic review assessing the therapy coenzyme Q1 0, six randomized 
clinical trials and three non-randomized trials were included. 15 The review suggests that 
CoQ1 0 may provide some protection against cardiotoxicity or liver toxicity during the 
cancer treatment. 
Guided imagery (GI) is also employed as a mind-therapy to adjuvant cancer patients' 
conventional treatments. In a systematic review including six randomized clinical trials 
poor analysis and heterogeneous endpoints made a firm conclusion impossible. 16 
However, it was suggested that GI may be psycho-supportive and increase comfort in 
patients undergoing therapy. 
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Acupuncture is applied to relieve cancer-related pain. In a systematic review including 
one randomized clinical trial, two non-blinded clinical trials and 4 uncontrolled clinical 
trials inadequate trial design, poor reporting and small sample size were prevalent. 17 
No evidence of efficacy of this treatment for cancer-related pain was found. 
Ukrain is a plant extract of the plant greater celandine (Chelidonium majus L. ) and is 
being used as an anticancer drug. In vitro studies, animal experiments, case reports 
and case series exist. In a systematic review 7 RCTs; were included. 18 All studies 
suggest that Ukrain has curative effects on a variety of different cancer types. However, 
all studies come from the same research team and are published in the same journal. 
Additionally, the methodological design is weak, their sample size small and data are 
poorly reported. 
Music therapy is often employed as a distraction stimulus for stressful procedures in 
hospitals. 19,20 In a systematic review of music therapy specifically applied to patients 
who underwent coronary conditions (bypass, artery grafting, myocardial infarction 
recovery) 12 randomized clinical trials were included . 
21 The review found that 8 of the 
trials found a significantly positive effect compared to the control group in a number of 
endpoints such as blood pressure, respiratory rate, heart rate, skin temperature but also 
in psychological outcome measures such as the State Trait Anxiety Inventory (STAI). 
The systematic reviews I chose to present here show that specific effects of a CAM 
therapy are small and tend to play a major role in palliative cancer care and in patient 
supportive care. Thus, CAM is of use to modern medicine for certain health conditions, 
albeit its application should be seen as in addition to rather than a replacement of 
Kata Boehm 
Acquisition, distribution and pcrspectives of healtheare information in complementary and alternative medicines (CAM) 
14 
conventional medicine. 
It was my intention to present an assimilation of my work, ranging from postal and 
Internet surveys to systematic reviews. With the help of my colleagues I have gathered 
information as to the safety and efficacy of various CAM modalities in cancer care. I 
have shed light on how that information is distributed to healthcare professionals with a 
multinational survey, which showed that education on CAM varies and is dependant on 
the medical school's curriculum. With my Internet surveys I have shown that when 
contacting CAM practitioners via e-mail the public can expect a range of replies 
including responses that are of responsible manner and responses that may be 
inconsistent with the practitioner's training. Some CAM practitioners also have been 
shown to give advice which is contrary to conventional medical advice, such as the use 
of vaccination. 
Significance of my work 
Safety of CAM 
The safety of CAM should always be considered before its efficacy to avoid hann to the 
public. In my Internet surveys I have shown that most CAM practitioners act responsibly 
in correspondence with the public but some give advice that might be considered 
harmful. 
Examples for direct risks of CAM therapies are, for instance, toxic oral remedies (e. g. 
adulteration, contamination), infected needles, trauma (e. g. spinal manipulation 
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therapies). Indirect risks could contain a general hindering of access to effective 
therapy, usage of harmful diagnostic practices and unnecessarily high costs. 
Herbal medicines hold their own possible risks. The quality of the product needs to be 
considered. The toxicity of plants and therefore correct dosages need to be established. 
Interactions with other medication and herbal therapies might occur. Precautions may 
have to be taken especially in pregnancy and during the lactation period. 
The safety of acupuncture has been established and the therapy is considered safe if 
applied by a qualified practitioner. 
Efficacy of CAM 
In healthcare there are various outcomes that healthcare providers need to consider. 
These are of physical, psychological and social nature. Many CAM therapists and CAM 
supporters claim that some of the CAM therapies encounter many of the symptoms at 
once. CAM for cancer palliation, for instance, claims to enhance the quality of life of 
cancer patients, to promote relaxation and reduce stress and pain, to reduce some of 
the side effects caused by chemo- or radiotherapy and to improve the quality of sleep. 
The widespread and well-documented use of CAM by patients has lead to an intensive 
research focus on the efficacy and safety of some of the CAM modalities. Some of 
these therapies are promoted as prevention, some are suggested as so-called 'cures' 
and some are used for supportive healthcare. Evidence-based data for supportive 
healthcare suggest that some forms of CAM have gained an important role as some of 
the data have shown to favor the CAM therapy, especially if it was applied in addition to 
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a conventional therapy. However, the present evidence for most therapies is 
controversial. 22 Furthermore, interpretation of studies differs depending on what 
methodological quality is being determined as adequate. Additionally, some medical 
interventions, such as CAM, can be seen as more complex than the more or less 
'straight-forward' methods used to evaluate pharmacological studies. Some elements of 
the therapeutic approach may work synergistically and simultaneously. Therefore, the 
possibility of a different approach of assessment may have to be considered. The 
circular model of evaluation suggests a consideration of whether a clinical study used a 
method well-suited to answer the research question and also whether it implements this 
method with the necessary scientific rigor. 23 
This area clearly deserves more research; in particular, it needs to be established 
whether treatments are in any way superior to conventional methods of healthcare. 
However, until more data are available, CAM can be cautiously recommended if the risk 
for harm is minimized through adequate supervision. All patients should inform their 
general practitioner and health specialist if they are using or thinking about using any 
forms of CAM. 
Regulation of and education about CAM 
There is a need to regulate how CAM information is distributed. As I have shown in my 
Internet surveys, CAM practitioners' responses vary greatly. Many systematic reviews 
that I have co-authored have shown that more rigorous clinical trials need to be 
financed and carried out independently to assess CAM efficacy and safety in those 
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CAM modalities where a specific effect is suspected and in others with non-specific 
effects possibly CAM therapist evaluations should be carried out. Further international 
options and regulations should be put in place regarding CAM education in medical 
schools and CAM training for healthcare professionals, as my surveys have underlined 
a need for these was expressed by general practitioners and medical students. 
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SUMMARY. Objective: To investigate whether there is a difference in general 
practitioners' attitudes towards CAM in the UK and Germany. Study design: A 
descriptive questionnaire was developed and sent to 97 GPs in the UK and 99 GPs in 
Germany. Results: The overall response rate was 68%. German GPs showed a 
(non-significant) overall more positive attitude towards CAM than did British GPs. 
British GPs made more referrals to complementary practitioners. The most popular 
CAM therapies that UK GPs referred their patients to were chiropractic treatment, 
acupuncture and osteopathy. German GPs referred their patients mainly to acupuncture 
treatment, chiropractic treatment and herbal medicine. A significantly higher number 
of German GPs reported having practised as a CAM practitioner before and having 
personally used CAM themselves. Seventy percent of British GPs and 76% of German 
GPs thought it is safe to prescribe complementary medicine and therapies to patients. 
Conclusion: There are small national differences in referring patients to various CAM 
modalities. Both nations have an overall positive attitude toward and a high interest in 
CAM. Lack of scientific evidence and information on training opportunities were 
important points that were continuously raised by GPs in both countries. 
0 2002 Elsevier Science Ltd. All rights reserved. 
INTRODUCTION 
Complementary and alternative medicine (CAM) is 
being used as an umbrella term in this study, de- 
spite the valuable argument that each CAM modality 
needs individual attention. The use of and interest in 
9 E-mail: pjacobs@plymouth. ac. ulc 
b E-mail: andrew. barton@phnt. swest. nhs. uk. 
CAM has been growing rapidly over the last decades. 
One-third to one-half of the general population is 
using one or more forms of alternative therapies. 1 
The demand for CAM also has an impact on the 
general practitioner. Tn a comprehensive literature 
review of surveys examining the practices and be- 
liefs of GPs between 1982 and 1995 it was found that 
large numbers of physicians are either referring to or 
themselves practising some of the more prominent 
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forms of CAM. 2 The review also found that a num- 
ber of GPs believe that some forms of CAM are 
useful or efficacious. In the UK about 40% of GPs 
now provide some complementary services for their 
patients. ' Sixty-seven percent of Health Authori- 
ties are purchasing at least one CAM treatment. 4 
Sixty-five percent of British hospital doctors believe 
that CAM therapies have a place in mainstream 
medicine. 5 
The market for herbal medicine is also expand- 
ing, especially in Germany, and it has been claimed 
that the number of the German "Heilpraktikee' has 
risen to around 10,000 in 19971 and by 1995,8.4% 
of all drugs prescribed were herbal medicinal drugs 
and homeopathicS. 7 In Britain non-medically trained 
practitioners are the main providers8 of CAM. Medi- 
cal doctors in Germany and the LJK also refer patients 
to CAM practitioners. 9 The increase in CAM over 
recent years has been accompanied by an increas- 
ing scepticism with regard to both the underlying 
principles associated with the practice of CAM, and 
the efficacy and safety of CAM. 10 Patients' use of 
CAM without their GPs' knowledge may also cause 
problems. Some herbal remedies can be dangerous to 
patients with epilepsy or diabetes and to those taking, 
for instance, warfarin. Ideally, GPs should routinely 
ask patients about CAM use in order to reduce the 
incidence of "complementogcnic" disease. 
There are national and cultural differences regard- 
ing referral to, use of and attitudes towards CAM. 
The organised, non-medically trained profession 
of the "HeilprakUce' (literally translated meaning 
'health practitioner') in Germany has no UK equiv- 
alent. In the LJK, however, there are homeopathic 
hospitals, which are part of the NHS. There is a very 
high prescription of herbal medicine in Germany 
whereas in the UK herbal medicine is not often 
prescribed. There are different traditions of practice 
within various CAM professions. Ethnic minorities 
also play an important role when establishing dif- 
ferences of CAM use and interest. However, little 
is known about these differences. In this study, we 
investigated differences in the perception of, and at- 
titude towards CAM in two European countries, the 
UK and Germany. To our knowledge cross-cultural 
differences in attitudes to and perceptions of CAM 
have not been investigated in this way before. 
METHODS 
A questionnaire was developed to study the attitudes, 
perceptions, experiences of, types of referral made, 
perceived efficacy, and concerns about CAM, and 
to elicit views about the future direction of CAM 
use within a national health provision (Appendix A). 
The questionnaire was developed using a two-stage 
approach. In stage one a review of the current liter- 
ature was carried out on Medline and the literature 
from the last three decades was searched for po- 
tential studies. Search terms used were 'use' and 
4 complementary medicine', 'use' and 'alternative 
medicine' to identify the main issues surrounding 
CAM use. Bibliographies of identified articles were 
checked for further potential trials. No restrictions 
regarding language of publication were applied. Af- 
ter reviewing the literature we decided to ask GPs 
about their overall attitude toward CAM, the number 
of referrals they made to CAM or CAM practi- 
tioners, specific illnesses to be treated with CAM, 
personal CAM practice and use, perceived safety 
of CAM, implementation and popularity of CAM. 
Demographic data were additionally sought and par- 
ticipants were asked to give a definition of CAM. 
For the overall attitude scale respondents had to rate 
their attitude on a scale ranging from I to 10 with 
'1' meaning 'no interest' and '10' meaning 'active 
interest' towards CAM. 
In stage two the questionnaire was presented to 
three GPs for refining questions, clarifying issues 
and considering ease of use by participants. 
The local health authority provided a list of ad- 
dresses for GPs by electoral ward in the Plymouth 
area. This list did not constitute a random sample 
but was ordered according to geographical area. 
German GPs were selected by randomly choosing 
addresses from the Yellow Pages for Mecklenburg- 
Vorpommcm, a north-eastern region in Germany 
(formerly German Democratic Republic). 
In the period March-July 2000,196 question- 
naires were posted to participants, along with a letter 
detailing the study aims and a freepost envelope for 
responses. Ninety-seven questionnaires were sent 
to GPs in the south-west of England and ninety- 
nine to GPs in the north-cast of Germany. The 
covering letter explaining the purpose of the study 
addressed each GP by name. It was suggested to 
tear off this letter when returning the questionnaire 
and thus a numbering system was applied to record 
response rates for participant anonymity. AI -month 
follow-up reminder letter and questionnaire were 
sent out to all initial non-responders. Data were en- 
tered into SPSS datasheets for analysis. Chi-square 
analysis was used to test for significant differences 
between groups. The significance level was set at 
P<0.05. 
RESULTS 
One hundred and thirty-three replies were received 
(response rate: 68%), of which 66 were from British 
GPs and 67 from German GPs. The majority of 
UK (94%) and German (63%) respondents were of 
male gender (Table 1). Age was distributed similarly 
and most participants were between 40 and 69 years 
of age (Table 1). The British sample showed less 
variation in years of practice when compared to the 
German respondents. In the British sample there 
were only two GPs who bad practised less than 10 
years, in the German sample there were 16 GPs who 
had practised less than 10 years. 
Cross-cultural differences in GPs' attitudes 
Table I Demographic data of GPs 
Gender 
Male Female <29 
British (p - 66) 62 (9', %) 4 (6%) 0 
German (n - 67) 42 (63%) 25 (37%) 0 
Age group 
30-39 40-49 50-59 60-69 70+ 
5 (8%) 22 "33%) 29 (11%) !D ý13%) 0 
19 
ý 
, 
28%) 25 (37%) 13 
ýý 2 C'W )0 
Attitudes towards CAM 
tiLl L. w Int-st 45 08ndsh Fig. I Attitudes to CAM. The overall GPs attitude toward CAM was more 
positive in the sample of Gen-nan GPs (mean = 6.75) 
compared to the attitude expressed by British GPs 
(mean = 5.81). However, the difference between 
German and British GPs' attitudes toward CAM is 
not statistically significant (Fig. I). 
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British GPs reported higher levels of referrals 
to alternative therapists than German GPs. The 
most popular CAM therapies that UK GPs referred 
their patients to were chiropractic treatment (79%), 
acupuncture (67%) and osteopathy (66%). German 
GPs referred their patients mainly to acupuncture 
CAM referrals 
I 
I 
Acup-mturc A! exander Aromathorapý, C%'opru! ýc HLrt)El 
Tachn, qw medicille 
u 
NdlOrOpWhy (. ), tCLpdttly ROfICXOJýgý shlatsý 
0 British GPilGerman GPJ 
Fig. 2 Referrals to CAM. 
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Table 2 GPs' response to safety' 
CAM is generally British German 
safe to be GPs GPs 
prescribed 
'Yes' 47 (71) 5ý (76) 
'No' 15 (23) 13 (19ýý 
' Not all GPs have responded to this question 
treatment (82%), chiropractic treatment (73%) and 
herbal medicine (28%) (Fig. 2). Significantly more 
British GPs referred patients to Alexander technique, 
aromatherapy, homeopathy and osteopathy- Signifi- 
cantly more German GPs referred their patients to 
herbal medicine and naturopathy. 
Seventy percent of British GPs thought it is safe 
to prescribe complementary medicine and therapies 
to patients, 22% thought that it was not safe and the 
rest did not mention safety. Seventy-six percent of 
the German GP sample said it is safe to prescribe 
CAM and 19% thought it was not safe (Table 2). 
Most GPs, irrespective of country, were con- 
cerned about the lack of scientific evidence about 
CAM. British GPs were also highly concemed about 
lack of knowledge about its indications and the lack 
of availability on the NHS. German GPs expressed 
that many practitioners are prejudiced against CAM 
and that generally there is less patient feedback on 
alternative methods (Table 3). 
GPs reported various illnesses for which they 
thought some CAM would be useful, the top three 
include stress, headache and depression (Table 4). 
However, considerably less British GPs would pre- 
scribe CAM for headaches and more British GPs 
would prescribe CAM for stroke, HlV/AlDS and 
ME (post-viral fatigue syndrome) compared to Ger- 
man GPs. 
A significantly higher number of German GPs re- 
ported having practised as a CAM practitioner before 
(n = 30) and having personally used CAM them- 
selves (n =3 1) compared to British GPs. This was 
specifically the case for acupuncture. Eight percent 
of British respondents claimed to practise or have 
practised chiropractic treatment, 5% acupuncture 
treatment, 5% homeopathic treatment and 39/6 os- 
teopathy. Nineteen percent of German GPs claimed 
to work or have worked as an acupuncturist, 11% 
as a chiropractor, 6% as a homeopath and 3% as an 
osteopath. Six percent of the British GP sample has 
personally used chiropractic treatment before, 2% 
acupuncture and 294. homeopathy. Eleven percent of 
Table 4 Illnesses for which CAM might be 
useful 
Illness British German 
GPs (%) GPs (%) 
Common colds 2) (32) 27 (40) 
Depression 15 (68) 38 (ý/) 
Asthma 14 (21) 24 (36) 
Headache 39 (59) 58 (87) 
Stress S4 (82) 46 (69) 
S-, roke 11 (17) 0 (0) 
HWAIDS 11 (17) 0 (0) 
Cancer care 21 (32) 22 (33) 
MI 36 (5s) '8 ()/) 
Digesiive osorders Q ýK) ý7 (10) 
German GPs have personally used acupuncture be- 
fore, 7% chiropractic and 5% homeopathy (Table 5). 
DISCUSSION 
This survey is unique in that it is the first one to com- 
pare GPs' attitudes towards CAM cross-culturally. 
The relatively high response rate (68%) might in- 
dicate a reasonably positive general attitude of GPs 
toward CAM. German GPs showed a more posi- 
tive overall attitude toward CAM than did British 
GPs, even though the difference was not statistically 
significant. However, looking at the amount of refer- 
rals made to complementary therapies, German GPs 
were not as active as were the British GPs. There 
are national differences in particular when referring 
patients to aromatherapy, herbal treatments, natur- 
opathy and osteopathy. The variation in responders' 
age could either be due to chance or to a greater 
numberof younger GPs in Germany in general. How- 
ever, we have not assessed whether age is related 
to the degree of attitude toward CAM. Our findings 
confirm those of another study amongst GPs in Liv- 
erpool where it was found that acupuncture along 
with osteopathy and chiropractic were the therapies 
most highly regarded in terms of effectiveness. '' 
In our study, German GPs referred their patients 
mainly to acupuncturists, chiropractors, honiecipaths 
and herbal medicine and some of' the German and 
British GPs reported that they have practised as a 
CAM practitioner, mainly applying acupuncture. In 
a similar small survey in Germany 95% (n = 38) 
used some form of CAM, most commonly herbal 
medicine, neural therapy or homeopathy. 12 
Safety ofCAM was perceived almost equally in 
both iroups. Both groups related a low intention of 
Table3 GPs' reasons for low intention to CAM use 
Reasons for low intention of CAM use 
Little knowledge abuut iridicatioris uf CAM 
Pr ejudice 
Leýs patient feedback on altemative methods 
Availability 
Lack of scieritific evidence 
British GPs German GPs 
il ())) 12 (18) 
21 (36) 36 (54) 
9 (14) 18 ()/) 
39 (59) 2ý (il) 
ýý (H i) -ý) (/8) 
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Table S Self-practice and personal use of CAM 
CAM British GPs (%) German GPs (%) 
Self practice Self use Self practice Self use 
Acupunmrc s 0") 
Chtropr-acLic 80 1) 
Homeopathy 5 (8) 
Kenexology 0 
Phytotherapy 0 
Naturopathy 0 
Aromatherapy ý (2) 
CAM use mainly to the lack of scientific evidence. 
British GPs further believed that lack of availabil- 
ity of CAM in the NHS is another reason for its 
rare application in the NHS compared to orthodox 
medicine. German GPs felt that prejudices against 
CAM deter patients from using it and GPs from pre- 
scribing it. Many British GPs believed that especially 
a lack of knowledge about the indications of CAM 
and its availability are reasons for a low intention 
for its use. British and German GPs both agreed 
that due to the media the population has increased 
expectations of the medical profession, which is 
the main information supplier. Additionally, some 
GPs mentioned that possibly dissatisfaction with the 
conventional medical system such as, for instance, 
waiting lists and lack of medical explanations to 
every problem causes many patients to turn to CAM 
therapists. Many GPs asked for more information on 
training opportunities for certain CAM modalities 
and CAM education for doctors. 
Perkin et al. 13 carried out one of the first studies 
in the UK comparing the attitudes of GPs, hospi- 
tal doctors and medical students towards alternative 
medicine. They asked GPs and hospital doctors to 
rate their attitude towards and knowledge of five 
alternative therapies, including acupuncture, chiro- 
practic, homeopathy, osteopathy and naturopathy. 
Seventy percent of hospital doctors and 93% of GPs 
had, on at least one occasion, suggested a referral 
for alternative treatment. In another study, 72% of 
the GPs participating in the study had made referrals 
to CAM. 14 Twelve percent of hospital doctors and 
20% of GPs were practising alternative medicine. 
The majority of the respondents felt that alterna- 
tive medicine should be available on the NHS and 
that medical students should receive some tuition 
about alternative therapies. Other studies also sup- 
port the outcomes of this study by having shown an 
increased interest in complementary medicine and 
therapies among GPs in the UK and in Gennany e. g. 
13,15-17. Reilly's study, for instance, confirmed that 
there is a contrast to the picture frequently painted 
by the media and the public of narrow-minded, drug 
orientated doctors. 
Most GPs in the UK and in Germany would like 
to be able to consider different CAM treatments on 
their respective merits if more scientific evidence 
was available from high quality research. Others 
2 (3) 1) (28ý 
6 (9) 11 (16) 
2 (3) 6 (9) 
2 (3) 3 (4) 0 
1 (2) 2 (3) 4 (6) 
52 (3) 0 
2 (3) 1 (ý) 1 (1) 
14S 
believe that it does not matter if a cure has not 
been fully understood as long as it might help 
some patients to get better or to improve their 
quality of life. Some GPs may fear for their financial 
existence and more competition and therefore, reject 
any alternative treatments. 
One of the main differences to take into ac- 
count when interpreting the data of this study is 
the diversity of medical health systems and training 
provided in the UK and Germany. The health system 
in Great Britain is mainly provided by the state and 
there are additional independent insurance plans. In 
Germany there is no direct ownership by the state 
but instead the health system consists of nationally 
guided insurance agencies and the state offers con- 
trolled private and public insurance plans. In 1994, 
the UK was the only EU country to have CAM 
hospitals in the public sector. 8 As far as the training 
of a complementary practitioner is concerned the 
situation is similar in the UK and Germany. Apart 
from osteopaths and chiropractors complementary 
practitioners can legally practise without any train- 
ing. However, most practitioners complete further 
education in CAM disciplines, despite the fact that 
there is a great variation in quality among the many 
training institutions since main registering bodies of 
the relevant disciplines accredit only few courses. In 
the German medical curriculum familiarisation with 
non-convcntional medicine is compulsory. 
As with most investigations there are various 
weaknesses of this study. The sample size in this 
survey is relatively small due to limited financial 
resources and time constraints. Additionally, tile 
participants' selection was not randornised and only 
involved a small area. We also have no information 
about the GPs who failed to respond to our sur- 
vcy. There is evidence from population surveys that 
the use of CAM in the south-west of Frigland is 
high- 16% instead of the national average of 10'/(,, 1 
Therefore, the samples involved in this study cannot 
be seen as representative for all GPs. Additionally, 
we must concede that respondents are likely to be 
among those GPs more interested in CAM. 
This study was an attempt to show any differences 
in GPs' attitudes toward CAM in two different 
countries. Further research needs to expand the area 
of receiving responses from GPs by, for instance, 
sending out questionnaires to surgeries all over the 
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country, including cities, towns, and rural areas. For should be carried out, involving British and German 
ftirther research more semi-structured interviews GPs with different levels of attitudes toward CAM. 
Appendix A. CAM attitude Questionnaire 
(please circle where appropriate) 
Gender. Female / Male 
Age: <29 30-39 40-49 50-59 60-69 70+ 
How many years have you worked in general practice? ...................................... Are you member of the Royal College of GPs7 Yes / No 
I am member of other professional organisations (please specify) .......................... 
1. Please rate your overall attitude to alternative /complementary therapies 
1= no interest ............................................................... 10- active interest 123456789 10 
2. How would you define alternative / complementary medicine? 
................................................................................. 
3. Have you ever made a referral to one of the following therapies? (please indicate) 
0 Acupuncture 0 Homeopathy 
0 Alexander Technique 0 Naturopathy and Nutrition 
[I Aromatherapy 13 Osteopathy 
0 Chiropractic 0 Reflexology 
0 Herbal Medicine 11 Shiatsu 
13 Others (please specify) ................................................ 
4. Can you personally relate to the following statements: 
4a. I do not use complementary therapies. Agree / Disagree 
4b. I do not believe in complementary therapies. Agree / Disagree 
If you 'agreed' In both questions can you please turn to question No. 8 
5. For which specific illness was your last referral to alternative / complementary 
therapy? ............................................................................................. 
6. Have you ever practised as an alternative therapist? Yes / No 
If 'Yes' please specify. 
7. Have you ever used alternative / complementary medicine or therapy for your own 
health? Yes / No 
If 'Yes' please specify: 
8a. Do you think it is generally safe to prescribe alternative medicine and therapies? 
Yes / No 
8b. If 'No' why not? ............................................................................... 
9. Do you believe a low intention to use alternative / complementary medicine stems 
from: (please indicate) 
0 Lack of knowledge about indications of alternative therapies 
0 Prejudice 
0 Less patient feedback on alternative treatments 
Cl Availability on the NHS (British GPs only) 
0 lAck of scientific evidence of efficacy and safety 
10. Do you believe alternative therapies have a place in (please indicate): 
t3 common colds 0 depression 13 asthma 13 headache 
0 stress 13 stroke 13 HIV / AIDS 0 cancer care 
0 ME (post-viral fatigue syndrome) 0 digestive disorders (e. g. IBS) 
(3 not at all applicable 
11. Which complementary therapies and medicine do you feel should be available in the 
NHS? 
................................................................................................ 12. In the last decade the POPUIIdtY Of &Iternative / complementary medicine and 
therapies has grown across Europe and in the UK. Why do you think this might be? 
............................................................................................................ 13. Do you have any other comments? 
Cross-cultural differences In GPs'attitudes 
REFERENCES 
1. Ernst E. Complementary medicine, doing more good 
than harm? Br I Gen Pract 1996; 2: 60-61. 
2. Astin JA, Marie A, Pelletier KR, Hansen E, Haskell WL 
A review of the incorporation of complementary and 
alternative medicine by mainstream physicians. Arch 
Intem Med 1998; 158: 2303-2310. 
3. Thomas IC, Fall M, Nicholl 1, Williams B. 
Methodological study to investigate the feasibility of 
conducting population-based survey of the use of 
complementary health care. Unpublished report 
submitted to the Research Council for Complementary 
Medicine 1993 , 4. Adams 1. With compliments. Health Service J 1995 
June. 
5. Coulson L BMA News Revisited 1995 July. 
6. Ernst E. Wien Med Wschr 1997; 18: 423-425. 
7. Wagner HJ. Besondere Therapieeinrichtungen in der 
Onkologic und bei banalen Erkrankungen: 21. 
Interdisziplingres Forum der Bundes&-ztekammer 
"Fortschritt und Fortbildung in der Medizin" vorn 27. his 
30. November 1996. Deutsches Arzteblatt 1997; 94: 
A988-A990. 
8. Fisher P, Ward A. Complementary medicine in Europe. 
BMJ 1994; 309: 107-111. 
147 
9. Visser G1, Peters L. Alternative medicine and general 
practitioners in The Netherlands: towards acceptance and 
integration. Fam Pract 1990; 7: 227-232. 
10. Pettigrew A. "Complementogenic" disease may be 
increasing. BMJ 2000; 320: 1341. 
11. Perry 11, Dowrick CF. Complementary medicine and the 
general practice: an urban perspective. Complement 
Ther Med 2000; 8: 71-75. 
12. Himmel W, Schulte M, Kochen MM. Complementary 
medicine: are patients' expectations being met by their 
general practitioners? Br J Gen Pract 1993; 43: 
232-235. 
13. Perkin MR, Pearcy RM, Fraser JS. A comparison of the 
attitudes shown by general practitioners, hospital doctors 
and medical students towards alternative medicine. JR 
Soc Med 1994; 87: 523-525. 
14. Wharton R, Lewith 0. Complementary medicine and the 
general practitioner. BMJ 1986; 292: 1498-1500. 
15. Reilly D. Young doctors' view on alternative medicine. 
BMJ 1983; 278: 337-339. 
16. White AR, Resch KL, Ernst E. Complementary 
medicine: use and attitudes among GPs. Farn Pract 
1997; 14: 302-306. 
17. Easthope G, Tranter B, Gill G. General practitioners' 
attitudes toward complementary therapies. Soc Sci Med 
2000; 51: 1555-1561. 
Research Report 
Multischool, International Survey of Medical 
Students' Attitudes toward "Holism" 
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Abstract 
Purpose 
Core and optional courses of study in 
complementary and alternative medicine 
(CAM) are being incorporated into 
medical curricula. The authors carried out 
this study to validate a tool to examine 
students' attitudes toward holism and 
CAM and explore the relationships 
between their attitudes and other 
demographic and education-related 
characteristics in a large, multischool, 
international sample of medical students. 
Method 
In 2003 the authors used a modified 
version of the Integrated Medicine 
Attitude Questionnaire (IMAQ) to survey 
students at a total of six medical schools 
in the United Kingdom, New Zealand, 
Canada, the United States, and Hong 
Kong, China. A three-factor model was 
tested using confirmatory factor analysis, 
and the internal consistency of the 
factors were identified using Cronbach's 
alpha coefficients. A multiple-indicator 
multiple-cause (MIMIC) analysis was 
carried out to determine the relationship 
between IMAQ factors and student 
characteristics. 
Results 
The authors validated a three-factor 
model for the IMAQ: (1) attitudes toward 
holism, (2) attitudes toward the 
effectiveness of CAM, and (3) attitudes 
toward introspection and the doctor- 
patient relationship. Cronbach's a 
coefficients ranged from . 41 to .71. The 
The 
reported prevalence of 
complementary and alternative medicine 
(CAM) use by the general public has 
gradually increased over the last two 
decades. 1-2 The United Kingdom's House 
of Lords Sixth Report on Science and 
Technology3 assigned particular priority 
to CAM research. Over a similar period 
there has been evidence of some 
cooperation between CAM and orthodox 
medicine as well as the slow introduction 
of CAM teaching and learning into health 
professions education in the United 
Kingdom, Canada, and the United 
StateS. 4-6 Regarding the latter change, the 
drive has arisen from a combination of 
interested acadernics, the change noted in 
the publies use of CAM, and the input of 
responsible bodies, such as the ministries 
and the departments of education. We 
carried out the study described in the 
Please see the end of this report 
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present report to validate a tool that 
explores students' attitudes toward CAM 
and holism and to exarnine the relationship 
between students' attitudes toward CAM 
and other student characteristics. 
Background 
Globally, accreditation bodies for 
undergraduate medical education have 
begun to provide recommendations 
regarding the incorporation of learning 
about the history, efficacy, and safety of 
CAM into medical school curricula. The 
United Kingdom General Medical 
Council states that graduates should have 
an awareness of the range of CAM 
therapies available to patients and their 
effectivenesS. 7 In Canada, there has been 
a multiphased education initiative, 
funded by Health Canada in 200 1, aimed 
at increasing the CAM knowledge of 
medical students. Over the past five years, 
several Canadian medical schools have 
taken steps to introduce CAM into the 
existing medical school curricula. $ in 
2000, the Australian Medical Council 
reported on a working party charged with 
the responsibility of developing standards 
MIMIC model indicated that various 
background variables were associated with 
IMAQ factors (gender, racetethnicity, and 
school), depending on whether students 
had previously visited a CAM practitioner 
and whether students were willing to 
undertake a special study module in 
CAM. 
Conclusions 
Further development work on the IMAQ 
is required and qualitative research to 
verify and examine the reasons behind 
the relationships found in this study 
between students' attitudes to holism 
and their demographic and education- 
related characteristics. 
Acad Med. 2005; 80: 955-963. 
for CAM education within curricula in 
Australia and New Zealand. 9 Medical 
schools in the United States are 
responding with a small but growing 
number of courses addressing CAM. 10 In 
Hong Kong, China, both of the city's 
medical schools have recognized the 
relevance of CAM in current and future 
clinical practice and have introduced 
some core and optional courses. " This 
curriculum change has recently been 
positively acknowledged by the Hong 
Kong Medical Council during their 
review visit. ' I However, although many 
medical educators agree that CAM can 
no longer be absent from their curricula, 
there is still an ongoing debate about how 
to include CAM. 
Previous studies about students' 
attitudes toward CAM 
Using electronic databases such as 
PubMed, EMBASE, Cinahl, and AMED, 
and using hand searches and personal 
files, we identified 13 studies that have 
assessed medical students' attitudes with 
sample sizes greater than 100.12-24 The 
surveys were carried out during the past 
Academiý Medicine, V01- 80, No. 10 / October 2005 955 
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decade: four in the United Kingdom, 12-15 
three in Germany, 16-18 tWoin the United 
StateS, 19,20 two in Israel, 21,22and one each 
in Australia 23and Hong Kong, China . 24 
Of these, nine were single-site studies, 
and all surveys employed their own 
instrument, which was constructed by 
each research group. These instruments 
were not validated, nor was their 
reliability tested. 
The key results from the United 
Kingdom surveys show that medical 
students' attitudes were generally 
positive, that there were no significant 
differences in their attitudes toward any 
individual CAM therapies in particular, 
that 37.3% had used CAM before, 12and 
that students displayed a greater level of 
knowledge of acupuncture and hypnosis 
compared than of other CAM 
modalities. 13Surveys showed that CAM 
experience was most common for 
aromatherapy, homeopathy, and 
chiropractic therapy. 141n Germany, 
medical students expressed a high interest 
in learning about acupuncture, 
homeopathy, massage, reflexology, and 
autogenic training. 16,17The U. S. surveys 
revealed that estimated CAM use among 
medical students was between 40% and 
74%, 19 and the most popular modalities 
were massage and relaxation 
techniqueS. 20 In Israel, there were high 
levels of interest amongst students in 
hypnosis, relaxation, meditation, 
acupuncture, and biofeedback. 21 Fifty- 
four percent of Israeli students surveyed 
in another study had prior theoretical 
knowledge of CAM through personal 
reading or had practical experience 
through treatments or courses. 22 
Most surveys showed a positive 
correlation between previous CAM use 
and a more positive attitude toward 
CAM. Younger medical students in the 
United Kingdom displayed a more 
positive attitude toward CAM and CAM 
teaching than did older students, 12 and 
several studies demonstrated that women 
had more positive attitudes toward 
C". 12,20,22Another survey also found 
that students from two medical schools in 
the United Kingdom displayed different 
levels of specific attitudes toward CAM 
when surveyed concurrently-'s 
Shortcomings of previous studies 
Although all of the studies discussed 
above have provided some understanding 
of medical students' attitudes toward 
CAM, they are not without their 
methodological problems. Nine of the 
studies report attitudes in single 
populations and schools, at different 
times, and with tools that had not been 
used before. There are no data to support 
the item reliability and validity of 
those tools. None of the studies have 
comprehensively examined the 
relationships between students' attitudes 
toward CAM and other correlates such as 
age, gender, and race/ethnicity, whereas 
general-population surveys in the United 
Kingdom and North America have found 
significant relationships between attitudes 
toward CAM and these characteristics, plus 
social status and health status. L15,25,2C27 
These North American and United 
Kingdom surveys have shown that CAM 
users are more likely to be younger, female, 
better educated, wealthier, and of poorer 
health status. 
In an effort to address the problems 
surrounding the measurement tools, 
Schneider et al. 28 developed and validated 
their 29-itern Integrated Medicine 
Attitude Questionnaire (IMAQ) to 
explore holistic attitudes in U. S. health 
care providers and medical students. The 
tool's items were established from focus 
groups with 196 faculty, fellows, visiting 
residents, and medical students at the 
University of Arizona Program in 
Integrative Medicine. 
Using exploratory factor analysis (EFA, 
principal components analysis with 
varimax rotation), Schneider et al. 28 
reported a two-factor structure for the 
IMAQ: openness to new ideas and 
paradigms (21 items) and value of both 
introspection and relationship to patient 
(eight items). They reported a 
Cronbach's a of . 89 
(n = 196) for the 
entire tool rather than for the two factors 
alone. Furthermore, Lie and Boker20 
examined the reliability of the 29-itern 
IMAQ with 272 U. S. medical students 
and also found it to have satisfactory 
internal consistency (Cronbach a =. 83). 
However, there are two key problems 
with the original validation study. first, 
they assumed, by using orthogonal 
rotation, that the factors were not 
correlated to each other (which we think 
is erroneous), and, second, the two 
factors explained only 38% of the 
variance in the responses, which we think 
is unacceptably low. 
Method 
Using a large, cross-sectional sample of 
medical students across institutions and 
countries, we carried out the current 
study in 2003 to address some of the 
methodological and size weaknesses of 
previous studies. Our research aims were to 
" validate a three-factor structure of the 
IMAQ, 
" determine the internal consistency of 
the IMAQ factors, and 
" examine the relationship between 
students' attitudes toward holism and 
CAM, as measured by the IMAQ, and 
other demographic characteristics of 
the students, such as age, gender, race/ 
ethnicity, school, and willingness to 
study CAM. 
Sampling and recruitment 
A total of 1,154 first-year medical 
students at six medical schools in five 
countries were asked to participate in a 
multischool anonymous survey. 131 from 
the medical program of the Faculty of 
Medical and Health Sciences, University 
of Auckland, Auckland, New Zealand; 
360 from Birmingham Medical School, 
United Kingdom; 130 from Peninsula 
Medical School, United Kingdom; 150 
from Hong Kong Medical School, Hong 
Kong, China; 199 from University of 
Toronto Medical School, Canada; 
and 184 from Georgetown University 
School of Medicine, United States. The 
questionnaire was designed to measure 
their attitudes toward the concept of 
"holism" in medicine, using a modified 
IMAQ. These schools were chosen for 
both theoretical and pragmatic reasons. 
Not only did the schools represent 
geographical and cultural diversity, but 
good relationships existed among the 
researchers, thus aiding the successful 
conduction of such a large and 
international study. All first-year students 
(second-year students in New Zealand *) 
at these medical schools were invited to 
participate by face-to-face invitation. In 
each case a researcher described the 
purpose and procedures of the study 
before or after a scheduled teaching 
session, and students were able to read 
the information sheet, sign the consent 
forms, and fill in their questionnaires in 
*Auckland has an 'overlapping* year 1, where all 
health sciences programs are taught a common 
foundation. Year 2 is the start of the separate 
medical program, we thought that year 2 equated 
better to year I at the other study institutions. 
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their spare time. The study instrument 
was anonymous and was kept separate 
from the consent forms. 
Instrument 
As the original questionnaire was 
developed for a U. S. setting, the 29-item 
IMAQ developed by Schneider et al. 28 
was piloted with a small sample of 
medical students from Auckland (n = 7) 
and Birmingham (n = 25). During the 
pilot we determined how comprehensive 
the tool was, considering that different 
terminology for certain concepts is 
sometimes used around the world. 
During the pilot study, it became 
apparent that some of the questions were 
ambiguous, double-barrelled, or 
repetitive. Therefore, a number of small 
changes to wording were made, and item 
26 ("Osteopathic manipulative therapy is 
a valuable method for resolving a wide 
variety of musculoskeletal problems") 
was deleted because it was perceived 
to be virtually the same as item 16 
("Chiropractic is a valuable method 
for resolving a wide variety of 
musculoskeletal problems"). Thus, our 
modified IMAQ version included 28 
instead of 29 items. Each item was 
accompanied by a seven-point Likert 
scale, ranging from I (strongly disagree) 
to 7 (strongly agree). A "don't know" 
option was also provided. Thirteen of the 
items were rewritten as negatively worded 
questions (items 1,2,4,6,7,8,10,11,13, 
17,18,25, and 27) to control for response 
bias. Additionally, demographic data 
were collected on age, gender, 
race/ethnicitY, school, previous 
CAM 
exposure, and willingness to study 
CAM. 
we also included a glossary of terms at 
the end of the tool to make sure students 
understood the meaning of each term. 
Data analysis 
validity and reliability of the Integrated 
Medical Attitude Questionnaire. 
Confirmatory factor analysis (CIA) was 
used to investigate the construct validity 
of the IMAQ and to determine whether 
the two factors reported by Schneider et 
al.,, -openness to new 
ideas and 
paradigms (factor 1) and value of 
both 
introspection and relationship topatient 
(factor 2)-provided a sufficient account 
of the data in the North 
American 
medical student population 
(n = 265). 
We also used CIA to 
develop and test an 
alternative model, which 
included three 
factors: attitudes toward holism 
(factor 
1), attitudes toward the effectiveness of 
CAM treatments (factor 2), and attitudes 
toward introspection and the doctor- 
patient relationship (factor 3). This 
model was initially tested and refined 
using data from the sample of North 
American medical students mentioned 
above. Data from the sample of United 
Kingdom medical students (n = 236) 
were then used to cross-validate the 
revised model. The use of CIA was 
appropriate in this context because 
Schneider et al . 28 
had previously reported 
the factor structure of the IMAQ. In the 
two-factor structure for the IMAQ 
reported by Schneider et al., items 1-13, 
16-19, and 25-27 loaded on factor 1, and 
items 14,15,20-24, and 28 loaded on 
factor 2. This two-factor CIA model 
was encoded into MPlus software 
Version 2.14 by defining the items 
that contributed to each factor and 
instructing the program to allow 
correlations between the factors . 29 The fit 
of the model to the data was explored 
using the chi-squared test of model fit, 
the comparative fit index (CFI), the root 
mean square error of approximation 
(RMSEA), and the standardised root 
mean square residual (SRMR). Models 
with nonsignificant chi-square values, 
with CF1s of more than 0.95, RMSEA 
values of less than 0.06, and SRMR values 
of less than 0.08 are generally considered 
to have good fit. However, the chi-square 
test is highly sensitive, and the value is 
often significant even when the fit is 
considered to be unacceptable by other fit 
indices. All the analyses were carried out 
using maximum likelihood estimation 
with the Satorra-Bentler correction to 
allow for departures from multivariate 
normality. This methodology has been 
used successfully in this way in previous 
medical education research. 30 
We hypothesized our own three-factor 
model because we had two major 
concerns about the two-factor structure, 
as mentioned previously. Schneider et 
al. 29 found that while 21 items loaded on 
their first factor, only eight items loaded 
on their second factor. We thought that 
some of the items loading on the first 
factor were conceptually different from 
one another and could be thematically 
separated into two related but different 
aspects of openness to new ideas and 
paradigms: the first is attitudes toward 
holism (our factor 1, which encompasses 
items 1,2,5,6,7,9,11,17 and 19); the 
second is attitudes toward the effectiveness 
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of integrated medicine treatments (our 
factor 2, which encompasses items 3,4,8, 
10,12,13,16,18,25,26 and 27). We 
maintained that all of the items loading 
on their factor 2 (value of both 
introspection and relationship to patient), 
with the exception of items 15 and 24, 
did hang together well conceptually. 
Therefore, with the exception of items 15 
("In research, measuring the quality of 
life is equally important as measuring 
disease-specific outcomes") and 24 
("Counselling on nutrition should be a 
major role of the doctor toward the 
prevention of chronic disease"), we kept 
those eight items in our model but 
renamed Schneider et al. 's factor 2 as our 
factor 3, which encompassed items 14, 
20,21,22,23, and 28. We thought that 
items 15 and 24 should load on our factor 
I (i. e., attitudes toward holism) so we 
added these to that factor (see Table 1). 
This three-factor CFA model was 
encoded into MPlus software by defining 
the items that contributed to each factor 
and instructing the program to allow 
correlations between the factors. Using 
the North American data first (n = 265), 
a number of changes were made to the 
model, in response to the factor loadings, 
the standardised path coefficient data, 
and the model modification indices until 
a solution with reasonable fit to the data 
was achieved. The fit of the model to the 
North American data was explored again 
using the chi-squared test of model fit, 
the CFI, RMSEA, and the SRMR. Once 
the fit had been established with the 
North American data, the fit of our 
model was then cross-validated using the 
United Kingdom data (n = 236). 
The internal consistency of the factors 
identified through the above process was 
determined for the North American and 
United Kingdom samples separately 
using Cronbach's ci coefficients on SPSS 
version II (SPSS Inc., Chicago, Illinois). 
How students' characteristics 
influenced their ranking on the IMAQ 
factors. A multiple- indicator multiple- 
cause (MIMIC) model was developed 
from the CFA using the complete data set 
from all schools. Of the 639 completed 
questionnaires, 35 questionnaires showed 
missing data, therefore the analysis was 
carried out for 604 complete responses. 
The MIMIC model was incorporating the 
extent to which background variables 
about the students (i. e., age, gender, race/ 
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Table 1 
Factors and Associated Items for the Revised Integrated Medicine Attitude 
Questionnaire Used In This Study * 
I 
I (attitudes toward 
holism) 
1 
2* 
5 
6* 
7 
9 
15t 
W* 
19 
A patient is completely cured once the underlying pathological processes are controlled. 
The doctor's role should be primarily to promote health rather than to treat disease. 
It is appropriate for doctors to use intuition (gut feelings) as a major factor in determining appropriate 
therapies for patients. 
The spiritual beliefs of doctors play an important role in patient care. 
The spiritual beliefs of patients play an important role in their recovery. 
End-of-life care should be valued as an opportunity for doctors to help patients heal. 
Healing, in a sense of reaching a state of contentment, is not possible when the disease is incurable. 
In research, measuring quality of life is equally as important as measuring disease-specific outcomes. 
The doctor's goal should be primarily to treat disease, not to address the personal change and growth of the 
patient. 
The innate self-healing capacity of patients often determines the outcome of illness regardless of treatment 
interventions. 
24t Counselling on nutrition should be a major role of the doctor toward the prevention of chronic disease. 
2 (attitudes toward 3 Patients whose doctors know about complementary and alternative medicine, in addition to conventional 
the effectiveness of medicine, benefit more than those whose doctors are only familiar with conventional medicine. 
IM treatments) 4 Doctors should advise against the use of well-established traditional herbs (botanical medicine) until the herbs have undergone rigorous testing such as is required for any pharmaceutical drug. 
8 Acupuncture has been found to be effective for chemotherapy-related nausea and vomiting. The system relies 
on unknown mechanisms (meridians). It is irresponsible for doctors to recommend acupuncture for conditions 
such as chemotherapy-related nausea and vomiting. 
10* It is not desirable for a doctor to take therapeutic advantage of the placebo effect. 
12 Doctors who know about complementary and alternative practices (e. g. Traditional Chinese Medicine) in 
addition to conventional medicine, generate improved patient satisfaction. 
13 Therapeutic touch is not credible as a form of treatment. 
16 Chiropractic or osteopathy is a valuable method for resolving a wide variety of musculoskeletal problems. 
18 Massage therapy may make patients 'feel better' temporarily, but cannot lead to objective improvement In 
long-term outcomes for patients. 
25 Doctors should avoid recommending herbs (botanicals) based on observation of long-term use in other 
cultures and systems of healing, because such evidence is not based on large randomized controlled trials. 
26 Information obtained by research methods other than randomized controlled trials has little value to doctors. 
27 It is ethical for doctors to recommend therapies to patients that involve the use of subtle energy fields in and 
around the body for medical purposes. 
3 (attitudes toward 
introspection and 
the doctor-patient 
relationship) 
14 Doctors who lead a balance lifestyle (i. e., attending to their own health, social, family and spiritual needs, as 
well as interests beyond medicine) generate improved patient satisfaction 
20 A strong relationship between patients and their doctors is an extremely valuable therapeutic intervention that 
leads to improved outcomes. 
21 Doctors who strive to come to terms with themselves generate improved patient satisfaction. 
22 Instilling hope in patients whenever reasonable is a doctor's duty. 
23* Doctors should be prepared to answer patients' questions regarding the safety, efficacy, and proper usage of 
commonly used herbs (botanicals). 
28 Doctors who strive to come to terms with themselves provide better care than those who do not. 
*These items did not load significantly on the expected factors and were removed from the model. 
f These items loaded significantly on factor 1 and 2, so they were removed from the model. 
This item was removed from factor 3 and added to factor I because it made more theoretical sense to do that. 
ethnicity, and geographical 
location of 
school) predicted students' rankings on 
the IMAQ factors. The model was also 
extended to explore the way 
in which 
attitudes to integrated medicine affected 
whether or not students themselves 
had 
visited a CAM practitioner and students' 
willingness to undertake a special study 
module in CAM. This was 
done by 
treating these two binary variables as 
additional indicators, which were 
initially 
allowed to load on all the 
factors. MIMIC 
modelling allows the effect of each 
background and indicator variable to be 
explored, while controlling the other 
background variables. it also estimates 
the correlations between 
factors, with any 
effects of the background variables 
removed. Paths that did not display 
significant influences were deleted in 
order to achieve the most parsimonious 
model. Again, this methodology has been 
used previously in this way. 30 
Results 
Participants' characteristics 
From the 1,154 medical students who 
were invited to participate, 639 students 
completed the questionnaire, giving a 
response rate of 55.4%. Of those, 144 
(23%) of the responses were received 
from the Georgetown University School 
of Medicine, 142 (22%) from 
Birmingham, 125 (19%) from Toronto, 
110 0 7%) from Auckland, 94 (14%) 
from the Peninsula Medical School in 
Exeter and Plymouth, and 33 (5%) from 
Hong Kong. (As stated earlier, 35 of the 
questionnaires had missing data, and 
therefore the analysis was carried out 
using only the remaining 604 satisfactory 
questionnaires. ) From the responders 
who provided demographic data, 485 
(80.4%) were born in Europe, North 
America, or Australasia; 98 (16.3%) in 
Asia; and 20 (3.3%) in Africa. A total of 
345 (57.1%) of the students were white, 
235 (38.9%) were Asian, and 24 (3.9%) 
were black. Students' ages ranged from 18 
to 57 years (median = 22, interquartile 
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range = 19 -23). Over half of the 
responders (343; 56.8%) were women, 
over a third (245; 40.6%) had previously 
used CAM, and 136 (22.5%) reported 
that they had previously visited a CAM 
practitioner. More than two-thirds of the 
responding students (463; 72%) 
expressed their willingness to participate 
in a special study module on CAM. 
Construct validity and reliability of the 
IMAQ 
The first iteration of our CIA model was 
based on the North American sample 
(n = 265), and tested the two-factor 
structure of Schneider et al. 25 The output 
indicated that the fit of this model to the 
data was unsatisfactory (X2= 786.442, 
df = 349, p< . 00 1, CH 
0.677, 
RMSEA = 0.069, SRMR 0.081). These 
poor fit indices reinforced our a priori 
concerns about Schneider et al. 's original 
study. 
The first series of analyses testing our 
three-factor model were also conducted 
on the sample from North America noted 
above. The first iteration of our model 
(X2= 733.9, df 347, p< . 00 1, CH = 
0.715, RMSEA 0.065, SRMR = 0.075) 
demonstrated that most items loaded 
significantly on their expected factors, 
with the exceptions of items 2 and 6 
(factor 1), item lo (factor 2), and item 23 
(factor 3). In addition, item 17 was found 
to load significantly on factor I and 
factor 2. Furthermore, the values of the 
fit indices showed that the fit of our 
model was not satisfactory. The model 
modification indices suggested that the fit 
of our model, without items 2,6,10,17 
and 23 (X2= 478.02, df = 227, p< . 00 1, 
CH = 0.790, RMSEA = 0.065, SRMR = 
0.071), could be improved if the residuals 
of some pairs of items were allowed to 
correlate. The relevant pairs of items were 
items 3 and 12,4 and 25,7 and 9,20 and 
22, and 25 and 26. These correlated 
residuals are indicative of shared 
influences on the two items in question 
over and above any factor that loads on 
them both. Typically, these shared 
influences derive from the two items 
being conceptually similar. The 
correlated residuals were considered 
appropriate, given the content of the 
relevant iterns. The final version of our 
model, incorporating these changes, 
produced a moderate fit of the model to 
the North American data (x' = 340.005, 
df = 222, p< . 00 1, 
CH 0.887, 
RMSFA = 0.045, SRMR 0.063). 
The RMSEA and SRMR values indicate a 
good fit, but the CFI is less satisfactory 
and the significant chi-square value 
indicates some disparity between the data 
and the model. The CH measures fit 
relative to a null model, which assumes 
that all the manifest variables are 
independent. It thus tends to be lower 
when applied to scales where correlations 
between the items are less than typical. 
This is the case with the IMAQ. 
We then cross-validated our model 
derived from the North American data 
using data from the United Kingdom 
sample (n = 236) and found the 
following fit indices for our model: X' 
285.99, df = 222, p= . 002, CH = 0.894, RMSEA = 0.035, SRMR = 0.065). 
Unusually, and reassuringly, there was no 
deterioration in fit on cross-validation. 
Although the model is not perfect, it was 
considered a satisfactory working 
approximation on which to base the 
remaining analyses. 
The internal consistency of the factors for 
the North America data was . 5584 (factor 1), . 6597 (factor 2), and . 7087 (factor 3). For the United Kingdom data, it was 
. 4103 (factor 1), . 6568 (factor 2), and 
. 6683 (factor 3). 
How students' characteristics 
influenced their ranking on the IMAQ 
factors 
The MIMIC model was based on the 
complete data set (n = 604) and on the 
three-factor CFA model outlined 
previously. The influence of background 
variables (i. e., age, gender, race/ethnicity, 
and geographical location of school) and 
indicator variables (i. e., whether students 
had previously visited a CAM 
practitioner and students' willingness to 
undertake a special study module in 
CAM) on the IMAQ factors were 
considered. The final model (X' = 
960.892, df = 422, p< . 00 1, CH = 
0.810, RMSEA = 0.046, SRMR = 0.054) 
indicated that the background variables 
gender, racelethnicity, and school were 
significantly associated with factor I 
(attitudes toward holism). Specifically, 
female students, white students, and 
students from North American and New 
Zealand medical schools had more 
positive attitudes toward holism than did 
maIe students, black students, Asian 
students, and students from Hong Kong 
and United Kingdom medical schools. 
Factor 2 (attitudes toward the effectiveness 
of integrated medicine treatments) was 
significantly predicted by the background 
variable gender and was reflected in both 
indicator variables (i. e., whether students 
had previously visited a CAM 
practitioner and students' willingness to 
undertake a special study module in 
CAM). Female students had more 
positive attitudes toward the effectiveness 
of CAM treatments than male students 
did. Individuals with more positive 
attitudes toward the effectiveness of CAM 
were more likely to have previously 
visited a CAM practitioner and to be 
willing to undertake a special study 
module in CAM. 
Factor 3 (attitudes toward introspection 
and the doctor-patient relationship) was 
significantly associated with the 
background variable school (see Figure 1). 
Specifically, those from New Zealand and 
North American medical schools were 
more likely to have positive attitudes 
toward introspection and the doctor- 
patient relationship than were students 
from Hong Kong and United Kingdom 
medical schools. 
In addition, although the background 
variable age was not associated with any 
of the IMAQ factors, it did have a 
statistically significant direct relationship 
with one of the indicator variables (i. e., 
whether students had previously visited a 
CAM practitioner), with older students 
being more likely to have visited a CAM 
practitioner than younger students. 
Furthermore, in addition to the 
background variable school being 
associated with factors I and 3 of the 
IMAQ, it also had statistically significant 
direct relationships with both indicator 
variables (i. e., whether students had 
previously visited a CAM practitioner 
and students' willingness to undertake a 
special study module in CAM) and item 7 
of the IMAQ (i. e., "The spiritual beliefs of 
patients play an important role in their 
recovery"). More specifically, students 
from medical schools in the United 
Kingdom, Hong Kong, and New Zealand 
were more likely to believe that spiritual 
beliefs did play an important role in 
recovery than did students from North 
American schools (and in particular 
students from the Canadian school). 
Students from the New Zealand and 
Asian medical schools were more likely to 
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have previously visited a CAM 
practitioner than were students from the 
United Kingdom and North American 
medical schools, and students from 
United Kingdom medical schools were 
less likely to be willing to undertake a 
special study module in CAM than were 
students from any of the other schools. 
Discussion 
Validity and reliability of the IMAQ 
When we tested Schneider's two-factor 
structure for the IMAQ, the fit of this 
model to our data was unsatisfactory. 
This is probably because Schneider et al. 
and we used different methods of analysis 
in our studies. In this study, we were able 
to validate the three-factor model and 
establish the internal consistency of the 
IMAQ factors with two large samples of 
medical students, one from North 
America (n = 265) and the second from 
the United Kingdom (n = 236). This is 
how we identified our three factors. 
Although the RMSEA and SRMR fit 
indices for this model with both sets of 
data indicated a good fit, our CFI indices 
were less satisfactory, showing that there 
was some disparity between the two sets 
of data and the model. However, there 
was no deterioration in fit on cross- 
validation with the United Kingdom 
sample, so we considered the model to be 
a satisfactory approximation on which to 
base further analyses. 
The internal consistencies of the three 
factors were determined for the North 
American and United Kingdom samples 
separately and ranged from a =. 4,103 
(factor 1, United Kingdom) to ct =. 7,087 
(factor 3, North America). Only one of 
the six Cronbach's a coefficients found 
met the minimum threshold of. 7 
suggested by Bland and Altman (see 
Table 2). 3 1 These reliability coefficients 
are substantially lower than those 
reported by Schneider et al. (a = . 89) 
and Lie and Boker (a = . 83). 
20 These 
differences probably result from the 
dissimilar number of items used to 
determine internal consistency. For 
example, internal consistency 
declines 
with a decrease in the number of 
items 
on a factor . 3-4 Both 
Schneider et al. 28 
and Lie and Boker 20 examined the 
reliability of the entire 29-itern tool, 
whereas we looked at the refiabilities of 
each factor separately (with eight, ten, 
Figure I The relationship of the factors of the revised Integrated Medical Attitude Questionnaire 
to background and indicator variables from this study. A three-factor model was tested using 
confirmatory factor analysis. 
*The background variables school and racelethnicity were incorporated in the model through 
dummy coding. The individual dummy variables are not shown in the figure, to maintain clarity. 
The standardized path coefficients shown for school and racelethnicity are the square root of the 
proportion of variance explained by the relevant set of dummy variables when taken together. 
'See Table 2 for the standardized coefficients for paths to indicator variables. 
*The correlated residuals were . 087 for item 7 with item 9; . 254 for item 3 with item 12; . 226 for item 4 with item 25; . 192 for item 25 with item 26, and . 109 for item 20 with item 22. 
and five items, respectively). These 
smaller numbers of items could account 
for the low reliabilities found, for 
example, for factor I (with eight items) 
compared with factor 2 (with ten items). 
Second, internal consistency declines 
with an increase in sample size, 32-34 and 
as already stated, our sample sizes were 
much larger than the sample size (i. e., 
100) considered adequate for reliability 
analyses. 35 
Relationship between attitudes toward 
holism and other student characteristics 
We developed a MIMIC model from the 
CFA using the complete data set (also 
including data from New Zealand and 
Hong Kong, n= 604). This incorporated 
the extent to which background variables 
such as gender predicted students' 
ranking on the three IMAQ factors and 
also the association between students' 
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Table 2 
Coefficients for Paths to Indicator 
Variables for the Three Factors 
Identified in This Study 
1 -. 314 
..................... ............... .......................... .- 5 . 093 
............... 7 . 409 
....................... ............ .......... ................ 9 . 508 4ý8 
J06 
416 
2 Sýo 
..... ......... -. - 4 
. 404 
28 -384 
2 12 K6 
. 
42 1 
2 
2 -472 
2 '-. j04 
M9 
A3 
IMAQ means Integrated Medicine Attitude 
Questionnaire. 
wtitudes and indicator variables such as 
Uillingness to undertake a special study 
1-nodule in CAM. 
heterodox systems, rebelling against 
therapies traditionally associated with 
their cultures and heritages and instead 
actively embracing Western medicine. 
For example, in discussing Hong Kong 
pharmacy students' attitudes toward 
CAM, Hon et al . 24 stated that despite 
Western and Chinese medicines being 
widely used by the public in Hong Kong, 
the students' pharmacy curricula mainly 
focused on Western (conventional) 
medicine. 
Although student age was not associated 
with any of the IMAQ factors, it did have 
a direct relationship with whether 
students had previously visited a CAM 
practitioner or not. Older students were 
more likely to have visited a practitioner 
than were their younger peers. This 
relationship may not be because older 
students had more positive attitudes 
toward CAM but was probably because 
they had had more time to choose CAM 
for health-related problems. The same 
relationship of age and frequency of visits 
to CAM practitioners has been found in 
studies using general population S. 36,37 
This finding differs from those in 
previous literature regarding medical 
students, which has suggested that 
younger students had more positive 
attitudes toward CAM than older 
students. 12,15 However, these finding may 
not be related to age per se but the stage 
of the medical school curriculum, as 
many studies have found medical 
students' attitudes becoming increasingly 
negative and cynical as the students 
progress through medical school. Im 
modules in CAM than were students 
from other schools. Furnham and 
McGill" found statistically significant 
differences between students' attitudes 
toward CAM at a London medical school 
and a Newcastle medical school in the 
United Kingdom. Those authors failed to 
make any suggestions for this finding, but 
we assume that that these differences 
could be influenced by the different 
curricula. 
The curricula of the United Kingdom and 
North American schools may indeed 
have been influences of this type. In the 
United Kingdom, the Peninsula Medical 
School has a problem-based learning 
curriculum and has a strong 
professionalism and humanism 
longitudinal theme, which permeates the 
entire five-year curriculum. Due to the 
perceived focus on the humanistic aspects 
of medicine at this school, students 
sometimes worry that they are not 
covering the biomedical sciences 
adequately and are therefore more 
inclined toward special study modules in 
biomedical sciences rather than holistic 
ones. Although Birmingham has a 
different curriculum, a similar picture 
emerges there, with students probably 
wanting to focus more on the biomedical 
aspects of medicine than those aspects 
focusing on holistic medicine such as 
behavioral sciences and professional 
development. In Auckland, a stronger 
professional development strand has 
been in place since 2001, and humanities 
options are available to balance the core 
biomedical science courses. 
We found various statistically significant 
relationships between students' attitudes 
toward holism (as measured by the three 
factors) and various background and 
indicator variables. For example, gender 
lpredicted ranking on factors I and 2, 
Itneaning that female students had more 
lpositive attitudes toward holism and the 
1ýffectiveness of CAM treatments. This 
result supports previous findings that 
there was higher interest in and higher 
Use of CAM by women. 12,14,20.22 
, Pacelethnicity predicted ranking on 
factor 
1; white students had a more positive 
ý4ttitude toward holism compared to 
Uack and Asian students. This is initially 
1ýýounterintuitive given traditional views 
'ý)f medicine in Asian culture. However, 
Uack 
and Asian students choosing 
k-nedicine as a career are likely to have a 
triore positive view of orthodox than of 
School predicted ranking on factors I and 
3; students from New Zealand and North 
America had more positive attitudes 
toward holism and introspection and the 
doctor - patient relationship compared 
to students from Hong Kong and the 
United Kingdom. Significant and direct 
relationships also existed between school 
and both indicator variables (i. e., whether 
students had previously visited a CAM 
practitioner, and their willingness to 
undertake a special study module in 
CAM). Students from New Zealand and 
Hong Kong were more likely to have 
previously visited a CAM practitioner. It 
is difficult to explain this finding without 
knowing more about the local settings at 
all sites regarding CAM access and 
referral. Students from the United 
Kingdom medical schools were less 
willing to undertake special study 
In the United States, Georgetown 
University Medical School has 
incorporated CAM-related topics in the 
medical school curriculum for the past 
four years. The first-year students who 
participated in this particular study were 
exposed to lectures on acupuncture, 
massage, and musculoskeletal 
manipulation within their gross anatomy 
course during the time period that we 
collected our study data. In addition to 
lectures in other core courses, all first- 
year medical students are offered the 
opportunity to participate in a mind- 
body medicine lecture and experiential 
course on a self-selection basis. Fifty 
students (about one-third of the class) 
participate in this activity every year. The 
early exposure of the Georgetown 
University students during their first 
semester in school to CAM-related topics 
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might explain the school-related 
differences observed in the study. In 
contrast, the University of Toronto 
medical school has a reputation for 
having a very rigorous science-based 
curriculum, despite attempts to increase 
the humanistic aspects of medicine and a 
growing focus on teaching "patient- 
centered" medicine. 
Factor 2 (attitudes toward the effectiveness 
of CAM had direct relationships with 
both indicator variables (i. e., whether 
students had previously visited a CAM 
practitioner and their willingness to 
undertake a special study module in 
CAM). These findings support those 
from previous studies, which were that 
students with past experience of using 
CAM had more positive attitudes toward 
CAM. 12.20,22 Hopper and Cohen23 also 
found that previous CAM teaching 
related to more positive attitudes toward 
CAM in medical students. 
Conclusions 
Although our findings add to the 
emerging literature on medical students' 
attitudes toward holism and the 
relationship between holism and other 
student characteristics, our study is not 
without its methodological limitations, 
some of which have already been 
discussed. Despite its multischool nature 
and its large sample size, the overall 
response rate was low at 55.4%. Students 
volunteered to participate in this study, 
in accordance with ethics guidelines, and 
therefore constitute a self-selected group. 
It is possible that the students in our 
sample had more positive attitudes 
toward CAM than did students not 
participating in this study. However, we 
have only reported the relationships 
between students' attitudes and other 
variables, rather than presenting 
potentially biased data on medical 
students' attitudes per se. 
The ImAQ should be seen as an 
instrument in development and needs 
farther work. For example, trials should 
be made of new items, and additional 
items should be removed, such as item 7 
(which is influenced by the geographical 
location of the school). These and other 
efforts could be guided by the factor 
structure presented in this report. 
However, it is clear that any attempt to 
distil people's attitudes toward holism 
and CAM into three factors is bound to 
be an oversimplification. 
Even so, there do appear to be interesting 
relationships between medical students' 
attitudes toward holism and other 
characteristics such as gender, 
race/ethnicity, and school. The 
underlying reasons for such relationships 
are beyond this study and require further 
data collection. For example, why do 
black and Asian students, as groups, hold 
more negative attitudes toward holism 
than do white students? Why do students 
from the United Kingdom have more 
negative attitudes toward holism than do, 
say, North American students? Further 
research is required to elucidate the 
influences on such relationships, and 
qualitative methodologies may be most 
appropriate here, such as interviews or 
focus-group discussions. Without such 
ftiture research, it may be difficult to 
tease apart the complex issues 
surrounding students' attitudes toward 
holism and CAM. 
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Health Risks Over the Internet: Advice Offered 
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Sunurtary: Objectives: The aim of this study was to invcs- 
tigate Internet advice offered by "medical herbalists" to a 
pregnant woman regarding herbal treatment of morning 
sickness. 
Study Design: Search engines were used to find relevant 
Web sites and all potential e-mail addresses were con- 
tacted. Herbalists were asked for advice regarding three 
specific medicinal herbs: ginger, raspberry andjuniper. 
Results: Eighty-three e-mail addresses were found and 
contacted. The response rate was 51 %. Nineteen (45 0/6) of 
all respondents recommended ginger, 9 (210/6) of them 
without mentioning adverse effects. Seven (17 0/6) re- 
spondents recommended taking raspberry; five (120/0) 
without mentioning adverse effects. No respondent rec- 
ommended takingjuniper during pregnancy and 12 herb- 
alists (29 O/b) warned about using this herbal remedy dur- 
ing pregnancy. 
Conclusions: Advice about herbal medicine is readily 
available over the Internet. The advice offered is mislead- 
ing at best and dangerous at worst. Potential Internet 
users should be made aware of these problems and ways 
of minimizing the risk should be found. 
(Men. Med. Wschr. 2002: 152; 190-192) 
Gesundheitsrisiken über das Internet: 
Ratschläge von "medical herbalists" 
an eine schwangere Frau 
Zusammenfassung: Eirfleitun : Das Ziel dieser Studie war 
es, medizinische Ratschläge von medical herbalists« (in aller 
Regel Nicht-Mediziner) zur pflanzlichen Behandlung von 
morgendlicher Übelkeit an eine Schwangere zu beurteilen. 
Studiendesign: Anhand von Suchmaschinen wurden rele- 
vante Webseiten aufgesucht und potentielle E-mall-Adres- 
sen wurden kontaktiert. Medical herbalists" wurden um 
Rat betreffs drei verschiedener medizinischer Pflanzen ge- 
fragt: Ingwer. Himbeere und Wacholder. 
Ergebnisse: Drelundachtzig E-mall-Adressen wurden gefun- 
den und kontaktiert. Die Responserate betrug 51 %. Neun- 
zehn (45 0/o) aller Studientellnehmer empfahlen Ingwer, und 
9 (21 0/o) erwähnten keine Nebenwirkungen. Sieben Studien- 
tellnehmer (17 0/o) empfahlen die Einnahme von Himbeere, 
5 davon (12%) ohne Nebenwirkungen zu erwähnen. Kein 
Studientellnehmer empfahl die Einnahme von Wacholder 
während der Schwangerschaft und 12 medical herbalists* 
(29 0/o) warnten vor diesem Mittel. 
Schlußfoleerungen: Ratschläge zum Gebrauch von Phyto- 
therapeutika werden im Internet angeboten. Diese Ein- 
pfehlungen sind häufig irreführend oder sogar gefährlich. 
Potentielle Internetbenutzer sollten auf dieses Problem hin- 
gewiesen werden. Wege zur Verringerung dieses Risikos soll- 
ten gefunden werden. 
Introduction 
CAM has become remarkably popular: Its 1 -year prevalence 
in general populations ranges from 65 % (Germany) to 25 % 
(UIQ (9,10). Most surveys agree that women use CAM more 
frequently than men (e. g. 8) and there Is reason to believe 
that pregnant women feel particularly attracted to CAM, not 
least because it is promoted as free of adverse effects. Yet 
there is a large body of evidence that this notion is n-dslead- 
Ing (e. g. 7). 
Consumers often obtain information on medical matters 
from the media and increasingly from the Internet (6). Given 
the likelihood that many pregnant women consult the Inter- 
net for advice on CAM, it seemed relevant to ask how reliable 
and safe such advice Is. This investigation was aimed at 
shedding some light on to these issues. In particular, we 
wanted to know whether a pregnant woman Is put at risk if 
she followed the advice obtained from medical herballsts of- 
fering recommendations over the Internet. 
Material and Methods 
We used the presently most popular search engines on the 
Internet to find useful e-mail addresses of medical herbalists 
world-wide. The following search engines were considered: 
www. excite. com, www, lycos. co , www. about. com, www. altavista. com. 
www. searchAOL. co , www. i! oogic. com, www. yahoo. com, www. asigeeves. Com. We also used further 
sites recommended to us by various sources: www. scirus. - 
pgm, www. naturalhealthlink. com, 
www. onemedicine. com, www. healthandage. com, 
www. thorne. com/altmedrev/`-. The search terms were *medi- 
cal herbalist" or "medical" + "herbalist". All sites thus found 
were visited. Web sites that did not provide an e-mail ad- 
dress were excluded. The study was conducted in May 200 1. 
E-mail responses were collected between 14 and 23 May. 
A letter was composed presenting a woman who Is 
12 weeks pregnant with her first child and suffers from neu- 
sea and vomiting in pregnancy (NVP). She asks the medical 
herbalist for advice on three specific herbs: ginger, raspberry 
and j uniper (for full text of letter see appendix A). 7be letter 
seeks an explanation of symptoms, recommendations of oth- 
er herbal remedies. and the effectiveness and safety of gin- 
ger, raspberry and juniper. Responses were assessed accord- 
ing to their advice on the effectiveness and safety of ginger, 
raspberry and juniper. 
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Results 
Eighty-three sites with operative e-mail addresses were lo- 
cated and were sent our letter by e-mail (Appendix A). Forty- 
two responses were received (response rate =51 %). Eleven 
(26%) of these advertised herbal products. Six (14%) of the 
respondents attached information and price lists about their 
u. s. Copyright Clearance Center Code Statement: 0043-5341/2002/5207-0190$15. oo/o 
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products. Forty-nine per cent of all respondents chose not to 
give any detailed advice - due to legal reasons, or lack of 
knowledge. Most of these 49% offered advice over the tele- 
phone or suggested making an appointment. Most replies 
came from the UK, 15 (36 %); followed by the US, 10 (24 %): 
Germany, 6 (14 %); Australia, 2 (5 %); and Canada: 2 (5 %). 
Table I shows the responses in relation to the three herbs. 
Nineteen (45%) of all 42 respondents recommended ginger 
as a herbal medication for morning sickness. None of them 
warned about possible adverse effects and 9 (21 %) claimed 
that no such effects existed. Seven respondents (17%) rec- 
ommended taking raspberry. Four respondents (10%) 
warned about adverse effects and suggested not taking rasp- 
berry before the last trimester of pregnancy. Five respond- 
ents (12 %) claimed that there are no adverse effects involved 
with raspberry. Two respondents (5 %) mentioned that rasp- 
berry is inappropriate for morning sickness, and one person 
(2%) explained that it helps to tone the uterus and prepare 
for contractions. No respondent recommended taking juni- 
per during pregnancy. Twelve respondents (29%) warned 
about taking it -6% said that large amounts of juniper can 
be "irritating on the kidneys". and three respondents (7%) 
advised that juniper is one of about 50 herbs NOT to be tak- 
en during pregnancy. Two per cent mentioned that juniper 
'affects the uterus" and another 2% said it "sounds too 
strong" for a herb to be taken during pregnancy. 
Other herbs, vitamins and minerals were also recommen- 
ded (Table 2). Further recommendations for treating nausea 
by changes in lifestyle are shown in Table 3. Six respondents 
(14 %) attempted an explanation of what morning sickness is 
and why it might affect pregnant women. The -explanations- 
are summarized in Table 4. They suggest hormonal imbalan- 
ces, stressful lifestyle. inadequate diet and emotional distur- 
bances. One person (2 %) provided references of clinical tri- 
als that support taking ginger for morning sickness. 
Seventeen percent of respondents admitted that they had no 
knowledge about herbal remedy use for NVII. Thirty-six per- 
cent were concerned about the legality of giving advice on 
the Internet. 'rlvelve percent required more information be- 
fore giving any advice, and 40 % referred the e-mail sender to 
a medically trained alternative health practitioner, insti- 
Table 1. Responses in relation to the three herbs mentioned in 
the letter 
Responses Ginger Raspberry Juniper 
Use recommended 19 7 0 
Warned about side effects 0 4 12 
No side effect mentioned 9 5 0 
Figures refer to numbers of respondents. 
Table 2. Other herball vitamin/ mineral rernedies recommen- 
ded by herbalists. 
Remedy Niimber of 
recommendations 
5 
Peppermint 4 
Blac, horehound 2 
Melissa officinalis I 
Spearmint 1 
Hops I 
Magnesium trisilicate I 
Bach flower remedies I 
"Morningined relief" I 
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Table 3. Additional lifestyle recommendations by herbalists. 
Nature of recommendation 
" Eating last meal of day around 6 PM 
" taking gentle walk I hour after dinner 
" avoiding spicy food 
" only sipping at drinks 
" drinking frequent amounts through the day 
" Drinking lots of water (2 L) 
" storing herbal mixture in fridge for no longer than 3 days 
before preparing fresh 
" trying mixture of meadow sweet, black horehound and 
camomile 
" taking internally hydrosols (ginger root or peppermint) 
" inhaling essential oils of ginger, peppermint or spearmint 
" contacting natural health food stores 
" contacting local qualified herbalist 
" visit homeopath 
" cut down or eliminate some of the foods in the nightshade 
family 
" eat lots of vegetables and protein 
" take folic acid and DRA 
None of these recommend at ioi is were given more than once. 
Table 4. F-vplanationsfor nausea given by herbalists. 
Nature of explanation 
" hormone surges but unsure about what determines it. who 
gets it and who does not 
" can relate to high toxicity in body, prevention best through 
a liver cleanse before falling pregnant 
" stress. diet and exercise involved with morning sickness 
but hard to predict who will suffer from it 
" relates to individual health. changes in hormones during 
pregnancy 
" hormone levels change. combined with low blood pressure 
" could be an effect of state caused by emotional problem/ 
disturbance. not always evident to mother 
tutes, or governing bodies (e. g. I lerb Line UK, Institute for 
Nattiropathic Physicians). 
Comment 
The above data show that jj&6, j(, c to Jay people jjI)o1jj hcr-bal 
medicine is readily available over tile Internet and raise con- 
cern about its accuracy and safety. Ginger is an effective 
treatment for nausea (16) but has been suspected to have 
eninienogogur (7) and abordfacient effects during pregnancy 
iftaken in large amounts (4.12,15). Front a cautious point 
of view, ginger should therefore be avoided during preg- 
nancy. Nevertheless, 451% of respondents in this study rec- 
ornmended it without any mention of adverse effects. Juni- 
per is not knowii to be eff . ective for nausea but has 
emmenogogue effects (3.5,15). Its volatile oil can irritate the 
urinary tract which. in turn, can lead to reflex uterine sthnu- 
lation (18). It is reassuring that, in our study, no respondent 
recommended jimiper for NVP. Raspberry is thotight to in- 
duce labOUr 117) due to its uterine stimulant activity (1.2) 
and exhibits antigonadotropic activity fit vitro (13). It is not 
known to be effective for nausea, yet 12 % of all respondents 
recommended it for NVP. Little consensus exists amongst re- 
spondents about the optimal herbal treatment for NVP (Ta- 
bles I and 2). Furthermore, no trial evidence exists for the ef- 
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ficacy of any of the additionally recommended herbal or oth- 
er treatments for NVP (Tables 2 and 3). Similarly, most of the 
explanations offered for morning sickness lack a scientific 
rationale. Most respondents provided minimal cautionary 
information. 
The lack of quality control on the World Wide Web has the 
potential to put patients at risk. Eysenbach and Diepgen 
have addressed the issue of quality control on the Internet 
and put forward a strategy of *distributed quality manage- 
ment- as a solution to the problem G 1). They suggested de- 
centralized control by third parties and users. Another sug- 
gestion was to self-label medical information by the author 
of the Web site in combination with a systematized critical 
appraisal of health-related information by third parties us- 
ing a validated standard core vocabulary. Other researchers 
have addressed the issue of safeguarding access to herbal 
remedies (14). To quantify agreement about which herbal 
remedies might be regarded as unsafe, US researchers com- 
piled a list of 113 potentially perilous herbals (PPHs) and 
compared it with various 'negative lists" (NLs) of herbals 
from 9 different European countries. They found widespread 
international disagreement about which medicinal herb was 
classified as dangerous and about how access to these herbs 
Is regulated. 
Ethical considerations also need to be addressed. The 
main intention of this study was to mimic the process of a 
lay person seeking advice from a medical herbalist. The sit- 
uation is comparable with what a pregnant woman or mem- 
ber of family could encounter when using the Internet for 
health care information. No patients were involved or put at 
risk. Nevertheless. this project entailed research on non-In- 
formed individuals (the herbalists). As there was no other 
way to conduct this investigation. we felt that this deception 
was permissible in the interest of gathering data generated 
to enhance patient safety. After data collection. we informed 
those who responded that they had received a flctitious e- 
mail which was part of a research project. In this way we 
tried to mirdn-Aze our violation of informed consent. At no 
stage did or will we disclose the Identity of the respondents 
to anyone outside this study. We would thus argue that our 
deception is justifiable and that health care professionals 
who use the Internet for offering advice can and should be 
challenged as to the validity of this advice. 
our study has several limitations. First, Its sample size is 
too small for results to be generalizable. It is conceivable that 
other herbalists would have replied differently. Second. we 
asked for very specIfIc advice. We chose NVP because we be- 
lieved it involves a serious safety concern. Yet it is possible 
that the problem posed was exceedingly complex and that a 
simpler question would have generated more consistent an- 
swers. it is difficult to measure a medical herbalisrs knowl- 
edge of Nvp and CAM. On the other hand. one should point 
out that responsible health care professionals should ab- 
stain from giving advice if they feel that the problem is be- 
yond their competence. 
In conclusion. this preliminary investigation suggests that 
advice on herbal therapies obtained over the Internet for 
NVP can be misleading and might put patients at risk. We 
feel that this area, because of Its implications for public 
health, requires further study and tighter regulation. Inter- 
net users should be made aware of these potential problems 
and we should find ways of minimizing the risks to our pa- 
tients. 
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AppendlxA 
Hello 
My name is Kaya Schmidt, I am pregnant (12 weekslftrst 
child) and lately sufferftom nausea. It is quite severe - Ifeel 
that the morning sickness affects my physical and mental 
state and therefore would like to ask you for advice. I've 
asked my doctor but he said he doesn't understand herbs. 
Do you know why this affects me? Afriend of mine is also 
pregnant but she Lsjlne. Can I take anythingfor it? I am wor- 
rted about taking any heavy medication (because of my un- 
born child) and therefore would like to use a herbal medtca- 
tion instead. Is there anything you can recommend? I have 
read somewhere that ginger raspberry andjuniper are good 
to takefor morning sickness. Is that true? And are there any 
side effects? 
I hope you willfind some time to answer this e-mail. 
77tank you very much] 
KatlaS. 
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SUMMARY. Objective: To generate preliminary data on how individual reflexologists 
deal with patients seeking medical advice on the Internet. Design: E-mail survey 
involving reflexologists who were partly blinded for their advice on the Internet. Setting: 
Cyberspace. Participants: Two hundred and seventy-seven members of the Association 
of Reflexologists. Of 842 e-mails sent out we received 323 responses (38% response rate) 
of which 46 participants later withdrew their responses (14% withdrawal rate). 
Intervention: Participants were asked to advise a fictitious patient via e-mail who 
presented various health problems. Main outcome measure: Rating of responses 
according to safety and claims made by reflexologist sample. Results: Eighty-five percent 
of all respondents advised the fictitious patient to present the health problems to a 
medical professional. Fifty-eight percent expressed urgency to see a primary care 
physician or other health care professional and 95% pointed out that a diagnosis cannot 
and should not be made by a reflexologist. Twenty-nine percent of responders suggested 
a differential diagnosis or underlying causes for the patient's condition. Conclusions: In 
this survey reflexologists from the UK Association of Reflexologists have responded In an 
encouraging manner to a fictitious patient's request for health advice via electronic mail 
as only 5% (or possibly 15%) of reflexologists from this survey need to be more cautious 
about the advice they give their patients. We hope that our study will further encourage 
therapists to be more cautious giving Internet health advice in the future. 
0 2003 Elsevier Science Ltd. All rights reserved. 
INTRODUCTION 
Reflcxology is a therapeutic method that uses manual 
pressure applied to specific areas, or zones, of the 
feet and sometimes the hands or cars that are believed 
to correspond to areas of the body, in order to relieve 
stress and prevent and treat physical disorders. ' It 
may be used together with other techniques by thera- 
pists of various disciplines. Some claimed benefits of 
rcflcxology include the acceleration of heating pro- 
cess by boosting and strengthening the immune sys- 
tcm, restoring energy levels by relieving tension and 
improving the functioning of the body by releasing 
'toxin build-up' and by providing deep relaxation. I 
Common disorders that are treated with reflexol- 
ogy include asthma, back and neck pain, migraine 
and headaches, chronic fatigue, sinusitis, arthritis, 
insomnia, digestive problems such as irritable bowel 
syndrome and constipation, stress-related disorders 
and postmenopausal symptoms. Reflexology is con- 
sidered a complementary therapy, and is often used 
alongside other forms of medicine. Some reflex- 
ologists have in the past claimed to be able to 
make a diagnosis. However, in one blinded study 
reflexologists' diagnosed conditions were no better 
than chance in identifying medical conditionS. 2 
More and more individuals turn to the Internet 
for medical advice, as the Internet has become an 
important mass medium for patients seeking health 
information and health care services onlinc. 3 When 
12,000 Americans were asked about their use of 
Internet health resources 92% said their research 
was useful. " About 47% said that the online health 
information they found influenced their treatment 
decision. This begs the question as to the safety and 
appropriateness of such Internet advice. It has been 
suggested that almost no evidence exists that the 
Internet advice does any harm. 5 Our own research 
implies that this statement does not necessarily apply 
to CAM. ', ' In previous studies of similar nature we 
CýýOkýcwo, y Therapm in MedxIne (2003). 
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found, for instance, that some providers of comple- 
mentary medicine were advising their clients against 
government policy regarding the measles, mumps 
and rubella vaccination. 6 No data are available on 
how many patients write to their own or any other re- 
flexologist asking for advice on specific symptoms. 
In this study we wanted to generate preliminary data 
on how individual reflexologists deal with patients 
seeking medical by electronic mail over the Inter- 
net. Specifically, we asked the following research 
questions: 
I. Do reflexologists respond to requests for clinical 
advice by e-mail? 
2. Is the response rate lower if the request is 
identifiable as part of a research project? 
3. Do reflexologists advise patients whether 'a liver 
is healthy' or not? 
4. Can rcflcxologists identify by e-mail when a 
patient needs a medical opinion? 
5. Do respondents make unconditional claims of 
therapeutic success? 
a fictitious patient as part of a research project. (In 
this way we tried to minimisc our violation of the 
informed consent principle. ) The letter also assured 
confidentiality, explained the intention of the project 
(to evaluate the quality and reliability of advice given 
via the Internet) and offered respondents the chance 
to withdraw their participation retrospectively. 
Free text responses were categorised by the first 
author and checked by the second. 
Responses were evaluated descriptively. SPSS 
version 9.0 was used to calculate confidence intervals 
for the response rate and various recommendations 
of reflexologists. Estimates arc reported with 95% 
confidence intervals, and Chi-square statistical test 
is used for comparisons of proportions in response 
rates. 
The ethics committee of the University of Exeter, 
School of Sport and Health Sciences gave ethical 
approval for the research protocol. 
RESULTS 
METHODS 
There are various teflexology groups and associa- 
tions that provide practitioners' e-mail addresses on 
theirwebsites. We decided to use the sample ofmcm- 
bers from the Association of Reflexologists (AoR). 
All e-mail addresses from one Internet-located data- 
base of reflexologists (http: //www. aor. org. uk/) were 
used as the sample. The website has a link for search- 
ing the database and finding a reflexologist by name, 
town/county or postcode. The website does not offi- 
cially state that practitioners will or will not give per- 
sonal advice by e-mail. This database contains only 
registered members of the AoR. E-mail addresses 
were randomised according to a computer-generated 
list of random numbers and thus divided into two 
groups. Group A consisted of 519 e-mail addresses 
and group B of 520 e-mail addresses from the 
directory. 
A letter (Appendix A) was sent to reflexologists in 
group A. In this letter, a (fictitious) patient reported 
that he suffered from abdominal pain, weight loss and 
low energy levels. These symptoms can be indicative 
of liver cirrhosis, liver secondaries or stomach cancer 
with liver metastases. Reflexo1ogists in group B were 
asked for their advice as part of a research project. A 
vignette was included in the e-mail, which described 
the same fictitious case as in group A (Appendix A). 
Thus, members of group A and B were asked the 
same question, only in different contexts. 
E-mails to group A were sent on 15 January 2002 
and our closing date for responses was 29 January 
2002. E-mails to group B were sent on 31 January 
2002 (after group A, to avoid contamination between 
groups) and our closing date was 14 February 2002. 
After data collection, we informed all respondents 
from group A that they had received an e-mail from 
Of 519 e-mails sent to group A, 94 could not be 
delivered. Of the 425 e-mails that were delivered, 
we received 221 responses (response rate = 52%). 
One e-mail response could not be opened because 
it contained a virus. After retrospectively debriefing 
the participants and asking them for their consent, 28 
participants withdrew their responses. Thus group A 
yielded 189 usable responses. 
Of 520 e-mails sent in group B, 417 were suc- 
cessfully delivered and we received 102 responses 
(response rate = 24%), of which 14 later asked to 
withdraw from the study. Group B yielded 88 usable 
rcflexologists' responses. Seven (8%) of those were 
categoriscd as 'non-responders' because they either 
did not answer any of the questions or wanted to 
discuss problems on the phone. One rcflcxologist 
responded but at the same time withdrew permission 
to use that response. The response rates were sig- 
nificantly different with X2 (3, n= 842) = 67.53, 
P<0.001. 
The majority of reflexologists in both groups 
declined to offer a diagnosis (Table 1): 65% in 
group A (95% C1,0.58-0.72), and 61% in group B 
(95% C1,0.51-0.71). Eighty-six percent in group A 
(95% C1,0.8-0.9) and 84% in group B (95% C1, 
0.86-0.98) suggested that the patient should see a 
doctor or other health professional, usually adding 
some degree of urgency (Table 2): 53% group A 
(95% Cl, 0.46-0.6) and 69% in group B (95% C1, 
0.59-0.79). Two rcflcxologists in group D gave a 
'yes' to the question 'Can you say whether I have 
something wrong with my liverT. 
A few reflexologists answered the question as to 
whether a cure can be offered and some explained 
that their code of ethics does not allow reflexologists 
to claim to cure. One TCflCXOIOgiSt was confident 
that reflexology could make the patient well again 
(Table 3). 
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Tablel Reflexologis& responses to the issue of 'diagnosis' 
Responses 
iý(Jlexoiugists not allowed to make diagrioý, - 
Rellexology is not a diagnostic tool 
No mention of diagnosis 
ýýan diagnose energetic imbalances 
Suggest condition concerns the liver 
Can diagnose 2 ("%) ) (I -"' 
Group A (n = 189) Group B (n = 8B) All (n 277) 
98 41 
S8 (30%ý ý8 izý) 86 iI iý) 
2 'Y' I %) '?, ') 
/ %) (ý, %) 10 O"N 
Table 2 Reflexollojists' responses to 'seeing a primary cam physidan' 
Responses 
Advise to ýee med, cal dooor 
-rgency expressed to see medical doctor 
No mention of doctor 
Advise to see naturopath 
Adviw to follow insti-cis when L: euding 
Group A (n = 189) Group B (n = 88) All (n = 277) 
100 (53%) 61 (69%) 
27 (14%) 12 (14%) 
01 
01 
61 (AV 
39 (14%ý 
1 
Table3 Reflexalogists' responses to the claim to cure ('making me well again') 
Group A (n = 189) 
Not (la rned 
Not nwnt oned 
Poss bl I 
ycý (1 
Some reflexologists attempted offering a differen- 
tial diagnosis of conditions or possible underlying 
causes of a disease the patient might suffer from 
(Table 4). The conditions most frequently mentioned 
were stress, incorrect diet, liver problem, irritable 
bowel syndrome, digestive disorder and allergies. 
Two respondcrits suggested a diagnosis of stomach 
cancer. 
Group B (n = 88) All (n = 277) 
30 (34%) ! )9 
51, (63%) 206 (/1'A, ) 
10 (4"ý) 
) (Iry, 
CAM therapies that were recommended in addi- 
tion included various diets, naturopathy, homeopathy 
and dctoxification (Table 5). 
Most reflexologists suggested that the patient 
must see a primary care physician in order to get 
a medical diagnosis and to rule out any serious 
condition. Some responders suggested blood tests. 
Thrcc reflexologists (2'//o) asked for a referral from 
Table 4 Possible conditions suggested by respondents 
Primary 
Allergy 4 
Appendicitis 2 
Rowel obstruc-tion I 
Cancer 2 
Cirit)osis 
),, Iiac disease 
onst, pation 
ýrohn's disease 
I ', g, ýtive disorder 4 
Call bladder I 
()all stories I 
Kidney infection 
Liver problem 
P, increatitis I 
P-ir ýsitidftjngal infection I 
(Pcptic) uIcer 
Stomach 
Tumours 
Possible underlying causes 
An, vt y 
Dept vwon 
Exercise 
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Table 5 Additional CAM 
recommendations 
Acidopnilus 
Acuprcssure 
ACLIpunc-ture 
Aloe vera 
Cooked millet 3x daily 
ý: ounselling 
raniosacral therapy 
Detoxification 5 
Uietary changes 9 
Energy healing I 
'dasses of water 6x daily I 
ý7, rapeseed extract I 
Green magic I 
iomeopathy I 
Kinesiology I 
emon and ginger tea I 
gum I 
*ýedical herbalist 3 
ýIilk thistle 
Naturopathy 5 
\utritionist 9 
Pycnog6pine bark I 
Reiki I 
Supplements 2 
Visceral nianipuldtiun I 
Vitamin BI 
the primary care physician to say that the patient may 
receive reflexology. Two responders (1%) suggested 
seeing a gastroenterologist. Two further respondents 
(1%) advised the patient to actively seek medical 
treatment. 
DISCUSSION 
This study investigated UK rcflexologists' advice 
given to a patient suffering Crom abdominal pain, fa- 
tigue and weight loss. The symptoms presented were 
chosen to be alarming and to warrant urgent medical 
attention. Our study has shown that reflexologists 
are more likely to respond to an unsolicited e-mail 
by a patient than to a researcher approaching them. 
The response rate of' the group who was covertly 
approached was more than twice as high as the other 
group. 
It is reassuring to see that 85% of all respondents 
advise the (fictitious) patient to present the health 
problems to a medical professional. If our data were 
generalisable, which they are not, we would have to 
assume that one in six UK rcflcxologists does not 
advise seeing a doctor. This finding, however, needs 
to be viewed with caution. 
It is also encouraging that 58% expressed some 
urgency in seeing a primary care physician or another 
health care professional and that 95% pointed out 
that a diagnosis cannot and should not be made by a 
reflexologist. However, 29% of responders seem to 
suggest a differential diagnosis or suggest underlying 
causes for the patient's condition. It should be noted 
that a number of reflexologists suggested that they 
could 'help the patient to heal themselves', which 
might by a patient be interpreted as claiming to cure. 
Most reflexologists in this study, however, reacted in 
a responsible manner. 
There are several limitations to our study. The 
low response rate (especially in group B) limits 
the general isabi I ity of our results. It was caused by 
interference from the AoR. The AoR stopped our 
research for approximately I week, advising AoR 
members to withdraw from our study if they had 
participated. Subsequently, after requesting and re- 
ceiving a copy of the ethics approval the AoR sent 
another e-mail to all respondents recommending 
co-operation. Through this interference we incurred 
55 withdrawals (39 group A and 16 group B) of 
which only 12 subsequently overturned their with- 
drawal. Moreover, our findings cannot be generalised 
to members of other reflexology societies. Addition- 
ally, summarising the results obscures the details of 
individual responses. 
It might be distressing for professionals to be 
tested covertly by this method but it is more dis- 
tressing for patients to be given unreliable health 
advice. The general principle should always be that 
practitioners need to be cautious about giving advice 
without knowing all details (i. e. via the Internet, 
telephone, etc. ) and patients should be very cautious 
in asking for and accepting such advice. 
Our research questions related to a possible area 
of risk to patients. We suspected that, without dc- 
ception, we would not generate a truthful picture. 
This suspicion was confirmed by our findings that 
the response rate fell from 52%, in the blindcd group 
to 24% in the open group. The latter low response 
rate might have been exaggerated by the nitcrfer- 
cnce from the AoR. However, other studies have 
also shown a lower response rate in the open group 
(30%) compared to the blinded group (53%) in a 
study investigating acupuncturists' response to an 
unsolicited e-mail. ' We would like to point out that 
very little harm was conceivable as a result of' this 
projcctý in fact we hope that the publication of' our 
results will encourage more cautious Internet health 
advice in the future, thus increasing patient safety. 
There is a very large grey area between asking 
general health questions and confronting a health 
practitioner with a clinical problem. ' Wlicrcas e-mail 
advice replying to general health questions is giv- 
ing general health information (which is not consid- 
ered 'practising medicine'), answering an unsolicited 
e-mail which is asking about a specific clinical prob- 
lem, can be regarded as medical practice. The UK 
General Medical Council advises medical practition- 
ers on how to deal with providing advice and medical 
services online or by telephone. ' They clearly state 
that standards ofcare may be compromised in online 
consultations because ofthe lack of a patient doctor 
relationship. They also advise that practitioners who 
wish to provide online health advice need to consider 
whether such services will serve their patients' in- 
terests. Professional associations and organisations 
might need to be involved in advising their members 
accordingly, 
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The AoR has been noted as taking the lead in 
regulation and standard setting for UK reflexologists 
(own observation). Possibly, further Internet studies 
of a similar kind could explore whether members of 
other professional reflexology organisations respond 
in a different way, and how seriously patients con- 
sider advice given by practitioners outside the health 
service. 
APPENDIX A. 
Letter to group A 
Dear reflcxologist 
By looking for reflexologists on the Internet I found 
your e-mail address. I'm 40 years old and suffer 
increasingly for about 6 months from stomach pains. 
I don't seem to have the energy to do anything and 
I think I'm losing weight. Even though I stopped 
drinking 3 years ago, I think I might have something 
wrong with my liver. Can you as a reflexologist tell 
whether I have? Can you make me well again? Do 
you think I should see my doctor even though I have 
completely lost faith in conventional medicine? 
Letter to group B 
Dear reflexologist 
My name is Katja Schmidt and I am a member 
of the Department of Complementary Medicine, 
University of Exeter. I found your e-mail address at 
http: //www. aor. org. uk/ on the Internet. I am currently 
working on exploring the field of reflexology. Would 
you please be so kind to read the following vignette 
and answer the questions involved? 
"By looking for reflexologists on the Internet I 
found your e-mail address. I'm 40 years old and 
suffer increasingly for about 6 months from stomach 
pains. I don't seem to have the energy to do any- 
thing and I think I'm losing weight. Even though I 
stopped drinking 3 years ago, I think I might have 
something wrong with my liver. Can you as a reflex- 
ologist tell whether I have? Can you make me well 
again? Do you think I should see my doctor even 
though I have completely lost faith in conventional 
medicine? " 
Thank you very much for your help. 
Best wishes, 
Katja Schmidt 
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F- Sdimid4 F- En=-Ibtemet advice by acupuncturists *a risk factor for cardiovascilar patients? 
Internet adyice byacupuncturists 
risk fadqr fbr cardiovascular patients? 
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Summarv 
Backgmltý- Acupuncture is often used for smoking cessation yet it has been 
shown to be no more effective titan shara and not to be entirely free of r1sL 
With more and more patients turning to the Internet for medical advice it 
stemmed appropriate to determine the reliability of the advice given by acupunc. 
tnrists over the Internet. 
Metho& and repd= E-mail addresses were located through a pre-defined su-&- 
tegy and randomly divided into three groups. A letter was sent to groups A and 
B hom a fictitious pacemaker patient asking about the safety and efficacy of. 
electro-ampunctnre treatment for smoking cessation. The differeace between 
group A aW B was that the patient in group B claimed to live in the acupunctim. 
riWs ana. Group C was siked for their advice on clectro-acupuncture for 
-smoking cessation as pad of a research project. 
The response rates in group A and B -were similar (55 % group A, 53 % group 
B) whereas in group C it was domificautly lower (30 %). Concerns with electro. 
gcopuncture administered to a patient with a pacemaker were issued by 33 % of 
all acupuncturists. 11tere are, however, significant differences between sul). 
Voups. When the question was asked in the context of 'a research project, the 
response was markedly more cautious. 
Conchaio= Recommendations;, Issued by acupuncturists regarding smoking 
cemation, are not based on the current evidence as to efficacy of this interven. 
tion and concerns about the potential ham of acupuncturists' advice emerge. 
Keywords: acupuncture, pacemaker, Internet 
Zusammenfinsung 
HWeigmn& Akupunktur wird häufig zur Raucherentwöhnung empfoLde34 ob.. 
wihl, sie s" nicht effektiver als Scheinakupunktur erwiesen hat und nichtvöllig 
frei von Rhiken Lqt. Immer mehr Patienten nutzeu das Internet, um medizW-. 
scheu Rat zu erhalten. Es schien uns daher ang"cht, 4Ze Zuverlässigkeit sol. 
cher jRatscMige zu untersuch«4 die von Akupunkteuren iber das Internet ge. 
geben wurden. 
, Wethodik FMÄU-Adressen wurden mit einer zuvor 
festgelegten Strategie lo. 
kaäsiert, raudomisiert und In 3 Gruppen eingeteilt Ein Briel! von einem Nr&en 
]ffemcbdttmacherpatienter4 in dem sich der Patient nach der Sicherheit und 
dem Nutzen der ElekÜ»akuPu2kblr*eMile ffir die lý2'm*ereBtw'Mmimg ex, 
klmdigK wurde an die Gruppen A und B gesandt. Der einzige, Unterschied 
zwischen den Gruppen A und B bestand darin, dass der Patient In der Gruppe 
B behamptete, in der Nibe des Akupunkteurs zu wohnen. Die Gruppe C wurde 
zu Eiddr«L-apunktur Kw die RäuclerentwÖhnung ab Teil eines Forscinmgs. 
projebes beftagt. 
e Die Responsraten. la Gruppe A und* B waren sehr ähnlich (SS % = 
53 IY6 Gruppe B); In der Gruppe C lag sie dagegen W 30 %. 33 % al. 
kr Akapmdmme äußert= Bedenken zur Anwendung der Elektroakupunktn 
h. i g., m Patienten mit Herzschrittmacher. Es bestanden Jedoch sieüükante 
Cigarette smoking continues to be the 
major cause of morbidity and mortali. 
ty in many industrialised countries. 
The Joint European Societies recently 
found that the prevalence of -Ung increased from 19.4 % (1994) to 
20.8 % (1998) (1]. Every Uth coro- 
nary heart disease (CHD) patient con- 
tinued to smoke despite myocardial infarction. Patients are more success- 
ful, in quitting if they receive inter- 
ventions from health care professio- 
nals [2]. A population survey in 1996 
suggested that 15 % of respondents 
would use complementary medicine ICAM) to quit smoking (3]. 
t has been suggested that acupunc- 
ture releases endopnpus opiýid pepti- 
des which may ass t in reducing opia- 
te withdrawal syndromes [4]. Acu- 
puncture, in particular clectn>-acu- 
puncture, is often used for smoking 
cessation [e. g. 5]. Yet it has been con- 
clusively shown to be no; more effec- 
tive than sham, [6]. Moreover, it is not 
entirely free of risk (7]. One particular 
risk of electro-acupuncture is the 
interference of the electrical 
with the function of a pacemaker. [8]. 
This risk is weJU known and is citec in 
standard texts of acupuncture [e. g. 9. 
10, and 11]. 
More and more individuals turn to the 
Internet for medical advice. When 
12,000 Americans were asked about 
their use of Internet health resources - 
92 % said their research was useful 
[12]. About 47 % said the answer they 
found for their own enquiries influ- 
enced their treaMent decision. This 
begs the question as to the adequacy 
of such Internet advice. It has been 
suggested that almost no evidence 
emsts that the Internet advice does 
any harm (13]. 
unteischWe zwischen den verschiedenen GmPPen- Wenn-die Fraje im Kort. 
text Woes 1FwsmmWPrOJeK'e$ gesTe'ul wume, wwc'L 4ue AwwOnelt deumch 
zmracMWtender. 
'Katja Schmidt was supported by The Pfl- 
bngton FamOy Thists 
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46 X Sdmd4 Z Ernm Internet advice by amipuncturists -a risk factor for cardiovascular patients) 
schtuisfolgemg. - Fmpfehlungen von AWpmdaeuren zur Pauclierentwöhnung 
basieren nicht auf der Evidenz zur Effektivi tit dieser htervention. I)er Plat von 
Akupunkteuren erscheint nicht rÜ&Ofrei zu seiit 
Milüsselwörter. Akupunktur,. Herzscbxittmacher, Internet 
We wanted to know how good advice 
of acupuncturists via the Internet is 
and used the model of a pacemaker 
patient wishing to give up smoking. 
We therefore sent a letter from a fic- 
titious patient, a method previously 
applied (eg. 141, in order to answer 
the following research questions: 
1. Do acupuncturists recommend acu- 
puncture for smoking cessation de- 
spite good evidence for the ineffec- 
tiveneuss of this approach? 
2. Do acupuncturists take amount of 
*the risks associated with electro- 
acupuncture for a pacemaker pa- 
tient? 
3. Do the answers of acupuncturists 
differ according to 
a) patient or researcher asking the 
question 
b) professional quahfimtion of the 
therapist 
location of the therapist (Le. in 
o area of patient or not)? 
Me&ods 
All e-mail addresses listed on the 
website www. acupuncture. com/Refer- 
ral/ were used to recniit our study 
sample. The* directory included the 
following countries: Argentina, Aus- 
tralia, Austria, Belgitm3, Barbados, 
British West Indies, Brazil, Canada, 
China, Cyprus, Den-a , Egypt, Fin- land, Fraj3ýce, Greece, Germany, Hong 
Kong, India, Irelandý Israel, Italy, Ja- 
pan, Korea, Mexico, Netherlands, 
Norway, Now Zealand, Pakistan, Por- 
tugal, Puerto Rico, Saudi Arabia, Sin- 
gapore, South Africa, Spain, Sweden, 
Taiwan, United Arab Emirates, LTK, 
USA and Viet NanL E-mail addresses 
were randomised acgording to a c=- 
puter-generated list of random num- 
bers : and thus divided into three 
groups. Group A consisted of 288 e- 
ruall addresses, group B of 288 e-mail' 
addresses and group C of 289 e-mail 
addresses from the directorY. 
A letter (see Appendix) was sent to 
group A. Ju this lettdr, a (fictitious) 
p=r2rteda to have been given a 
pace er an acute myocardial 
infarction two months ago and asked 
about the safety and efficacy of acu- 
puncture treatment for smoking cessa- 
tion. A slightly different version of 
that letter was sent to group B (see 
Appendix). The difference was that 
the patient claimed to live in the acu- 
puncturist's area. After collecting re- 
sponses for group A and B we found 
that only five respondents fxom group 
A (4 %) and twenty-two respondents 
from group B (23 %) expressed their 
concern about using clectro-acupunc- 
ture in the presence of a pacemaker. 
We therefore decided to send a fol- 
low-up e-mail to all respondents of 
group A and B'in which the patient 
inquired specifically about the safety 
of electro-acupuncture (see Appen- 
dix). Responses to the initial and fol- 
low up question were used in the ana- 
lysis* Group C was asked for their ad- 
vice on electro-acupuncture for smok- 
ing cessation as part of a research 
project. A vignette was included in the 
e-mail, which described the same fic- 
titious case as in group A and B (see 
Appendix). Thus, members of group 
A, B and C were asked the same qaesý 
tion with the difference that group A 
and B were blinded to the fact that 
this was a research projecL 
E-mails to group A and B were sent 
on 18.072001 and our closin date for 
responses was 06.08.2001. 
Y= 
to 
group C were sent on the 30. (Y72001 
(after gToup A and B to avoid conta- 
mination between groups) and our 
dosing date was 08.082001. All re- 
sponses were collected in the period 
between 18.07. - . 
08.08.2001. After 
data collection, we informed all re- 
spondents from group A and B that 
they had received an e-mail from a fic- 
titious patient, which was part of a re- 
search project. (Ia this way we tried to 
I... violation of informed 
consent) Ilie letter also assized con. 
a' and explained the inten- 
tttf the project (to evaluate the 
quality and reliability of advice given 
0 
via the Internet) and offered tespon- 
dents the chance to withdraw their 
participation retrospectively. 
Finally, we categorised respondents 
according to their qualification as an 
acupuncturist listed on the www. acu- 
puncture. com referral webpage. Data 
were evaluated descriptively. SPSS 
version 9.0 was uied to calculate con- 
fidence intervals for the response rate, 
the recommendations of acupuncture 
treatment and any mention of adverse 
effectL Esthnates are reported with 
95 % confidence intervals, and j2 sta- 
tistical, test is used for comparisons of 
proportions in respowe rates. 
Remits 
Ile main professional groups were. 
Licensed acupuncturist (Ucensed 
=A cturist, Acupuncturist with 
Acupuncturist Physickui, 
Registered Acupuncturist, Certified 
Acupuncturist), medical doctors, 
DOM (doctor of'orienul medicine), 
other qualification (e. j. Bachelor of 
Acupuncture, PhD) and no discernible 
qualykation. Table 1 shows the sam- 
plb 4zes and response rates for all 
three groups. 
Group A 
Group A consisted of originally 288 e- 
mail addresses, 62 addresses were re. 
tamed with the note *user unlmownK. 
Thus 226 e-mails were sent and re- 
ceived in group A. We received IZ 
responses (initial response rate = 55 %) (Table 2). No participant 
wished to withdraw from the study. 
Most of the responses we received 
were from licensed acupuncturists 
(LAc). One hundred and fifteen re- 
spondents (92 %) recommended the 
use of acupuncture (95 % CI, 87 % to 
97 %). Forty-four respondents (35 %) 
stated that acupuncture was safe it 
performed by a qualified a ctu 
rist (95 % C1, V% to 43 %)NreTty- 
two respondents (18 %) stated that 
acupuncture treatment involved few 
or. milnimal risks (95 % CI, 11 % to 
25 %). Five respondents warned ab- 
out the application of electro-acu- 
puncture for the patient (Table 3). 
After sending our follow-up e-mail re- 
garding clectro-acupuncture (see ab- 
ove) we receiýed 42 responses from 
respondentsý of gro A (follow up re- 
eo (Table 4). Most spoxise rate- 34 %1 
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Table L- sample size of group A, B. C and all group together 
Group A Group B Group C All Iroups 
Blinded, Blin" Unbliuded 
genexal local 
sampis size 226 221 223 670 
Nmmber of respomm received 125(55%) 117(53%) 67(30%) 309 (46%) 
, Defmed as a-maas sent and rweived 
Table 2. Group A- initial responses listed by proftsion (%) (bM w medical doctor, I)OM 
doctor of od=tal medicine, CI - confidence interval) 
Licamsed MD DON Others Nediiwwm-bU AN professions 
03atM (==3) (nag) (nol) quallacadon (n. 1) (mp. M 
&=pun=m 94(84) 2 (67) 7 (88) 1(100) 1(100) 
reconnneaded 
Acupumcmra 39(35) 1 (33) 4 PD) 0 (0) 0(0) 
safe 
Risb involved 2D (18) 0(0) 1(13) 1(100) 0(0) 
iascapuncUm 
Tgbje 3. - Cgoup B- initial responses listed by professign, (%) (MD - medical doctor, DOM 
doc= of orimtal medicine, CI - confldqnze Interval) 
105(84) 
95 % Cl. 87 to 97 
44(35) 
95 % Cl, 27 to 43 
22(18) 
95 % (Z 11 to 25 
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of dune responses were frour. LAc. 
Thirteen respondents (31 %)- recom- 
mended Wing electro-acupuncture if a 
practitioner is applymg it 
17 % to 45 %). Fourtech; re- 
spondents (33 %) recommended not 
using electro-acupuncrure, (95 % CI, 
19 % to 47 %). Seventeen respondents 
(40 %) expressed their concern about 
the na er (95 % Cl, 25 % to 
55%). - 
Group B 
La group B, 288 e-mails were sent; 67 
e-mails could not be delivered becau- 
se 'uwr unknown. Thus 221 e-mails 
were sent and received in group B. One hundred seventeen responses 
were receivedCmýtial. response rate =: 53 %) (Table. ' ). Again, most respon- 
ses we received from licensed aca- 
puncturism Four participants from 
this group wished to withdraw from 
the study. 
Ninety-nine respondents (84 %) re- 
commended acupuncture treatment if 
aglied bya qualified acupuncturist 
(% C1,75 % to 89 %). Twenty-five 
respondents (21 %) claimed acupunc- 
tare is a safe therapy if used by a qua. 
lified, acupuncturist (95 % CI, 14 % to 
28 %). forty respondents (34 %) men- 
tioaed that there are few to minirnal 
risks involved (95 % CL 25 % to 
41%). Twenty-two respondents 
(19 %) expressed their concern abput. 
the pacemaker. 
After sending the follow up e-mail, we 
received 70 responses (follow up re-. 
sponse rate - 60 %) (Table 5). Twelve 
respondents (17 %) recommended the 
use of electro-acapiwctare (95 % C1, 
8% to 26 %). Thirty-eight partici- 
pants (54 %) recommended not using 
elear cture for the particular 
conM=nc 
r95% 
ý CT, 42 % to 66 %). 
Thirty-nine, participants (56 %) ex- 
pressed their concern about the pace- 
maker (95 % a, 44 % to 68 %). 
]Ucsnnd MD DON Otbfts NodwenuMe AD lm*feniom 
(A.. 9s) (nmM (nm3) (*-4) ga"Cadou (a-12) (iwll7) 
Acupuncmye 
mcoiamcided 
Acapa=tm 
safe 
Risks luvolved 
In &=puncmm 
79(25) 6 (8§? ) 3 (100) 3 CM 8(67) 
21(22) 1(14) 0(0) 1(25) 2 (M 
30(32) 2 (28) 1 (33) 2 (50) 5 (4m) 
99(85) - 
95 % Cl. 75 to 89 
25 CU) 
95 % Cl. 14 to 28 
40(34) 
95 % CL 23 to 41 
Table 4. - Gxoup A- follow-up. r. CsPORýft listed by profession. (%) (MD - medical domor, DOM an do&= of oriental medicme, a- confidence 
interval) 
Lkemed MD DOM Odmv No&ctmUe AJ pru&Wom 
(n-37) (xwl) (imm3) (A-AO) qualfficod" (UMI) (8=Q 
Eectzj)ý, m=pnn=e 13 (35) 0(0) O(D) 0(0) 1 
(IM) 
recoammmded 14(38) 0(0) 2(67) 0(0) 0(0) Mom"wýww=, 
d 
Qmcems about 17(46) 0(0) 1(33) 
0(0) 0(0) 
pacmakw 
14(33) 
95 % Cl. 17 to 45 
16(38) 
95 %a 19 to 47 
18(43) 
95 % Cl. 25 to 55 
Table 5. CuvV B- fonow-up responses listed by profession (%) (MD = medical doctor, 
DOM = doctor of oriental meaicinE, 
CI M C003fiderice interval) 
Licemed HD D40M Otbom Nodweemble All pmhsdow 
(A=55) (n-4) N-I) (-I) quawleadou (U-9) 
a (15) 3 (75) 0(0) 0(0) 
recommended 
r: jccav. =Mgm=c3O 05) 1 C4 
1 (100) 0 (0) 6(67) 
OUr"Ognjuended 
Concerns about 31(56) 1 (25) 1 (100) 0 
(0) 6(67) 
Pacmaker 
12(17) 
95 % C4 8 to 26 
38(54) 
95 % CI, 42 to 66 
39(56) 
95 d-' tZ 44 to 68 
Group C 
= ila u C, 289 e-mails were sent of 
63 were retumed because 'user 
unknown!. Ilus, 223 e, -mails were 
sent and received. We received sixty- 
eight responses (response rate = 31 %) (rable 6). Most responses we 
received from licensed acupuncturists. 
One participant wished to withdraw 
from the study. -, 
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Table 6: Group C- initial responses listed by profession (%) (MD medical doctor, DOM doctor of cuiental medicine, a= confidence interval) 
Ucensed MD DOM Odws NodiscemlMo AM professions (n-53) (n=3) (u=4) (-2) qualfficafion (n-6) (a-67) 
Blectro-acupuncture4 (8) 0(0) 0(0) 0(0) 0(0) 
momnmeaded 
Electro-=punctura44 (83) 3 (100) 4(100) 2(100) 5(83) 
not recommended 
Concern about 37(70) 3(100) 4(100) 2(100) 5(83) 
pmMaker 
4(6) 
95%Cl. ltoll 
58 (87) ' 
95 % Cl. 77 to 93 
51(76) 
95 % C4 65 to 85 
Table 7. Responses according to their professional status (MD a medical doctor, DOM 
doctor of oriental medicine) 
Liemsed MD 
A-9-chnig 
Number of Juitial 177 
respoim received 
Number of foHow-up 92 
respoom received 
(pvV A+B) 
RecommendatWn to 25(17%) 
lise elecuvacupuncturc 
Pacemaker concern 85(59%) 
numtioned 
Recommendation to 173 (98 %) 
use 
(gmup A+B)' 
Dohi Other No dbmmoAc 
quaffiadon qmMcation ... 23 15 19 
54 10 
3(38%) 0(0) 0(0) 2(13%) 
4(50%) 6 (75%) 2(67%) U (69 %) 
8(62%) 10(67%) 4(S7%) 8(47%) 
Table 8- Additional oAnterventions suggested by groups A. B and C (some co-interven. 
tions were recommended more than once) 
Bthlkyiowml 
Aro=aberapy 
Belbavioar MOMM600 
Progralo, 
Bioftedback 
Breadingineditations 
Counselliq 
DetoOdfication 
Drainage techniques 
(homeopathic + biomedical) 
Ear seeds (wine treated 
vaccaria) 
Enzyme therapy 
Emerdw 
Hatal dwjW 
Homeopathic remedies 
Hypnodwrapy 
Join group 
MacrobLotics 
Maditadon 
Naturopa&Y 
Now bobbies 
Prayer 
Psychotherapy 
ptelmoon 
4 ýZ alking pattew change Softl= acupunctuft 
SUPPqrt groups Tai chi 
Telling. others 
lbought field therapy 
walei 
yoga 
Ortbimbmfhfe&cal 
Gum 
N]wtinegum 
N'=tjne patches 
Zyban antidepressant 
Nu&idonal 
L AvoWAnce 2. Recascinen-4- aim 
Alcohol Ardisia tablets 
Caffeine Chinese herbal 
Smokers supplements 
Soda pop@ Chinne teas 
Sweeft coenzyme 0 set 
Decreau augarfutake CO-Q 10 
Hot spicy food Drinking water 
Flaxseed 
Flower Metires 
Fniit + vegetables 
Orapa-seed extract 
Green tea 
Hawthome 
L*Oua tea 
Lobelia thicture 
Nutritional advice 
Olive Oil 
Vegetarianism 
Vitamin A&C 
Vitamin B 
vitamins C&B 
Four respondents (6 %) from group C 
recommended electro-acupuncture 
treatment (95 % CI, I% to 11 %). Fif.: 
ty-eight respondents ($7 %) recom- 
mended not using electro-acupuncture 
(95 % CI, 77 % to 93 %). Ydty-oaa 
participants (76 %) expressed their 
concern ab6ut the pacemaker (95 % 
CI, 65 % to 85 
Differences between groups 
The response rates in group A and B 
were similar (55 % group A, 53 % 
group B) and group C had the lowest 
response rate (30 %) which was signi- ficantly smaller than groups A and B Oe 23.97. df 1, p<0.001). The respon- dents from group C bad the lowest 
rate for recomm n4ing e1ectro-acu- 
F uncture for *the tient (6%), fol- 
owed by group B 
ýla7 
I%) and group A (33 %). Ibis difference between 
groups A, B and C was significant ()e 
13-87, df . 5. p<0.05).. Similarly, con- cerns about the pkýer were ex- 
pressed by 51 (75 %) res gondents in 
group C. followed by 3 (56 %) in 
group B and-17 in group A (43 %). 
Our results show that 55 % (group A) 
and 51 % (group B) of acupuncturists 
responded to an e-mail from a (fic- 
titious) patient and 30 % (group Q 
responded to a query from a resear- 
cher. These response rates were signi- 
ficantly (response rates in groups A 
and B silmificantly differed to group C 
- X2 23.97, df 1, p<0.001). 
Dimuslon 
One of our primary research ques- 
tions related-to the recommendations 
by acupuncturists to use acupuncture 
for'smoking cessation. The evidence 
shows that this is no more effective 
than sham acupuncture [61 and con- 
sidering safety concerns related to the 
presence of a pacemaker (8]. Our 
results show that 10 % of all acupunc- 
turists (33 % of group A, 17 % of 
group B and 6% of group Q would 
recommend electro-acupuncture in 
this particular situation. The respon- 
dents of group A significantly differed 
in their recommendation for electro- 
acupanctive treatment cDmpare4 to 
group C 7bus, 
;; =endations 
seem to vary gccording to blinding/de- 
ception. When a researcher approach- 
ed acupuncturists openly, the re- 
sponse ratt was 24 % lower than when 
periusion 0=02 12 15. Jahrfflg 0 %IM PERFUSION Cmblt NumberuMzu« 
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Appendix 
Letter sent to Group A 
Dear acupuncturist, 
I found your e-mail address in the *International Acu. 
punctuxist Referral DirectoryK on the Internet. My 
name is Paul Stanfield, I am 53 years old and recove ig 
from a heart attack, which I had 2 months ago. I now 
live with a pacemaker. I realise that I need to change a 
few things about my lifestyle. I am a heavy smoker and 
bave tried everytbýng to quit smoking. I want to get bet- 
ter and give up cigarettes for good. Can acupuncture 
help me? Arq there any risks involved? 
I hope you can give me some advice andhave the time 
to reply. 
Best wishes, Paul S. 
Letter sent to Group B 
Dear acapuncauist, 
I live in your area and found your e-mail address in the 
*International Acupuncturist Referral Directory4c on 
the Internet. My nn-e is Paul Stanfield, I am 53 years 
old and recovering from a heW attack, which I had 2 
months ago. I now live with a pacemaker. I realise that I 
need to change a few thinps about my lifestyle. I am a 
heavy smoker and have tned everything to quit smok- 
ing. I want to get better and give up cigarettes for good. 
Can acupuncture help me? Are there any risks invol. 
ved? I hope you can give me some advice and have the 
time to reply. 
Best wishes, Paul S. 
Letter sent to Group C 
Dear acupuncturist, 
My name is Kaqa Schmidt and I am member of the De. 
ff artment of Complementary Medicine, Univertity of 
eter. I found your e-mail add s in the *Iatematio- 
nal Acupuncturist Referral Directoryx on the Internet. 
I am currently working on a research project in which I 
am looking at the role of acupuncture in dealing with 
smoking cessation. Would you please mad thz following 
vignette and answer the questions below?. 
Mr S. is 53 years old and recoverin .gma 
heart attack, 
which he had 2 months ago. He ý70! 
01ives 
with a pace- 
maker. He wýnts to change his lifestyl& He is a heavy 
smoker and has tried various methods to quit smoking. 
He wants to get better and give up cigarettes for good. 
Would you think acupuncture is efficacious for tmoking 
cemdon in his case 
Do you Uxink acupuncture involves risks for Mr S.? 
Do you have any other comments? 
11ank you very much for finding the time to answer 
and support my research project in this way. I apprecia- 
te you co-operation. 
Sincerely, Katja Schuxicit, 
7ollow- '. U group A P 
Thank you very much for your reply to my e-mail (iee 
below). 
I have now spoken to my cousin who swears by electro. 
acupuncture for smokiq cessation. Do yqu think this 
will work for me or does it involve any risk? 
I will attach. my previous e-mail in case you have for- 
gotten what it was about. 
Again, thank you very much 
Best wishes, Paul S. 
Dear acupuncturist, 
I found your e-mail address in the *International Acu. 
puncturist Referral Directory4c on the Internet. My 
name is Paul Stanfield, I am 53 yeam old and recovering 
from a heart attack, which I had 2 months ago. I now 
live with a pacemaker. I realise that I need to change a few things about my lifestyle. I im. a heavy smoker and have tried everytNng to quit smoking. I want to get bet, 
ter and give up cigarettes for good. Can acupuncture 
help me? Are there any risks involved? - I hope you can give me some advice and have the time 
to reply. 
Follow-up group B 
Thank you very much for your reply to my e-mail (see below). 
I have now spoken to my cousin who swears by electro- 
acupuncture for smokin* cessation. Do you think this 
will work for me or does it involve any risk? 
I will attach my previous e-mail in case you have for. 
gotten what it was about. 
Again, thank you very much 
Best wishes, Paul S. 
Dear acupuncturist, 
I live in your area and found your e-mail address in the 
4aternational Acupuncturist Referral Directoryqc on 
the Internet. My name is Paul Stanfield, I am 53 years 
old and recovering from a head attack, which I had 2 
months ago. I now live with a pacemaker. I realise that I 
need to change a few things about m y lifestyle. I am a 
heavy smoker and have tried everything to quit smok- 
ing. I want to get better and give up cigarettes for good. 
Can acupuncture help me? Are there any risks invol- 
ved? I hope you can give me 3omo advice and have. the 
time to reply. 
49 
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being approached by a patient How- 
ever, acupuncturists did not significant- 
ly differ in their recommendation to 
electro-acupuncture according to their 
lomfity when comparing jr6up A and 
B. In group C the proportion of re- 
commendations for electro-acupunc- 
ture decreased to 6 %. Ubis implies 
that acupuncturists tend to answer dif- 
fexently depending -on the context in 
which they are being asked. Ilese re- 
sults imply that deception is a n6ces- 
sary prerequisite for conducting in- 
vestigations into the safety of Internet 
advice. 
Concerns about electro-acupuncture 
admiaistered to a patient with a pace- 
maker were expressed by 62 % of all 
acupuncturists. 7here are, however, 
remarkable differences between sub- 
groups. The least concerns about a 
risk were expressed in group A. The 
difference between group A and 
group C was significant (see ccinfiden- 
ce intervals). GrouplI may have issu- 
ed more cautious recommendations as 
they had to consider the possibility of 
actuatly treating this patient. When 
the question was asked in the context 
of a research project, the response was 
markedly more cautious, and 85 % of 
respondents voiced concerns. 
Our other research question, whether 
different groups of acupuncturists is- 
sue different recO=endatiOlls, does 
not siem to be answerable on the ba-' 
sis of the data generated. Except for 
the gToup of LAc the subgroups are 
too ima to provide reliable respon- 
ses. 
The expression of safety concerns V&- 
ries according to the use of deception. 
X &hmidt, F- Emsr Internet advice by acupuncturists -a risk factor for cardiovascular patients? 
We are well aware of the ethical issues involved in this study. We- wanted to 
determine whether Internet advice 
pFtý patients at risk with a view of mi- 
numsing it. Iliese special circum- 
stances, we believed, allowed us to disregard informed consent in group 
A and B. We suspected that, with in- 
formed codsent, the risk of obtaining 
a false picture was considerable. ýIus 
we decided to conduct a comparison (group A and B v3 group 9 which, in 
fact, confirmed pur suspicion (see 
above). By debriefing all respondents 
in group A and B, and offering the 
chance to withdraw retrospectively, 
we attempted to minimise the ethical 
problems. We felt that our breach of 
Informed consent can be justified 
through our concern for patient sa- 
fety. 
This study has several limitations. In 
particular, the low response rate limits 
the ageneralisation of our results. Ad- 
ditionany, our descriptive statistics are 
sensitive to the totals from which they 
are calculated and it is important to 
describe thý response spread across 
various qualifications as well as the 
average values of all respondents. 
In conclusion, the recommendations issued by acupuncturists regarding 
smoking cessation are not based on 
the current evidence as to efficacy of 
this intervention and concerns about 
acupuncturists' attitude towards the 
potential harifi of electro-acu uncture 
emerge. 7bus, in this p=Z situa- 
tion, Internet advice is not as sound as 
one would hope it to be. 
There is a significant difference for Acknowledgments 
groups A and B regardiug the men- 
tion of risks of acupuncture treatment 
and for not recommending electro- 
acupuncture. It is, however, encourag. 
ing thatthe majority did not recom- 
mend ejectro-acupuncture ana mus 
seems to be aware of the evidence re- 
garding efficacy (Table 6). It is possi- 
ble dLat some respondents did not re- 
commend electro-acupuncture, becau- 
se, they generally do not apply it and 
not because of their belief in the evi- 
dence. 
We would Eke to than Dr. Adrian 
White for his support in the design 
and analysis of the study. 0 
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LETTER TO THE EDITOR 
Sir, 
Are asthma sufferers at risk when consulting 
chiropractors over the Internet? 
Classic chiropractic theory claims that vertebral sub- 
luxation blocks the flow of "innate intelligence" which, in 
turn, affects the health of asthma patients (1). Chiroprac- 
tors often use spinal manipulation (SM) to correct such 
malalignments and treat asthma (2). Several clinical trials 
of chiropractic SM exist, but the most rigorous ones are 
clearly negative (3,4). Chronic medication with corticos- 
Eeroids can lead to OSEeoporosis, a condition, which is a 
contra-indication to chiropractic SM (5). Given this back- 
ground, we aimed to determine whether chiropractors 
would advise an asthma patient on long-term corticos- 
teroids (5 years) to try chiropractic as a treatment for 
this condition. 
All 3SO e-mail addresses listed at wwwinteradcom. - 
com/chiro/html were randomised into two groups. A 
(deceptive) letter from a (fictitious) patient was sent to 
group A while group B was asked for advice on chiro- 
practic treatment for asthma as part of a research pro- 
ject. Thus, groups A and B were asked the same question 
in different contexts: is chiropractic safe and effective for 
an asthma patient on long-term steroids. After data col- 
lection, respondents from group A were informed that 
the e-mail had been part of a research project, 
Of 97 e-mails in group A, we received 31 responses 
(response rate = 32% (95% Cl, 0.23-0.41)). Seventy- 
four per cent (23 respondents) recommended visiting a 
chiropractor (95% Cl, 0.59-0.89). Thirty-five per cent 
(11 respondents) mentioned minimal or no adverse 
effects of SM (95% Cl, 0.18-0.52). Three chiropractors 
responded that some adverse effects exist, e. g. risk of 
bone fracture, stroke. Two respondents noted that other 
investigations (X-rays, spinal and neurological examina- 
tion) were required before chiropractic treatment. 
Three respondents suggested additional treatments and 
one warned about a possible connection between 
asthma and measles vaccine. Of 77 e-mails sent to group 
B, we received 16 responses (response rate = 21% 
(95% Cl, 0.17-0.25)). Eleven respondents (69%) recom- 
mended visiting a chiropractor (95% Cl, 0.46-0.91). 
Ten respondents mentioned minimal or no adverse ef- 
fects of SM (95% Cl, 0.39-0.87). Five chiropractors re- 
sponded that adverse effects of SM exist (e. g. bone 
fracture). Five respondents suggested pre-testing of the 
patient to check bone density, allergy, diet, exercise level, 
hydration and blood. Additional treatments were 
recommended by three respondents. The pooled results 
of groups A and B suggested that the majority of 
chiropractors recommend chiropractic treatment for 
asthma and the minority mention any adverse effects 
(Table 1). 
Our results demonstrate that chiropractic advice on 
asthma therapy is as readily available over the Internet 
as it is likely to be misleading. The majority of respon- 
dents from both groups (72%) recommended chiroprac- 
tic treatment. This usually entails SM, a treatment 
modality which has been demonstrated to be ineffective 
in rigorous clinical trials (3,4,6). The advice may also be 
dangerous: the minority of the respondents of both 
groups (17%) caution of the risk of bone fracture. Our 
findings also suggest that, for the research question 
asked, a degree of deception is necessary The response 
rate in group B was 12% lower than that of group A, and 
the answers received differed considerably between 
groups. In group A, 10% acknowledged the possibility of 
adverse effects, this figure was 33% in group B. 
In conclusion, chiropractors readily provide advice 
regarding asthma treatment, which is often not 
evidence based and has the potential to put patients at 
risk. 
Katla Schmidt was supported byThe Pilkington Family 
Trusts 
TAsLE 1. Responses for efficacy and safety for groups A and B 
Group A (n=31) (%) 
Efficacy 
1. Chiropractic treatment recommended 23(74) 
2. Insufficient evidence for recommendation 2(6) 
3. Chiropractic treatment not recommended 6(20) 
Safety 
1. Minimal or no adverse effects mentioned 11 (3S) 
2. Adverse effects mentioned 3(10) 
3. No comments about adverse effects 17(55) 
Group B (n= 16) (%) Groups A+B (n=47) (%) 
11 (69) 34(72) 
2(13) 4(9) 
3(18) 9(19) 
10(63) 21 (45) 
5(31) 8(17) 
1 (6) 18(38) 
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Letters 
United Kingdom for six years and had not 
travelled abroad in the recent past or had 
contact with rubella. The mother was 
susceptible to rubella on routine antenatal 
testing at 12 weeksgestation. The infant was 
bom at 34 weeks'gestation with intrauterine 
growth restriction and thrombocytopenia 
but no other serious sequelae. 
The infant and mother both tested posi- 
tive for rubella IgNt The mother gave a dear 
history of a transient, non-itchy rash at 26 
weeks' gestation. We could not find any 
social or community link between this 
mother and those in our two previous cases. 
Rubella is highly infectious. In a recent 
case report from another London hospital 
rubella virus was nosocomially acquired by 
an infant being cared for in the same 
neonatal nursery as an infant with the 
congenital rubella syndrome! As we know 
that at least three infants are excreting 
rubella virus in north west London, we now 
test for rubella IgM in all infants with severe 
intrauterine growth restriction (birth weight 
< 3rd centile). 
We believe that rubella infection may 
be underdiagnosed, given the recent 
decline in uptake of measles, mumps, and 
rubella (MMR) vaccination and the exist- 
ence of at least five cases of congenital 
rubella infection in areas of London with 
large numbers of immigrant women from 
countries where rubella is endemic and 
childhood vaccination is not routine. A 
review of antenatal screening data from 
maternity units in north London showed 
that 23% of primiparous women of 
Sri Lankan origin were susceptible to 
rubella on routine antenatal screening 
testing in 1996-9 (P Tookey, personal 
communication). 
A high index of suspicion and appropri- 
ate investigation of any suspicious rash in 
pregnancy are needed if the devastating 
efrects of the congenital rubella syndrome 
are to be prevented from again becoming 
widespread in the United Kingdorm Clear 
guidelines on the management of, and 
exposure to, rash in pregnancy are con- 
tained in a report fom a working party of the 
Public Health Laboratory Service. ' 
Primary healthcare workers and mid- 
wives need to be aware of the need for 
targeted inummisation before pregnancy 
and for extra vigilarim particularly in 
women of childbearing age who have 
recently arTived fi-om countries where 
rubella is endemic. 
Roslyn M 11101nas MMUaUrPaediatricim 
Nilesh M Mehra *eeld'st reotr-, -Wal inte-i- 
efft unig 
Northwick Park Hospital, Harrow HAI KU 
roo. thomas@nwl&nhs. uk 
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Survey shows that some homoeopaths 
and chiropractors advise against MMR 
EDrroit-Vaccination for measles, mumps, 
and rubella (MMR) is highly controversial. ' 
One of us (EE) found that some providers of 
complementary medicine have a negative 
attitude towards immunisation! We there- 
fore evaluated and compared the response 
of professional homoeopaths, chiropractors, 
and general practitioners to an inquiry 
about MMR vaccination. 
We obtained the email addresses of the 
three health professions from these websites: 
www. homeopatILco. uk/duwwry, wwwxbiro- 
online. com/inter-adcom, wwwinternetgp. 
corrx/gpsites/alphabetham We also visited 
die private homepages of homoeopaths and 
chiropractors on die interriet. We sent a letter 
in which a mother asked for advice about the 
MMR vaccination for her I year old child to 
all the addresses. We explained to all those 
who responded that the query was, in faLt, 
part of a research project. giving them 
opportunity to withdraw their answers. The 
study was approved by die local ethics 
committee. 
We contacted 168 homoeopaths, of 
whom 104 (72%) responded, 27 (26%) with- 
drawing their answers. We contacted 63 chi- 
ropractors, of whom 22 (44%) responded, 
six (27%) withdrawing their responses. No 
general practitioners responded. The table 
shows that only a few professional homoco- 
paths and a quarter of the chiropractors 
advised in favour of the MMR vaccination. 
Almost half of the homoeopaths and nearly 
a fifth of the chiropractors advised against it. 
These data suggest that some providers 
of complementary medicine are advising 
people against government policy. General 
practitioners, on the other hand, seem not 
respond at all to patients' emails on this 
delicate matter. 
K Schmidt PUkiVon raearchfiUoto E Ernst dwedor 
Department of ComplementAry Medicine, 
University of Exeter, Exeter EX2 4NT 
I Feffiman A. London snaycmr attacked for doing'Vreý 
ble dainageon MMP- BAV2002; 325-66. (13jtdy) 
2 Ernst L Rm in populmity of complernetnazy and altema. 
tiw medicine: teaýu and consequences for vaccinittion. 
Wý 2002,20: S90-3. 
Trying to find biological cause for autism 
does not make sense 
EMOR-Can vaccines cause audsm? Not 
really. Autism has no actual physical form; it 
is identified and diagnosed behaviourally, 
and most medical practitioners do not 
possess psychological competence. I am 
therefore not sure that something like 
autism is entirely contained in the medical 
sphere. I am a social psychologist and there- 
fore interested in human interaction and its 
effects on behaviour. I am autistic myself and 
was not immunised with the measles, 
mumps, and rubella (MMR) vaccine. 
Kurt Lzwin, founder of group dynamics 
in social psychology, found that there are sy3- 
tems based around any individual that give 
rise to tensions between individuals. 1 These 
tensions operate Eke electrostatic fields and 
interact, resulting in behaviour (as people 
sense and perceive, and then construe) that 
reorganises the tension systern. The occur- 
rence of "problem behaviours" might be seen 
as the end result of a system reorganising in 
such a way as to "force a "leak7 of behaviour 
at the point of least resistance. 
The Fumish neuropsychologist Timo 
jk"Aehto seems to support this idea firom a 
social neuropsychological viewpoint! His 
work accentuates the existing neurobiological 
substrate that can be said to underlie any per- 
soWs behaviour but that none the less cannot 
possibly be the sole cause of that behaviour. 
We cannot assume that autism is an "Hi- 
ness" with the same types of actiological 
factors seen it% for example, haemorrhoids. 
Autism is best seen as a continual set of 
possible response states by the individual, 
concerned with inhospitable situational fac. 
tors with which he or she has to deal. It is 
the best possible defensive response by the 
autistic person to the expectations and atti- 
tudes of the society into which he or she has 
been born. An autistic person may behave 
totally differently in any two different situa. 
tions, which seems to support the notion of 
tension systems in that person's system that 
encompass organism and environment. ' 
I believe that biological causes for 
autism cannot be found. regardless of 
contributory factors. For this reason, I find 
the whole vaccine debate tiresome. ne 
research should be oriented to discovering 
the types of interactions between the person 
and his or her environment are that bring 
about autistic states. Trying to find a biologi- 
cal cause for autism is akin to attempting to 
find a psychological basis for pfleL 
David N Amdrews psychala& in training 
SatarnakAtu 15 B 15,48100 KotkA, Finland 
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Responses of three health professional groups to letter from mother asking for advice about 
vaccinating I year old child against measles, mumps, and rubella 
Response rate 
Professional group (% (No)) 
HomoeopaMs (n. 168) 72(104) 
Chiropractors (r-63) 44(22) 
General pracNoners 0 
D-111) 
Withdrawal rate No (%) advising No (%) advising against 
(% (No)) Immu"llation* Immunissficts* 
26 (27) 2/77 (3) 31/77 (40) 
27(5) V16 (25) 3116(19) 
NA -iw 
Tirectly or Indirectly (of those who responded and did not withdraw). NA-not applicable. 
NA 
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Abstract 
We wanted to investigate what advice UK homeopaths, chiropractors and general practitioners give on measles, mumps and rubella 
vaccination programme (MMR) vaccination via the Internet. Online referral directories listing e-mail addresses of UK homeopaths, 
chiropractors and general practitioners and private websites were visited. All addresses thus located received a letter of a (fictitious) patient 
asking for advice about the MMR vaccination. After sending a follow-up letter explaining the nature and aim of Us project and offering the 
option of withdrawal, 26% of all respondents withdrew their answers. Homeopaths yielded a final response rate (539/0, n= 77) compared to 
chiropractors (32%, n= 16). GPs unanimously refused to give advice over the Internet. No homeopath and only one chiropractor advised 
in favour of the MMR vaccination. Two homeopaths and three chiropractors indirectly advised in favour of MMR. More chiropractors than 
homeopaths displayed a positive attitude towards the MMR vaccination. Some complementary and alternative medicine (CAM) providers 
have a negative attitude towards immunisation and means of changing this should be considered. 
(D 2002 Elsevier Science Ltd. All rights reserved. 
Keywords: MMR; Vaccination; Internet advice; Complementary practitioner 
1. Introduction 
Complementary and alternative medicine (CAM) raises 
much public and professional interest and the predictions are 
that CAM will become even more popular in the future. In 
the United States the CAM usage in the general population 
has risen from 33% in 1990 to 42% in 1997 [1]. In the UK 
this number is smaller (20% in 1999) but also increasing [2]. 
The reason people turn to CAM are diverse, one is dissat- 
isfaction with areas of the mainstream medicine, including 
immunisation. 
Immunisation is presently a highly controversial topic. 
Many CAM practitioners are supporters of the 'anti- 
vaccination movement'. The measles, mumps and rubella 
vaccination programme (MMR) has been of recent concern 
among professionals, parents and the general public. This 
concern was caused by claims that the MMR vaccination 
could be related to autism, Crohn's disease and inflamma- 
tory bowel disease (3]. As a consequence, rates of MMR 
vaccination fell from 92% in 1996-1997 to 88% in 1998 
[4]. In a survey for BBC Radio 5 Live, more than half of 
Corresponding author. Tel.: +44-1392424-839; 
fax: +44-1392424-989- 
E-mail address: kaýa. schmidt@pms. ac. uk (K. Schmidt). 
GPs surgeries reported that the uptake of the MMR vaccine 
had fallen [5]. 
Anti-vaccination groups and campaigns are gaining sup- 
port, particularly in the USA and Western Europe [6]. Chi- 
ropractors, homeopaths and naturopaths often advise their 
clients against immunisation [7]. In a survey investigating 
US chiropractors' attitudes, one-third agreed that there is 
no scientific proof that immunisation prevents disease and 
that vaccinations cause more disease than they do prevent 
[8]. In an Australian survey 83% of all Sydney homeopaths 
did not recommend immunisation [9] and a German survey 
found that active immunisations against the 'classic child- 
hood diseases', including MMR are used with more restraint 
among homeopathic physicians [10]. In another study of 
117 Austrian homeopaths only 33 homeopaths rated im- 
munisation as an important preventive procedure [I I]. The 
chiropractic profession has also repeatedly expressed their 
negative view on vaccination [12]. The reasons for this 
are complex and rooted in the early philosophy of these 
approaches to healthcare. The early chiropractic philoso- 
phy considered most diseases to be a result of spinal nerve 
dysfunction caused by misplaced vertebrae. A minority of 
chiropractors is still accepting this concept [13]. 
On this background, the purpose of this survey was to 
investigate what advice UK homeopaths, chiropractors and 
general practitioners give regarding MMR vaccination. 
0264-41OX/02/$ - see front matter C 2002 Elsevier 
Science Ltd. All rights reserved. 
p1l: S0264-41OX(02)00628-X 
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2. Method 
All e-mail addresses listed in UK practitioner referral 
directories online and private websites were extracted. 
Homeopaths' e-mail addresses we found at http: //www. 
homeopath. co. uk/directory and at homeopaths' private 
homepages. Chiropractors' e-mail addressees we recruited 
from http: /Avww. chiro-online. com/interadcom/engl-dc. html 
and at various chiropractors' private homepages. GPs' 
e-mails were extracted from http: //www. intemetgp. com/ 
gpsites/alphabet. htin. We also intended to involve natur- 
opaths. However, no database for UK naturopaths was 
accessible. Thus, only homeopaths, chiropractors and GPs 
were chosen. 
All practitioners thus identified received the same query 
about MMR immunisation from a mother hesitating to give 
the MMR vaccine to her baby daughter (Appendix A). Af- 
ter 2 weeks of data collection (spring 2002), all respondents 
were informed that they had received an e-mail from a fic- 
titious patient, as part of a research project. Confidential- 
ity was assured, the intention of the project was explained 
and all participants were given the option of withdrawing 
from the project at this stage. Consent was implied through 
a non-response to the follow-up e-mail (Appendix B). 
The following criteria were applied for evaluation of the 
remaining data: (1) Do practitioners respond to requests for 
vaccination advice by e-mail? (2) Do the respondents advise 
in favour of vaccination? (3) Are there statistically signifi- 
cant differences between the three groups regarding the na- 
ture of the advice given? Responses were categorised into 
(a) advising to have MMR (positive response), (b) advising 
not to have MMR (negative response), (c) indirectly advis- 
ing to have MMR (for instance, using phrases, such as "If 
I had a child I would probably sway towards vaccinating it 
using the MMR vaccine") (positive response), (d) indirectly 
advising not to have MMR (for instance, stressing that own 
children were not vaccinated, or using phrases, such as "in 
principle I am against inoculation! ' or "I would most likely 
look at alternatives to vaccinatioW') (negative response), (e) 
advising to obtain as much information as possible (neutral 
response), (f) no advice (neutral response) and (g) advis- 
ing to have separate vaccinations for measles, mumps and 
rubella. Our local ethics committee gave ethical approval to 
the protocol of the project in April 2002. 
The responses were analysed independently by two 
blinded researchers. X2 analyses were employed to sta- 
Table I 
Professional grOUP 
tistically assess differences between groups using SPSS 
statistical software. 
3. Results 
One hundred and sixty eight e-mail addresses of home- 
opaths; were contacted (Table 1). Of the 144 e-mails that 
were delivered we received 104 responses (response rate = 
72%). Of those, one response arrived at a date beyond the 
deadline. Twenty-seven homeopaths (26%) wished to with- 
draw from the project after being debriefed about its na- 
ture. Of the 77 participating homeopaths, none advised the 
mother in favour of the MMR vaccination for her daughter, 
3 (4%) openly advised against the MMR vaccination, 2 (3%) 
homeopaths indirectly advised to get the MMP, 28 (36%) 
indirectly advised not to have the MMR, 22 (29%) advised 
the mother to obtain as much information as possible before 
deciding, 14 (18%) gave no advice but offered their tele- 
phone number or a consultation with another homeopath, 
5 (7%) advised to get individual vaccines and two home- 
opaths (3%) suggested neither to have the MMR nor any 
homeopathic vaccine but to treat the illnesses individually 
with a homeopathic remedy when they occur. Twenty-one 
different websites were recommended for further informa- 
tion. 
Sixty-three e-mails to chiropractors were sent out, of 
which 50 were delivered. We received a total of 22 responses 
(response rate 44%). Six chiropractors (27%) withdrew their 
response. One chiropractor (6%) recommended getting the 
MMR vaccination, three (19%) indirectly advised not to 
have MMP, three (19%) more indirectly advised having the 
MMR and a Ruihcr three (19%) advised to obtain as much 
information as possible before making a decision. Five chi- 
ropractors (3 1 %) gave no advice and one (6%) suggested 
getting individual vaccines. Three websitcs were suggested 
by chiropractors for further information. 
We sent e-mails to III GPs, of which one message was 
returned. We received no responses from GPs. We therefore 
decided to send the same letter to National Health Service 
(NHS) Direct and received the following reply "... (we) are 
unable to provide advice on the MAM vaccine. We are able 
to give general information about the vaccinefrom accred- 
ited public health websites only. We cannot advise you on 
single dose vaccines, or where to obtain them. " NHS Direct 
recommended four websites for more information. 
Response rate (*/o) Withdrawal rate (6/. ) 
Homeopaths (n - 168) 104(72) 27(26) 
Chiropractors (n - 63) 22(44) 6(27) 
General practitioners (n 0(0) NAb 
Advise to immunisci Advise not to 
immunisel (%) 
2/77 (3) 31/77 (40) 
4/16(25) 3/16 (19) 
NA NA 
$Directly or indirectly (of those who responded and did not withdraw). 
bNA: not applicable. 
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Using X2-test to compare responses between homeopaths 
and chiropractors, we distinguished between positive and 
negative attitudes towards MMR. There was no significant 
difference in negative attitudes between responses from chi- 
ropractors and homeopaths, X2 (1, n= 92) = 1.74 (P = 
0.05). However, there was a significant difference in positive 
attitudes between the two groups, X2 (1, n= 92) = 10.18 
(P = 0.05). Significantly more chiropractors displayed a 
positive attitude towards MMR vaccination. 
4. Discussion 
None of the practitioners involved in this study can be 
seen as representative of any organisation nor are they rep- 
resentative of their profession. When visiting websites of 
homeopaths' and chiropractors' organisations, no policy 
statements for guiding parents on the vaccination debate 
were found. 
Our results confirm previous observations [5] that some 
CAM providers advise their patients against immunisation. 
The conclusiveness of our findings is limited by the small 
sample sizes and the low response rates. The sample sizes 
were determined by the number of e-mail addresses we were 
able to locate. The response rates were reduced through the 
option of withdrawal, which we felt was an ethical imper- 
ative. Initially, homeopaths showed a good response rate 
(72%) compared to chiropractors (44%). These figures were 
reduced to 53 and 32%, respectively, through subsequent 
withdrawals. Remarkably, GPs unanimously abstained from 
advising over the Internet, which resulted in a response rate 
of zero. No homeopath and only one chiropractor directly 
advised in favour of the MMR vaccination. Two homeopaths 
and three chiropractors indirectly advised in favour of the 
MMR. More chiropractors displayed a positive attitude to- 
ward the MMR when compared to homeopaths. 
We are keenly aware of the fact that this study raises im- 
portant ethical issues, it represents research on human sub- 
jects without informed consent. In order to minimise our 
ethical dilemma we fully debriefed all participants after re- 
sponses had been received. This step does not, however, en- 
tirely solve the ethical problem of not obtaining informed 
consent. Informed consent would have rendered this project 
impossible. We (and our ethics committee) felt that identi- 
fying a potential safety issue in the interest of public health 
had sufficient potential benefit to outweigh the small risk, 
namely wasting practitioners time or alienating them. In fact, 
several respondents were appreciative of our project and ac- 
cepted that it might contribute to participants' re-thinking 
their position on the MMR-vaccine and the nature of any 
advice given on the Internet. Others felt that a study such as 
ours could help CAM professions to be more accepted and 
to obtain a better status in healthcare. Unfortunately, we also 
received three official complaints about our investigation. 
If one accepts, firstly, that MMR vaccination does more 
good than harm and, secondly, that some CAM providers are 
an obstacle in obtaining this net benefit, one must consider 
ways of changing the attitude of such practitioners. Obvi- 
ously, this is much easier said than done. We believe that 
a strategy to achieve this aim should include a rational and 
open debate about the pros and contras of immunisation in 
the chiropractic and homeopathic literature. Moreover, the 
media would have an important role to play in objectively 
informing both, the general public and the growing popula- 
tion of CAM providers on the potential risks and benefits of 
(MMR) vaccination. 
In conclusion, our study has confirmed previous inves- 
tigations, suggesting that some CAM providers have a 
negative attitude towards immunisation, specifically MMR. 
With the raising popularity of CAM this could amount to a 
major threat to public health. Ways of rationally debating 
the issues with proponents of CAM should therefore be 
found. 
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Appendix A 
Dear homeopath/chiropractor/GP, 
My I year old daughter is coming up for MMR vaccina- 
tion but I am not sure whether she should have the MMR 
at all. I want the best for her but there is so much about it 
in the news at the moment. My friend has been told by her 
therapist better not to get the MMR for her son. Can I ask 
your advice? Should I go ahead with the TATAR, should I 
try separate vaccination or should I not vaccinate at all? Or 
perhaps, is there an alternative to vaccination? 
I would very much appreciate your opinion. 
Best wishes, Laura Phillips. 
Appendix B 
Dear homeopath/chiropractor/GP, 
A few weeks ago you received an e-mail from a young 
mother asking you for advice on vaccination for the im- 
munisation of her child. The patient 'query' you received 
was part of a research project investigating homcopaths'/ 
chiropractors'/GPs' responses to this vignette. The aim of 
the project carried out by the Department of Complemen- 
tary Medicine, University of Exeter is to investigate what 
sort of MMR advice is given via the Internet and to publish 
the results in a scientific peer-reviewed journal. This study 
is part of a wider research project about the safety of Inter- 
net advice and our protocol has received ethical approval by 
an indepcndcnt ethics committee. 
You can rest assured that confidentiality will be strictly 
observed and that at no stage will your identity be disclosed 
K. Schmidt, E. ErnsilVaccine 21 (2003) 1044-1047 
to anyone outside this research project. If you have any 
questions, please do not hesitate to send me another 
e-mail. 
This e-mail is a follow-up, asking you retrospectively for 
your informed consent. If we may use your original re- 
sponse you do not need to reply to this. We will then as- 
sume you agree. However, if you would like to withdraw 
from the study please reply to this e-mail and state that you 
would like to withdraw, in which case we will exclude your 
response from the report and completely remove it from 
our records. Responses received 14 days after we have sent 
the original e-mail will be discarded and counted as non- 
responses. 
Thank you very much for your understanding. 
Best wishes, Kaýa Schmidt. 
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MISTLETOE FOR CANCER? 
A SYSTEMATIC REVIEW OF RANDOMISED. CLINICAL TRLMS 
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f46tletoe extracts we widely used in the treatment of 
camer. The results of clinical trials am howevw highly incon- 
sistenL We therefom conducted a systematic review of all 
randombed clinical trials of this uncomenctional thwWy. 
Eight dstabases were searched to Identify all stucries that met 
our Incluslonlexcliuslon criteria. Daft war% irml4pendently val. 
idated and extr2cted by 2 "hors and checked by the 3rd 
according to predefined criteria. Statistical pooling was not 
sable because of Ow ~--asne-M-y - the primary studies. 'r"re 
A narrative systim"atic review was conducted. Ton 
trials could be Inckided. Most of the studies had considerable 
weaknesses In terms of audy design, mportint or both. 
Sor" of the weaker studies Implied benefla of mistletoo 
exawts, particularfy In turrin of quality of [We, f4one of the 
y1cally = tftb exhibited wfflcacy In tarms me!: doh 
IF quolity 11* Surv or odbw outcome measures. 1111196r- :T L. 
trai. 1sof mistletoe extracts ftJl to dei onstrate eftecy of 
this therapy. 
0 2003 Wiley-List. hw. 
Key words: saisderve: alternative inedicime. viscuot album cam-or 
"Alternative" cancer curts remain in wideq)read use. 1 Puticu. 
lady in continental Europe, mistletoe (v4cum album) extracts 
(anthroposophical or hertial remedies) are amongst the most popý- 
ulAr ouch dwapies-3 Mom than W $30 million is spent on Iniij- 
detot extracts annually In Germany and the yeady increase i_0 sales 
has been estimated at 20%. 3 It is therefore imporumt to ask 
whether MiSdew CXWAMS M Of benefit tO CAACer patients. Nu- 
mcrous clinical trials have Attempted to answer this qucsdon with 
high)y varyiog ri8our and results, the study of Majcwgki and 
Bentelp-, Several mviews have summarised Tbc clinical tvidatice, 
for example- mferences 5-10. Mn only syste7natic review of the 
subjeo concluded in 1994 duLt "the wie of gnisdetoe extfacts in the 
treatzn= of cancer patients (cannot be recommended] with an 
! Xccption for paticots involved W clinical trials. "10 M113 MVICW 
included nourandomised studies and inky themkire hove been tVen 
to biu. MuMver, it Is 'low ouLdated As several now trials have 
smergedL 
The cufrent wticle iS aimed K critically evaluating the evidcrice 
for or apinst mistlewe extracts as a treatment of cancer from 11) 
randomised clinical alals available to date. 
MATERML AND 36MTHODS 
systematic literature searches of Medline, Embase. BIOSIS. 
Afý, = (Britith Ulwary), Scitusa. Clinical trials. com, CISCOW 
(Research Couwil for Complementary Medicine, London, UK) 
and the Cochrane Library (sJU fivm thcir reipective inception to 
july 2oa2) wen performed to Idwdry all randomiaed clinical uialo 
of mistiewe fix any type of human cancer. 711a search tents were 
alternative medicine, cancer. controlled chnicW trial. Eurixory, 
Heijxor*, Iscado&, lectia. malignancy, Nstel, mistIctoe antl de- 
rivatives. In addition, manufacturers of commercial miqderoe 
products and uLhcr experts wem asked to contribute published as 
well as unpublished materW, and our own ext6a6ive Ales were 
hand-scarcbed. A manual Oc=11 was also performed of the bibli. 
o8raoies of studies and reviews located through the compuwlr 
searcbes and through scaArking Our Own dles. 
All prospective- randotnised. clinical trials (RCT3) conducted 
with bum&" cancer *entS wcre conxiLkned. RCTs were excluded 
if they only reported rionclinical outcome Measures, e. 9, immu- 
nological parametm, or failed to Include an adequate comparison 
SMP (e. g., one Mistletoe Prquittion vs. another). DUAI publia- 
bons were only 1rcluded once. All misdetoc preporitions were 
considered. including pure mistletoe 1cctin prcpastioas. No lan- 
guago restrictions*wers impo3e4L Both adjuvant and mano-tberapy 
trials of mi6detoo extracts wem considered. Dam cxtrwtion and 
validation waft performed by 2 authors and chocked by die third 
author using standardi3ed. prodefincd criteria: study design, sam- 
ple size. patient description. interveritions, primary endpoints =d 
main results. The scoring system developed by laded et al. 11 was 
used to evaluate methodological quality (Table 1). Statistical pool- ing of data had been anticipated. bowever. due to the heterojeneiry 
of the primary studies, this plan had to be abandoned. 
RESULTS 
Ten RCTs met our inclusion critcsi& Key data we vmamadsed in Table I and described in narrative ibirm below, 
Doawes and colleaguesiz randmnised 60 padecEs with histolog. ically verified metastatic colorecral carcinoma Inuo 3 groups. Group A received only chemodwapy (5-fluoruracil &ad folinic 
acid), group B -as treated with the mistletoe extract Hcaor* (slow. insidious commencement up to a dose of 200 ms daily stIbcManeous) plus chemodicrapy and group C wei treated with xcvopale paptides (Ney Tuinorins) plus chemodwspy. ne fra- 
quencles of complete rtmivsios. partial rernission. minimal re- sponse. cumour staxxis4W and progression were similar in all groups. Mcim survival time in groups A and 8 was about twice that 
of group C.. 
R is unclear wtdch of tbase endpoints was the primary outcome 
rneasure, the text implies Mat remission rates were the prýmary and 
survival dw secondary endpaiift. The " number ot chemnothcr. 
9PY Cycles in each group was nor a atcly reported. It was vot f eý )fV mentioned ho- many IRjections of elixor* or Ney Tumoritif won actually admin's, red and otber concomitant biolo&al wtu. men -ere administered but inadequatply accounted for. Finally, dtis 
:Z 
-as nix patient-bUnded. 
Dold et aL13 "riessed the offects of 18cador* (smup A) com. pared to PolyerpO (Sroup B). a glycopoptide extracted from the 
spleett of sheep. with a multi-vitamin 'Vbcebo' (group Q in 408 
patients widi histologically confirmed advanced nonsitudl-ce)l car- cinomiL Iscador* Q (oak ate) and bcadot4o U (elm tree) *ere used both *ich Hydrar8yrum DS (dilution 10-1), Patients were stratified accordial to clinical severity and stages groupings. The total drOP-out rate was 17%, yet no inteation-to-treat analysis was 
OC%)MVOI$dgz3cf 10! DCPAMMAA? of Otaftnolayngology, Todwigcho UnlvcWtit MgbchC"- KIfnIkUM fVChU ddr ISAt- ISIMAiDta3uuSC 2z 81675 MiirwMn. Coermuy. Fax: -49-0-89-41406347. &mail: 
Received 3 Fdwvwv 2UO3, Av-cpwd 14 Manb 2W3 
DOI)O. )oMjr-ll3% 
Ptsb6hOdOnlifit 6 Aup. 112003 ittWl)eytnwSciencs(www. LntersciaL: is. -iLcy. ctmk 
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carried OUL NUdian suitVival -" 9.1 (95 % CT: 6.8 - 10.7) months, 
9. () (1.1-t 1.5) months wid 7.6 (6.0-8.9) trionths for groups XB 
mid C, respectively. Two-year survival was 113%. L3.9% und 
10.1%. mpectLveiy. None of these diffirences was rAtistically 
significant- Quality of Ufe (measmil with the 
Karnotsky Index) 
wa similar in oil 3 groupt. However, more *cnts 'in group A 
experisaced intprovemear of their genwal well4being, 
Even though this was a relatively rigorous triaL it is not flaw less. 
Tim tack of piidcvtýbliacling rerAers the subjective cridpoints, of 
debadLe value. 'TU high dropout rate may hAve jeopardised 
compa, rability bera= gMpL No intentkon-w-wa analysis was 
paforrvýd. There was no check of compharim =4 the authors fail 
to mcnition the number of lscador* injections; that the patients 
actually received. The study was published In book form aod has 
therefore not passed the usual pea-review process. 
Salzcr cc at-14 randomUed 218 patients with histologically ver. 
ified norismull-call bronchial c2accr to receive the mistletoe extra" 
16c4doc* (group A) of no treatment (grivilt 8) to addition to 
CMVCUtior, J' Care. The report lacks inany Methodological details 
essential for evaluation. Tbe authors $tam that Iscadorill) is clini- 
c4y "clearly udvanotgeom however. from a statistical poiLt of 
view. there is no sIgnificarA differatce., .. 7 
Tle K*Ian. Mcicr 
curves pteitented in the "Cie suggc* a better survival rate of the 
experilmot4d oomPared to the control group, which becomes ap. 
parent after 2-4 years of therapy. 
This report provides little dam essential for aideid mluadogL 
The most reliable hard ondpoint is the rate or patients rerrilining 
free of recurrences, which does not show .1 statistically si"cgal 
C&CL 
LMNZ and Colleagues'$ randomised 35 patients with histolog- 
icaily verified gliorna (stage grouping TIT or lv) to receive ei&, er a 
Migle ICCti0-I (ML-1) St&UdMXdi*1! A1 Mistletoe eXUa" (I ng ML-1 
per kg twice weekly for 3 modths) or no such treatment in addition 
to Conventional cart 44. # surgery and raidiation). A raoSe of 
immunological parameters saved as primay outcome mea,, Ums 
" quality of Me (Spitm quadoaftaim) was 4uandfied as a 
secoit42ry endpoint. After 24 weeks of thempy. there was a dir. 
ference between die 2 groups of &bour 1.5 VjiOu 00 the Spim 
sc*. The authors report no statirtica) ANSCSSIneut (nor exact num. 
bas with stwitlud deviations) but noto that these was -1 consid- 
crable irnprovement for the vaum grourx" Pow yem aftr their 
initial publicalioo, a twit identical) team vf authors repomd the 
Mon ,, uTvivW rates Of this tri4 after 2 
tOUJ follow-up Of 50 ths. No 
beoebdal effect was noted in the total PlkTi=t group. A sub- 
analysis Of %LAO grouping aM patients, however. demotistritted 
4 0801=t PrOiOnSatiuu Of the Overall survival in the therapy 
group (20-05 = 3.5 month# vs. 9.9() = 2,1 month3). oq 
This study has several obvious drawbiwks. Ibc Clinical cndý 
points were employed as secondary outcome Mea., ums. aAd no 
evatuable results am preAwated for quality of life_ Lakck Of pii, ni. 
blinding, ubwace of adequate dwripfion: j Of candomi., acion or 
dropours/withcIrn-als and the small sample size constitute ructher 
wealma*& Most importantly, die 2 published reports Of tW3 
! rudy are highly InconsisteaL In the first ardcle. ci the simple size 
w 35, while in the StCorld. It it Is 38. In the first urtirle, is only stage 
vouPing M/IV PlLdcum wCFC mcnfioruxL while in the second 
publicatioA16 the authors diftlemadate between analyses of WI 
stages and one of ~ grouping IJIAv patients only. 
Mcirty, and Allbrecbtl? randomisted 79 patients with advanced 
colorectal cancer low 2 grwp. "e control group received gg, - 
dud cart while the f-xPcrimcnud group received 
in addition EuriAOr* (0-5-1 ng NM-1 per kS every 7--P hr for 8 
weeks, followed by 4 weeks no treUMVU and repeat ofcyck). 1he 
result$ $150wed dM &ignificanfly fewer patients in the experimental 
group SUMN4 hom mucusitis luage M. Similarly. the average 
length 01 "a COMPlicuiOd -3S Sigr1ificantly shorter in this group. 
ThM Wert DO Sig1lific-11111 diffUtnCeS ft remission rates, length of 
remissi- 1--urrim-r- isiterval of survival time- 710 primw 
endpoint of Ots mudy was quality Of lift that was quantified with 
a Vi3UA1 2=10900 W,: -* (VAS)- This PW=tff Significacttly favoured mistletoe. After 7 weeks of therVy. the difference 
amounted to 18 mm on a WO Mm VAS. 
Tbis study is burdened with Leveral problems. MV Authors %Utc 
%hat 107 paicicnis participsted in the trial but only 79 were random- 
ised. They note that the study was randomised but continue to 
explain that it fisilowed a matched pair debign. As the numbers in 
the 2 groups wen riot equal. a proper matc1ting 4dems implausibW- 
They aiso rziýntion that quality of We -as measured with a vc" 
mdnl scale but present the results of a VAS in com. The study was 
m *ect-bftdcd and sukadyi; outcome measures could dicre- 
fore be unreliable. 
Metberg cc al. 111 reported results for the EORTC Melivitnis 
Cooperadve Group (so fu only) in the form of an abstract. Mel- 
anoma paients were mdomised into 3 groups: low close r EFN-u2 
(WW or r IFN-y (0.2 mg) both subcurancous qod for 12 months 
or to placebo. All patients teceived staridard cut ii) addidon. The 
German Association of Medical Oncology adLko a Atli group to 
this triaL Tt consisted or patients treated with 1"or4P (subtuta- 
neous twice M week) and monitored every second month with a 
quality Of WO 111CMICID611t. Time to progression and leno of 
survival were the primary outcome metutures. Analysis was by 
intention to treaL Eight hubdrW thirty patients were followed for 
5.5 years on average. Compsci#ont were stratified by melanoma 
stage grouping at randomisation. Compared to placebo. the relxdve 
risk in the Iscado& group W discase-freii Interval was 1.33 (95% 
C1 0.93-). 89). Tbe stutliors conclude that *Vic clinical bc=fits of 
--- Ucador iuc most Uciy not iznportanO This saidy is difficult to "uste because the abstrisci Lacks sufficitat detail. 
A widely malled doctitzient from Madaus, Germany described 
dw following mW ticentre trial of Lektinol$ý a ML. I starulardised 
preparadort. 19 Two hundred sevewy-alne women with breast can- 
cer (TI-3 NO-N+ MO) were randomised after surgery into 4 
il"S: 5.15 and 35 AS ML twice weekly for 15 weeks of placebo. 
The study was doutile-blind. Two hundred 3ixty-LWO PalientS Weft 
included in the intention-to-treat wWysis. The treatment group 
recciving the idoesmedista dom "wed a sigaificant advantage in 
term Of quality of life (VAS. GLQR and Spitm Scale). rw 2 
other exPOtirOtfital groups yielded results that were similar to those 
of placebo. 
7bg results of this Study look encoutMing. Unfortunately it has 
114A Yet been Published in a peer-mviewed journal kthe manufac- 
Curer L11fortned us that publicatift of this tria is not pijinned). As 
the frequency of local adverse reactions increased with iAaessing 
doses, patient-bUnding may have been Inade4uare, whicls would 
seriou ily weakim the quality of life resulm The sbort promotional 
text 
= 
the ramufacturer tnay not be the best source of rclitblo infOrIttatiOn. and critical *valuation of these data is therefmc nA 
"sible. 
GrOssarth-Madock er at. " reported 2 RCTx including 49 and 17 
matched pain of patients with v%itious c&nce" with various Kqe 
groupings. These patients rwived either Iscadore (no mention ,r host tree) Of no such Adiumt therapy. Neither the doie. the type 
of IsWor* injected nor the treatment 3cheduk, were docum, 01cd. T'hO AuthOfs mPm SignificsotlY 100861 survival times (3-5 vs 2.5 
yeUs and 4.8 vs. 2.4 Years, no stud" deviations provided) for 
the experimcritid VYIUPL 
This smdy is either P00171Y NpOned or poorly cuodtwted or both. 
A detailed cotattienury is Qv%UbIC elsewhere and cuts serious doubt on the rigour of ads stotly. al The dam pmvided am incow 
Piece, cOrtfusidg. contradictory and 11MVIM of debatable value. Information is insufficient in respect of Infogingil cons"t. study design. randcniiisstiott and vngccictit schadulc No entry has tbat. 
fOm btcn m&& of this study in Table L 
Sleuer-Vogt and Coll-gues22 suidied a toW of 477 pisticaLs with Is" and neck squamous ceU cmbwmL patients in the expeli_ 
meDW ZrOVIP received suboutaneous injections of & milmletot ex. 
w4a (Eurixor's') with a 91AAdardised amount of mistletos lectin I (I 
allft bodywcighL twice vfflOklY Over 4 60-wmý periud). Treat- 
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ment cycles labied- 12 wecks followed by a mistletoe-free interval 
of 4 weeks. 71iree cycles were given in total. 71Z primurY end oint 
was disoasc-free survival (DFS). Disease-xpýcific Survival 
ISS) 
w2s a se=dary endpoiliL The 4usted hazard ratio for DIFS wits 
0.959 (95% C1 0.725-1.269). Five-year Survival and quaility of 16 
also did not significaritly favour nd3tlewe. The authors concluded 
that "the used mistletoe preparation has no Mcation in the adju- 
vaný treatment of patients -ith head and Aeck squartious cell 
carruwma. ' 
This stady Is probably the most rigorous rnistleme-trist pub- 
lislied to dat& It inchides a formal. power calculation. adequate 
follow-up and itntification ftw oonvcotional treatments. One 
weakness is the lack of pittabo and thus parient-blindiAg. 
TU most recent RCT of mistlew was published by Goebel) et 
al. 23 Forty-dve patients with pTa 0 1-2 bladder cancer were 
randomi*cd after *WLMMOU%l resection into receiving Adjuvant 
dwspy with 0.1 ml mistletoe lectin or no Stich therapy. The 
mistletoe treatment schedule commericcd 2 weeks after surgery 
arid involved rwice weekly subcutaneous injecti(mi of t tril cxna 
smridardised for the jalactoside-specific ML I for 3 months. Sub- 
sequently there were 3 months of no such 41jections followed by A 
second cycle. Recufftrice-free Interval und the total number of 
recurrences were dw endpoints during 18 rhonths of follow-up. 
goth variables did not differ significantly between groups: there 
were 30 and 31 recuTvnoes. and Ow recurrence fte intervals 
aveMed 9.0 and 10.5 months. respectively. Similarly. secondary 
ouwatnevuiables did not demonstrate statistically Significant or 
cu"Y relevant differctices between the 2 groups, 
Even though TvMvdy rijorous. this study has severd limim- 
done: it did not report quality of life- it was neidw placebe.. 
e"Wotled nor double-blind and. perhaps most importantly. its 
sample size was SnAll. 
DISCUSSFON 
The cOllective evidecce reviewed above does not lený strong 
support W the eflcacy/effectivcness of mistletod extracts as a 
curative or sUPPoWv0 cancer thempy. In reviewing II controlled 
clinical trials, Kkijnn and KApschild cum to slutila conclu. 
sions. 10 Only 4 of the II studies in their review were adequately 
randomised. In 1989, Kieve reviewed 46 clinical studies or mis. 
tlewcandstlivedatarnucbKoof encouraging over" rCSUILS This 
review inuluded uncontrolled. historically controlled and mtro. 
spective studies. As it is important to eliminate selection bias in 
clinjeW trials-, mw emphasis was an randoadsed scudies only. Apalt 
from one study. ý3 none Of dig included RCTS have carried out a 
power calcuMcm to estinwid how many p"cipanu are needed to 
be sum of finding somethinS important. Numerous other weaký 
nessa of the primary studies = mentioned above. The overall 
. 
pictm thm em6rpi shows; that those trials that are Lusufficiently 
vigoro" to be conclusive do not dernonarrate the effiný4veness of 
mistletoe OXUWt3. 
One p. robleal with our systematic review is tbata dlv*r3e variety 
of miwetoe extracts (differerit misdctoe species. different forms of 
extsudon and different host aws) and treatment regimen exist. 
Tivese had to be assessed together lot the Purpose of ibis article. it 
13 not always clear which extructs have been tested (Table 1). and 
the number of aWs on each extract is oot suffickadv large to 
conduct separate SYS%Msdc reviews. However, no cbeai evidence 
erneros firom this review that one Mul migIn be superior to 
another. -Claims about twAlth effects must idcally besusuined... 
for every single misdeme extracC16 aiad the Wdon of proof 
clearly reso wiEb those who manufacture iod promote dimm treat. 
ments. A further PrOblcm is that MISTIMe extrACU Are used for 
most forms of cancer. For the purpose of this rev iew. we thesvfýve 
WLNST ST Al- 
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pooled the data relzing to differeot types of malignancy. A&L 
the information currently available is too scant to allow sub3oaly- 
ses for diffmn: cancers. All one can therefore: state with confi- 
dence is that the existing evidence doci not imply that alisdetoc 
exuuts are mom effective for one type of umlipancy thin for 
another. 
Our sy%aemadc review was hampered by several uEher factors. 
Some trials ofmi5decoe appear irtrelatively 001curejoumals; even 
thouLb our 3earch strategy was thorcruot. we cannot be ubmAutely 
cerlain that all relevant RM were included. Many of t1w retrieved 
RCT* art poorly reported. Some have beert published 2-4 times 
with considerable contradictions between these repom. Some 
manufacturers were less dun helpful in assisting our c1foru. even 
doubting our motivation in conducting this review. We therefiort 
ftar that unpublished trials. if they cxlv4 may not bave been 
Included in our analysis. For obvious reasons, these would be 
studies with & negative result. 
The treatment of cancer *iLh mistletoe exuzets was *uSpsted 
by R. Sceiner, the founder or anduvpological medicine? Steiner 
was guided by philosophy rather than science. Considerinir Ws 
Ithrory it seems surprising " mistletoe extracts do, itt fact. 
possess several immunological cffects dw could be useful in %be 
tratment of cawer. Most importantly. mistletoe extracts have 
been shown to increase the severity of mmm necrosis factor ot- 
interleukin- I and interleukiv-4.2-1 7beso could decre3se Cancer call 
viability, 26 MueDce their migratory bchaviour" and render cancer 
cells own sensitivc to induction of a is. -$ While these effects 
appear encouraging. oat hai to consider that they an based on in 
virm experiments. Propnown of mistletoe therapy tend to cxtmp- 
ofate W optimistically &om the preclinical ADdinp to die clinical 
situation. " Furthemore, Cmbius and Gablus have pointed out that 
it-6tral in vitro, ipg vivo and clinical studies suggest that interieu- 
kids can al3o atirratiate (tather thart suppress) the proliferation of 
certain camer cells-6 h3 other words, mistletoe therapy has the 
portential W bar- cance patients. 
TbO notion that MiSletoe extracts may r4c alwayf he harmlest is finthOt SUPPQT%d by the fact that day me Contra-indicated fjw 
patients with Primary or secondary brain turnouts. leukatmias of 
malignant lYmPhotaLl" Adverse effects occur in up to 45VI and 
include local feactions at the site of injection, fever, elevation of intr3cembral pressure, swtWng of lymph Do&s, thrombop"Itis, headache, circulatory problems and allergic reactions including 
anaphylaxis. 30 This high frequency of adverse effects readcrv 
p[w, cbu-.: omolkd trials a near impossibility-& fact that deserves 
consideration when evaluating or planning Nturs clinical trials in dtis am&. 
The iSSUO arise$ 9f hOW to dtWdVtIY Answer OW qUlstiOn 
whether mistletoe extracts ate clinically efftcdvr- Obviously. we 
need high Q"UtY tdxlx conducted by trustworthy experts and 
monitored according to GCP guidelines. No leoG than 30 different 
mistletoe PrePwstifts Are On the CAM= Market. 31 As these vastly differ (for instance. LO 1OCtin wntent). o" preparation should be 
tested And avaluaied separately. As one cannot necessarily extrap. 
Olm ftm uni type Of cancer to Inodker. cub extract should be tested i's each cancer for which It is clairued to be effective. The MeNch &Oft thut; needed 13 huge, and Is seem unrealistic to 
cxPcct the necessary dwa to emerge in die foreseeable future. The 
mom reasortub)t alternative is therefore to irwst that mAnufactur.. 
US' cWmo am suppomed by convincing dam or they are not deemed acceptable. 
to conclusion. the evidence (TOM rigorous P'CTS Of mistletoe 
extroa does not Imply that this widespread and collectively costly 
then" has any benefit for cancer Patients. 
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Efficacy of Coenzyme Q 10 for Improved Tolerability of 
Cancer Treatments: A Systematic Review 
Liz Rol/c, Katia Schinith, and FtLard Ernst 
ABSTRACT 
Purpose 
The aim of this systematic review was to summarize and evaluate the evidence available 
for oral supplementation with coenzyme Q10 (CoQ1O) to improve the tolerability of 
cancer treatments. 
Materials and Methods 
Searches for all published and unpublished controlled trials were carried out on seven 
databases. Manufacturers of CoO10 were identified and contacted. Controlled clinical trials 
of monoprepa rations of CoQ1O administered orally to cancer patients were included. No 
language restrictions were imposed. Data were extracted independently by two authors 
according to predefined criteria. 
Results 
Six studies were included in the review, including three randomized clinical trials and three 
nonrandomized clinical trials. Patients in five of six studies received anthracychnes. The 
results suggested that CoCl 0 provides some protection against cardiotoxicity or liver toxicity 
during cancer treatment. However, because of inadequate reporting and analysis, as well as 
questionable validity of outcome measures, the results are not conclusive 
Conclusion 
Suggestions that CoClO might reduce the toxicity of cancer treatments have riot beer) 
tested by rigorous trials. Further investigations are necessary to determine whether COQIO 
can improve the tolerability of cancer treatments. 
J Clin Oncol 22: 4418-4424, @ 2004 by American Society of Clinical Oncology 
Complementary and alternative medicine 
(CAM) has become an important issue 
among cancer patients. The inability of con- 
ventional medicine to treat all aspects of 
cancer and the patients' desire for an ac- 
tive role in the decision-making process 
regarding their treatments have been re- 
garded as some of the contributing factors 
as to why CAM has become more popular 
over the last decades. " 
A systematic review of surveys on the 
topic included 26 investigations, from 13 
countries, published between 1977 and 
1998. The average prevalence of CAM usage 
in cancer patients was reported to be 31 O/o. ' 
A more recent survey of 148 breast cancer 
patients in the state of Vermont reported 
considerably higher prevalence figures; 
62.8% reported using at least one CAM 
treatment after surgery, with vitamins and 
nonfood supplements being the most fre- 
quently used. ' 
The widespread and well-documented 
use of CAM by cancer patients has led to a 
need for intensive research focused on the 
efficacy and safety of some of the CAM mo- 
dalities. Coenzyme Q10 (CoQ10), also 
known as vitamin QIO, ubiquinone, or 
ubidecarenone, is one of the top 10 comple- 
mentary therapies being promoted on the 
4418 
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Internet for cancer care. ' A Danish survey of 769 cancer 
patients found that 18% used CoQ10.7 
A coenzyme is an organic, nonprotein molecule that 
binds with a protein molecule to form an active enzyme. 
The formula of CoQ10 (C59H94104) is synthesized endo- 
genously in humans and is also found in virtually all 
aerobic organisms. " The primary action of CoQ10 occurs 
in the electron transport chain for cellular respiration. It 
is a lipid-soluble quinone and is essential for the synthe- 
sis of adenosine 5'-triphosphate (ATP). It affects the 
function of all cells in the body in its role as a mobile 
electron transporter, assisting enzymes in the oxidation 
of nutrients in the mitochondria of cells to produce 
energy for growth and preservation. 
' CoQ 10 is also me- 
tabolized to ubiquinol, which prolongs the antioxidant 
effect of vitamin E. 10 
CoQ 10 is widely promoted for enhancing or modulat- 
ing the immune system. Levels of immunoglobulin G in 
serum of patients treated with CoQ10 have been found to 
increase, " and in 1993, a small uncontrolled trial on 
healthy participants suggested that CoQ10 supplementa- 
tion may help support immune responses by increasing 
immunoglobulin G and T4/T8 lymphocytes. ' 2 Other un- 
controlled studies have suggested that CoQ10 maysuppress 
tumor growth. 13- '5 However, no controlled trials have been 
published assessing the use of CoQ 10 alone as a prevention 
or treatment for cancer in humans. 
CoQ 10 is manufactured as a dietary supplement by the 
fermentation of beets and sugarcane with yeast and is taken 
widely in Japan. In the diet, it is primarily derived from 
meat and poultry. "' After absorption in the gastrointestinal 
tract, CoQ10 is distributed to the liver and incorporated 
into very low-density lipoproteins. 
9 Serum concentrations 
of CoQ10 have been found to increase after ingestion of 
CoQ10 both as a supplement and postprandia1ly. " It is 
absorbed well but slowly from dietary and supplementary 
sources, with peak plasma levels occurring 5 to 10 hours 
after ingestion. 9 
Deficiencies of CoQ 10 in humans occur with age, the 
use of certain medications, and with diseases including 
cancer. " The incidence of CoQ10 deficiency 
has been 
found to be significantly higher in cancer patients than in 
healthy controls. 18 In a studyof 200 women hospitalized for 
breast cancersurgery, a CoQ10 deficiencywas noted both in 
patients with malignant (80 patients) and nonmalignant 
lesions (120 patients). '9 Serum levels of CoQ10 may be de- 
pleted by 3-hydro)cy-3-methylglutaryl coenzyme A-reductase 
inhibitors (including lovastatin), which are usually used for 
lowering cholesterol. 17 
Anthracyclines, commonly used in chemotherapeu- 
tic regimens, have been shown to 
interfere with the 
energy- generating biochernical actions of 
COQ1020,21 
and to generate free radicals, which affect cell growth and 
tumor production. CoQ10 is a free-radical scavenger, 
and its antioxidant activity and membrane- stabilizing 
properties help to protect against and repair damage to 
DNA caused by free radicals. The impact of free radicals 
on DNA is thought to be the link between free radicals 
and cancer formation. 22 
Nnthracyclines are also known to cause cardiotoxic- 
ity. 23,24 Acute toxicity is usually manifested by changes in 
ECG, including arrhythmias, but delayed dose-related car- 
diomyopathy can also occur, resulting in congestive heart 
failure 
. 
24 CoQlO supplementation can have favorable ac- 
tions in various cardiovascular conditions'; thus, studies 
have investigated the use of CoQ 10 for reducing the adverse 
effects of cancer treatments and have particularly focused 
on the card ioprotective effect of CoQ10 in cancer patients 
treated with anthracycline antibiotics. 
The aim of this systematic review is to summarize and 
critically evaluate the available evidence for or against the 
efficacy of supplementation with CoQ 10 for improved drug 
tolerability in cancer patients. 
Electronic literature searches were performed to identify all con- 
trolled clinical trials in which CoQIO was administered to cancer 
patients. The following electronic databases were searched from 
their inception until July 2003: the Allied and Complementary 
Medicine Database (inception 1985), the British Nursing Index 
(1994), CINAHL (1983), DH-DATA (1983), EMBASE (1966), 
MEDLINE (1966), and the Cochrane Central Register of Con- 
trolled Trials. The search terms used were cancer or oncolog$ or 
carcinogen$ or tumo$r and ubiquinone or ubidecarenone or co- 
enzyme QIO or CoQIO or CoQ 10 or CoQ- 10 or Co-QIO. Addi- 
tional hand searches were carried out on the bibliographies of the 
obtained articles and on our departmental files. 
Twenty-eight manufacturers from five countries were sent 
letters requesting details of any clinical trials they may have con- 
ducted with CoQ 10 on cancer patients. Three manufacturers re- 
plied, all stating that they had not conducted trials of this nature. 
No restrictions were placed on the language of publication. 
Studies were included only if they were controlled trials in which 
monopreparations of CoQ 10 were administered orally to cancer 
patients in addition to standard cancer care. Studies were excluded 
if they measured CoQIO levels rather than clinical effects of' 
CoQIO supplementation. Reviews were also excluded after the 
bibliographies were searched for more trials. Figure I shows the 
inclusion and exclusion process. 
Papers were translated in house by other researchers where 
necessary, and data was extracted independently front each study 
by two reviewers (L. R., K. S. ) according to predefined criteria. The 
methodologic quality of studies was assessed using the jadad 
score. " The Jaclad score is calculated by assessing the following 
three criteria: methods of blinding, randomization, and reporting 
of dropouts and withdrawals. The maximum number of points 
that can be achieved on the ladad score is 5. The heterogeneity of 
the studies precluded statistical pooling of tile results. Therefore, 
they were tabulated and described narratively. 
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19 arucieS relevant to 
CoQ 10 for cancer 
4 
Case reports 
2 studies 
did no( use 
monopreparations of 
COQJD 
2 studies investigated 
cancer protection in 
healthy participants 
not cancer patients 
6 controlW trials 
included 
3 
Preclinical/aninial 
studies 
I study used 
historical controls 
In I study 
COQ 10 was 
administered 
intravenously not 
orally 
Fig 1. F lowchart of excluded studies - 
CoO 10, coenzyme 0 10. 
Nineteen studies were retrieved in the literature searches. 
Six trials met our inclusion criteria. Two studies were ex- 
cluded because of the administration of combined treat- 
ments consisting mainly of 
CoQ10, vitamin C, vitamin E, 
beta-carotene, selenium, and zin C. 26,27 The extracted data of 
the six studies that met our criteria 
28-33 are listed in Table 1. 
21-11 
The included studies were carried out in Japan, 
Ita ly, 31,32 and the United StateS33 between 1982 and 1996. 
Three of the studies were randomized controlled trials. 
29-31 
There was one placebo-controlled 
double-blind stud Y. 28 All 
other studies were open trials 
in which the experimental 
group received CoQ10 plus standard care and controls re- 
ceived standard care only. 
Sample sizes ranged from 19 to 
88 patients, and dropouts and withdrawals were mentioned 
in two stud ieS. 32'33 All participants 
included in the studies 
had previously been 
diagnosed with various types of cancer. 
The ages of participants were reported 
in all but one study 
and varied widely across the studies 
(range, I to 71 years). 
One study included children. 
31 Sex was not specified in two 
studieS, 28,3' but all other studies 
included both male and 
female patients. 
Studies examined the protective effect of CoQIO 
against toxic adverse effects of cancer drug treatment and 
whether CoQIO improved the tolerance of anthracyclines 
or other cancer treatments. This was assessed using various 
measures of heart function and toxicity in five studieS29-33 
and using hair loss and liver enzyme levels in one study. 2' 
Cancer treatment included anthracyclines in all the studies 
except one, in which patients were treated with lovastatin. 33 
The CoQIO dosage ranged from 90 mg/d to 240 mg/d. 
Although daily recommended allowance has not yet been 
established for CoQ 10, manufacturers advise a daily intake 
between 10 and 100 mg. No toxicity has been reported for 
daily intakes as high as 300 mg. However, safety has not 
been established in pregnant or lactating women. 
The duration of treatment with CoQ 10 varied accord- 
ing to an individual's cancer treatment. No adverse effects 
of CoQ1O were reported in any of the studies. None of the 
included studies recorded sur-vival outcomes or measured 
changes in tumor responses. The individual studies are 
narratively described in the following paragraphs. 
Akihama et a128 investigated the protective effect of 
CoQIO against hair loss and abnormalities of liver enzymes 
during treatment with anthracycline antibiotics in a 
double-blind, placebo-controlled trial. Nineteen partici- 
pants diagnosed with acute leukemia, blastic crisis of 
chronic myeloid leukemia, or malignant lymphoma were 
included. Eight participants received 120 mg/d CoQ 10. No 
significant differences were found in hair loss between the 
experimental group and the placebo group. It was suggested 
that this might be a result of low absorption of CoQ 10 when 
administered orally. Serum levels of AST increased signifi- 
cantly in the placebo group (P < . 01) but not in the treat- 
ment group. 
larussi et al" conducted a randomized controlled trial 
of the protective effect of CoQIO on anthracycline cardio- 
toxicity. Ten of 20 children with acute lymphoblastic leuke- 
mia or non-Hodgkin's lymphoma were given 100 mg of 
CoQ 10 twice daily. Myocardial function was measured us- 
ing echocardiography. Measurements were taken at base- 
line, at a cumulative dose of 180 mg/rn-, and at the end of' 
treatment. A significant reduction in percentage of left ven- 
tricular fractional shortening was noted in both the CoQ 10 
and the control groups between baseline measurements and 
the end of treatment with anthracyclincs. In the control 
group, a reduction in percentage of left ventricular frac- 
tional shortening appeared earlier than in the experimental 
group. However, in the experimental group, no significant 
changes in left ventricular fractional shortening were found. 
A significant reduction in interventricular septal wall thick- 
ening was noted in the control group only. No significant 
changes were found in left ventricular posterior wall thick- 
ening in either group. The authors suggest that CoQI 0 had 
a protective effect on left ventricular global function and 
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Table 1. Controlled Clinical Trials of Orally Administered Coenzyme 010 for Improved Tolerance of Cancer Treatments 
No Participants 
Jadad of - Cancer Treatment Primary Outcome Within-Group Between-Group 
Reference Design Score Patients Type of Cancer No. and Dosage CoO10 Dosage Measures 
Results Results 
Akihama CCT 2 19 Acute leukemia 6 Anthracycline 120 mg/d for Hair loss; serum level of 
Both enzymes No si f ? ni icant 
et a 128 antibiotics: 
2-6 months AST and ALT liver levels raised in if d erences in hair 
Bl stic crisis of 
doxorubicin 2 enzymes the placebo 
loss or enzyme 
a in = 11) or group (P < . 01) levels between chronic 
myeloid 
daunomycin no significant 
i i 
groups no 
i ýi 
leukemia in - 8); cumulative 
d fferences n 
CoQ10 group 
protec on aga nst 
hair loss 
Malignant 11 dose: 50-100 
lymphoma mg 
RCT 2 20 Acute 17 Anthracylines, 100 mg bid, Card iotoxicity/myocardial 
Significant reduction LVFS reported to be larussi 
t at" lymphoblastic cumulative 
duration not function in % _VFSin significantly 
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was effective in protecting myocardial function during ther- 
apy with anthracyclines. 
in an open, controlled, clinical trial, Lucarelli et al" 
investigated the effect of CoQ 10 on toxic cardiopathy from 
antiblastic therapy with the anthracycline duanoblastine. 
Fifteen of 30 patients diagnosed with hematologic cancers 
took 30 mg CoQIO tid (Ubiten; Italfarmaco, Milan, Italy) 
for 30 days. Blood pressure, ECG readings, and heart rate 
were obtained at the beginning and the end of treatment. 
Systolic blood pressure measurements were taken at rest 
and after gentle exercise; after gentle exercise, the measure- 
ments were not significantly different in the treatment 
group compared with the control group, but when they 
were measured at rest, they increased significantly in the 
treatment group at the end of treatment (P < . 05). This was 
attributed to an improvement in general health. The dia- 
stolic pressure increased slightly in both groups and was 
reported to be significant in the experimental group. The 
authors suggest that a positive effect of CoQ 10 was demon- 
strated by improvements in general health and less cardio- 
toxicity. The ECG remained stable in more patients in the 
treatment group than in the control group. Nine patients in 
the CoQIO group had a normal ECG reading at the begin- 
ning of treatment, and six had a normal reading at the end 
of treatment; whereas in the control group, seven patients 
had a normal reading at the beginning of treatment, and 
four had a normal reading at the end of treatment. No 
statistical analysis of this difference was reported. No signif- 
icant alterations in heart rate or blood sugar were found in 
either group. Repolarization alterations were more frequent 
in the control group. No adverse effects attributable to 
CoQ 10 were reported. 
In a 13-center, randomized, clinical trial, Okuma et a129 
examined the protective effect of CoQIO in 80 patients 
treated with chemotherapy including doxorubicin. Patients 
suffered from 10 different types of cancer, including 30 
patients with lung cancer and 30 patients with malignant 
lymphoma. CoQIO was administered to 39 patients at a 
dose of 90 mg1d beginning I week before chemotherapy and 
continuing until the treatment with 
doxorubicin was com- 
pleted. Serial ECGs were recorded immediately 
before and 
after each administration of doxorubicin. QRS voltage 
de- 
creased in the control group but increased 
in the CoQ10 
group at treatments 1,2, and 3. QRS 
duration became 
significantly lower in the control group than the 
CoQIO 
group (P < . 05). 
QTc duration was significantly longer and 
QRS voltage decreased in the control group. In patients 
taking CoQ 10, both variables remained stable. 
In 1982, Takimoto et al" carried out a randomized, 
open study investigating the effects of 
90 mg/d CoQ 10 on 
myocardial toxicity 
during therapy consisting of an irradi- 
ation of cobalt and an 
infusion of doxorubicin, cyclophos- 
phamide, and fluorouracil. 
Forty patients suffering from 
lung, breast, and thyroid cancer received doxorubicin, cy- 
clophosphamide, and fluorouracil every 3 weeks for 4.4 -3 
months (experimental group) or 5.8 -± 3 months (control 
group). Twenty patients in the experimental group received 
CoQ10. Patients in the CoQIO group showed a significant 
increase in their cardiothoracic ratio when compared with 
the control group. There were no differences between the 
two groups in heart rate and ECG measures, such as QRS, 
ST segment, T-wave, and arrhythmia frequency. 
In 1996, Thibault et al" investigated the effect of 240 
mg/d CoQ10 on 88 cancer patients enrolled onto an open, 
controlled, clinical trial primarily designed to measure the 
tolerability of lovastatin when administered at progressively 
higher doses to achieve antiproliferative activity. Patients 
suffered from various forms of cancer. Patients were treated 
with four different doses of lovastatin, which was adminis- 
tered qid for 7 days in monthly cycles. CoQ 10 was admin- 
istered to 56 of 88 patients to prevent lovastatin- induced 
myotoxicity in stage 2 of the study. Of the 56 patients, only 
27 had previously been treated with lovastatin during stage 
1 of the study. The remaining 32 patients were treated with 
lovastatin only during stages I and 2. The activity of lova- 
statin was determined using biochemical measurements of 
pharmacologic parameters. Musculoskeletal toxicity was 
assessed, and toxicity was graded according to the National 
Cancer Institute Common Toxicity Criteria. Tumor re- 
sponses were also monitored. CoQ10 had no effect on the 
activity of lovastatin; cholesterol concentrations declined 
significantly in both groups, with no significant intergroup 
differences. The administration of CoQ 10 did not decrease 
the incidence of musculoskeletal toxicity, but its severity 
was significantly reduced. It is unclear whether the analysis 
was carried out with just the 27 patients in the CoQI 0 group 
who had previously received lovastatin or whether all 56 
patients who received CoQ 10 were included. 
These results indicate that CoQ10 may provide some pro- 
tection against toxicity associated with cancer treatments. 
However, weaknesses in the design and reporting of all the 
studies create ambiguity. The overall methodologic quality 
and reporting of the trials was poor. Between-group analy- 
ses, which are necessary to detect a therapeutic effect in 
controlled clinical trials, were absent from two studies. ' 1,32 
Sample sizes were small, with the exception of two stud- 
ieS, 11'3' and power calculations were absent from all reports. 
Only one trial was a placebo- controlled and double-blind 
study, " but it was not clear whether this study was randorn- 
ized. None of the studies scored over 2 points out of 5 on the 
jadad score. 
Certain aspects of methodology and statistical analysis 
were inadequately reported in all trials. The statistical values 
were lacking from all the studies, and few mentioned 
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whether baseline differences or withdrawals had occurred. 
None of the studies reported an intent-to-treat analysis. 
Only two studies mentioned the manufacturer of the 
CoQ10 used in the trial, and neither identified the actual 
preparation used (Table 1). Although we aimed to include 
only monopreparations of CoQ10, we cannot be certain 
whether emulsifying agents (which can include vitamin E) 
were present. 
Treatment controls varied across and within the trials. 
Individual differences in patient requirements prevent 
standardization of the type, dose, and duration of cancer 
treatments within trials of this nature. These and further 
variations in types of cancer and outcome measures made it 
impossible to submit these data to a formal meta-analysis. 
Despite this high level of heterogeneity, there were 
some common features between the studies. In five of six 
studies, anthracyclines were administered to patients as part 
of their chemotherapy regimen, and half of the studies 
measured ECG to assess cardiotoxicity. Between-group 
analyses revealed significant changes in QRS voltage, QRS 
duration, QTc duration, " and cardiothoracic ratio 30 in the 
control groups compared with the treatment groups. Thus, 
CoQ10 may have a stabilizing effect on the heart, but more 
definite conclusions cannot be drawn to because of insuffi- 
cient reporting of data. 
It was unclear in some studies precisely when the out- 
come measures were taken. Arrhythmia occurs during ad- 
ministration of anthracycline antibiotics or within several 
hours of treatment. Disturbances in electrocardioarrhyth- 
mia, such as lowered voltage of QRS complex, usually dis- 
appear spontaneously within hours or weeks after the 
completion of chemotherapy. 3" Therefore, the timing of 
measurements is critical for diagnosing acute toxicity. 
There is also controversy over the validity of different 
monitoring techniques for detecting cardiotoXiCity. 
24,34,35 
it has been suggested that ECG and echocardiography are 
limited in their ability to detect early reversible cardiac 
damage or disturbances and that radionuclide angiocardio- 
graphy provides more accurate measurements of left ven- 
tricular function. 34 The transient nature of ECG changes 
makes detection difficult, requiring 24-hour continuous 
ECG. 34 However, this was not carried out in any of the trials 
included in this review. 
The effectiveness of the dosages of CoQ10 adminis- 
tered in the studies reviewed here could not be evaluated. 
only one Study33 measured and reported pre- and post- 
treatment plasma levels of CoQ10. A significant increase in 
serum requires supplementation with approximately 100 
mg1d COQ10,17 but three studies administered a dose of 
only 90 mg/d. OPtilnum levels of CoQ10 have not been 
determined, and plasma levels are intrinsically variable 
within a patient. Many factors have been linked with the 
bioavailability of CoQ10, such as the CoQ10 preparation 
used, the age, sex, race, diet, and nutritional status of an 
individual, and the stomach content and alcohol consump- 
tion. 36,37 Significantly increased plasma levels of CoQlO 
occurred (without supplementation) after treatment with 
doxorubicin in a recent study. 38 Studies measuring CoQlO 
levels before and after courses of anthracycline chemother- 
apy are lacking. 
No adverse effects of CoQ1O were reported in any of 
the trials. CoQIO is structurally similar to vitamin K and 
possesses procoagulant effects. Case reports have suggested 
that CoQlO may interact with the anticoagulant effects of 
warfarin therapy, and concurrent use may cause a dimin- 
ished response. 3', "' Caution is also advised in selecting a 
brand of CoQ10 supplement; ConsurnerLab (White Plains, 
NY) reported in January 2004 that one of the 32 products 
investigated contained no detectable CoQlO and another 
exceeded its concentration by 75%. 41 
CoQlO was not found to interfere with standard treat- 
ments in the clinical trials included in this review. It is 
uncertain whether the cytoprotective and antioxidant activ- 
ities of CoQ 10 may decrease the efficacy of chemotherapeu- 
tic agents, such as anthracyclines, which work by inducing 
oxidative stress. There is no biologic rationale for the selec- 
tive protection of healthy cells, and interactions between 
antioxidants and cancer treatments vary according to tu- 
mor type and the type and dosages of antioxidant and 
chemotherapy. 4' A nonsysternatic search of preclinical 
studies revealed conflicting preclinical evidence regarding 
whether supplementation with CoQ 10 benefits or inhib- 
its chemotherapeutic treatments. A preclinical study of 
doxorubicin concentrations in mice advised caution with 
concomitant use of CoQ 10 and doxorubicin . 
43 However, 
a more recent preclinical study found that CoQ 10 treat- 
ment had no significant effect on the pharmacokinetics 
of doxorubicin. " 
Balancing the benefits and risks of chemotherapy and 
other cancer treatments is a continuous concern for oncolo- 
gists and cancer patients and their caregivers. Potential 
benefits and risks from adjuvant therapies also require care- 
ful consideration. Despite encouraging suggestions from 
clinical trials that CoQ10 might reduce the toxicity of can. 
cer treatments, such effects have not been tested rigorously. 
There is still much uncertainty over the interactions be- 
tween CoQ1O and anthracyclines. Further investigations 
are necessary to determine whether supplementation with 
CoQ10 is appropriate for improving the tolerability of can- 
cer treatments. 
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SUMMARY 
Aim: The aim of this paper is to summarise and critically evaluate the evidence available from controlled clinical 
trials regarding the use of guided imagery as a sole adjuvant therapy for cancer patients. 
Methods: Electronic searches for controlled clinical trials were carried out in eight databases and two clinical trial 
registers. Trials that featured guided imagery as a sole adjuvant therapy were included. No language restrictions 
were imposed. Data were extracted and validated independently 
by two researchers. 
Results: Six randomised clinical trials were included. Detailed results were available for four studies only. Poor 
reporting and heterogeneous populations, interventions and outcome measures across trials precluded statistical 
pooling of results. The methodological quality was on average low. Three studies reported significant differences in 
measures of anxiety, comfort or emotional response to chemotherapy for patients who received guided imagery over 
the control groups. Two studies showed no differences between guided imagery and other interventions in any of the 
outcome measures. 
Conclusion: Guided imagery, as a sole adjuvant cancer therapy may be psycho-supportive and increase comfort. 
There is no compelling evidence to suggest positive cffects on physical symptoms such as nausea and vomiting. The 
data seem sufficiently encouraging for the use of guided imagery as an adjuvant cancer therapy to merit further 
research. Copyright (D 2005 John Wiley & 
Sons, Ltd. 
INTRODUCTION 
Guided imagery has recently been identified as one 
of the 10 most frequently recommended comple- 
mentary cancer therapies on the Internet (Schmidt 
and Ernst, 2004). It is a technique used to 
harness 
the power of the mind to form mental representa- 
tions of objects, places or situations, which are 
perceived through the senses (Post-White, 
2002). 
The term 'visualisation' is often used interchange- 
ably with imagery. Although visual 
images are 
most commonly evoked, sounds, smells, tastes and 
sensory or affective feelings may also 
be induced. 
Guided imagery refers to the use of imagination 
to invoke one or more of the senses. It involves the 
6guiding' of an individual through experiences in 
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medical School, Universities of Exeter and Plymouth, 
Institute 
of I-lealth & Social 
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the mind, in order to access physical, emo- 
tional and spiritual dimensions to affect bodily 
change (Achterberg, 1985). In a guided imagery 
session a practitioner or other individual leads the 
participant through an imagery technique or 
script. This can take place in group or in one-to- 
one sessions. Recordings of spoken scripts on 
audiotapes are also commonly used, allowing 
an individual to practise in a location of their 
choosing. Individuals may also use imagery with- 
out the guidance of a script. Gentle background 
music often accompanies imagery sessions to help 
maintain a relaxed state and to free the mind from 
other thoughts. 
Imagery techniques are frequently used to bring 
calmness and a sense of space to alleviate anxiety 
and pain (Spiegel, 1993; Lang and Patt, 1994) and 
are claimed to encourage the receptivity of 
treatment and facilitate the process of recovery 
(Simonton et al., 1978). Guided imagery techni- 
ques encourage people to feel a connection 
between their mind and their body and can aid 
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in facilitating feelings of empowerment in order to 
help individuals manage certain difficulties in their 
lives. Studies have suggested that guided imagery 
may influence physiological outcomes such as 
white blood cell count in medical patients includ- 
ing cancer patients, (Donaldson, 2000), narcotic 
medication requirements (Tusek et al., 1997a, b) 
and other immunological effects (Gruber et al., 
1993; Walker el al., 1997). Psycho-neuroimmuno- 
logical theories propose that the psychological 
response to guided imagery may down-regulate the 
hypothalamic-pituitary-adrenal-axis, resulting in 
a reduced stress response, increased immune 
function and sense of well-being (Post-White, 
1998). However, immune responses to emotional 
stress are complex and heterogeneous (Post-White, 
2002). 
Guided imagery techniques vary, but generally 
involve guiding the imagination towards places 
(environment or situation) in which the patient 
feels calm, safe, content, happy and relaxed. 
Similar to meditation, guided, imagery encourages 
individuals to free their mind of interfering 
thoughts, release their concerns from daily life 
and become absorbed in the session (Post-White, 
1998). Scripts have been developed to address 
particular conditions or problems, which may 
introduce the participant to new experiences and 
enable them to break out of inflexible or negative 
thought patterns (e. g. Post-White, 2002). 
Guided imagery interventions in oncology have 
focused on four areas: efficacy in pain manage- 
ment, influence on surgical outcomes, improve- 
ment in quality of life and changes in immunity 
(Lee, 1999). Specific techniques for cancer patients 
may involve directing their thoughts to 
locations 
of the turnour or metastases. The images evoked 
may vary according to the technique or the 
individual's preference, from visualising a healing 
light shining on the tumour or affected area of the 
body, to the immune system or cancer treatment 
attacking and destroying cancer cells. 
Scripts may 
address concerns over treatments, provide positive 
thoughts and encourage new coping behaviours 
for managing pain, anxiety and nausea 
(Post. 
White, 2002). 
The boundaries between the different types of 
mind body therapies are not easily 
defined, and 
therapies are therefore often discussed collectively 
(Astin et al., 2003). Guided imagery is often used 
to aid hypnosis, or meditation, or combined with 
other techniques such as progressive muscle 
relaxation, but the technique can also 
be used 
alone. Relaxation is not always thought to be 
necessary for guided imagery (Post-White, 2002) 
although many relaxation or guided imagery 
sessions incorporate elements of each practice 
and use similar techniques. Previous reviews of 
guided imagery trials have included combined 
interventions (Wallace, 1997; Luebert et al., 
2001) but did not include all randomised-con- 
trolled trials of guided imagery with cancer 
patients available to date. We would argue that 
the therapeutic effects of guided imagery as a sole 
adjuvant intervention should be evaluated in order 
to clarify its role in other therapeutic regimens. 
A systematic review can be viewed as a scientific 
and systematic examination of the available 
evidence in a specific topic (Bigby and Williams, 
2003). The aim of a systematic review is to 
systematically and thoroughly assess the best 
possible scientific evidence about the effects of a 
healthcare intervention (Cochrane Library, 2004). 
The method of this systematic review was based on 
Cochrane Collaboration principles. Our aim was 
to summarise and critically evaluate the evidence 
from clinical trials for or against the use of guided 
imagery as a sole adjuvant intervention with 
cancer patients regarding any physical or psycho- 
logical change. We asked the following research 
questions: 
Are there benefits to cancer patients from the 
use of guided imagery as a sole adjuvant therapy? 
What does the evidence from controlled clinical 
trials suggest regarding the effectiveness of ima- 
gery as an adjuvant cancer therapy? What out- 
come measures have been tested and are they 
appropriate? What is the methodological quality 
of the studies? 
METHOD 
Systematic literature searches were performed to 
identify all randomised controlled clinical trials in 
which an imagery intervention was applied to 
cancer patients. The following electronic databases 
were searched from their inception until March 
2004: the Allied and Complementary Medicine 
Database (inception 1985), the British Nursing 
Index (1994), CancerLit, CINAIIL (1983), Cur- 
rent Controlled Clinical Trials Register (inception 
1998), DH-DATA (1983). EMBASE (1966). ISI 
Web of Science (inception 1975), MEDLINE 
(1966), National Research Register (inception 
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2000) and PSYCHINFO (1987). The search terms 
used were cancer or oncolog$ or carcinogen$ or 
tumo$r and imagery or visualisation or visualisa- 
t, ion. Reference lists of reviews and our depart- 
mental files were hand-searched for additional 
trials. 
Studies were required to include a control 
group. No restrictions were placed on the lan- 
guage, place or year of publication. The terminol- 
ogy used in the primary reports was used to 
determine and distinguish between the types of 
therapies. Articles were included if they specified 
the use of guided imagery, imagery or visualisation 
with cancer patients as a sole adjuvant interven- 
tion to standard or palliative cancer care or as a 
sole supportive intervention in cancer patients 
who were not concurrently undergoing treatment. 
There were no restrictions placed on the site 
or stage of cancer. Studies in which the guided 
imagery intervention was described as occurring 
in a support group environment, or as guided 
imagery combined with any other therapy or 
coping package, such as hypnosis, relaxation 
therapy, music therapy, cognitive behavioural or 
any other coping package were excluded. 
Data were extracted independently from each 
paper by two reviewers (L. R., K. S. ) and verified by 
a third reviewer (E. E. ) according to pre-defined 
criteria. The methodological reporting of the 
studies was assessed using the Jadad score (Jadad 
et al., 1996). The Jadad score was calculated by 
assessing three criteria: blinding and description 
of the method of blinding, randomisation and 
description of the method of randomisation 
and reporting of dropouts and/or withdrawals. 
The maximum number of points that can be 
achieved on the Jadad score is 5. In guided 
imagery it is impossible to blind patients, as it 
will be obvious whether an intervention was 
received or not. However, one point was given 
for blinding if the outcome assessor was blinded. 
The validity of each trial was assessed according 
to a previously published score ranging from 
0 (minimum validity) to 3 (maximum validity) 
where one point was given for a positive answer to 
each one of the following questions: (1) Was the 
study sample relevant? (2) Was the intervention 
appropriate? (3) Was the outcome measure suita- 
ble? (Ernst, 2002). The heterogeneity of popula- 
tions, interventions and outcome measures across 
trials precluded statistical pooling of results. 
Results were therefore tabulated and described 
narratively. 
RESULTS 
The literature searches located 103 articles inves- 
tigating guided imagery for cancer patients. From 
these, 97 studies did not meet the inclusion criteria. 
The remaining six trials were included in the 
review. Figure I summarises the exclusion process. 
Examples of some of the more relevant but 
nevertheless excluded trials are six RCTs that 
assessed the effects of guided imagery in combina- 
tion with relaxation techniques in cancer patients 
(Burish et aL, 1991; Gruber et aL, 1993; Arathuzik, 
1994; Richardson et aL, 1997; Walker et aL, 1999; 
Xie-Zhong, 2001). Five RCTs combined guided 
imagery with progressive muscle relaxation in the 
experimental group (Burish and Lyles, 1981; Lyles 
et al., 1982; Syrjala et al., 1995; Liu et al., 2001; 
Baider et al., 2001). Two RCTs combined guided imagery with music therapy (Xie-Zhong, 2001; 
Bums, 2002). One other RCT combined guided 
imagery with hypnosis or meditation in the 
experimental group (Rapkin et al., 1991; Targ 
and Levine, 2002). 
Furthermore, four ongoing or completed 
RCTs in the UK were located from the National 
Research Register (http: //www. update-software. 
com/national/), of which the majority are com- bined interventions. These assess the efficacy of 
guided imagery in cancer patients undergoing 
surgery for colorectal cancer (completed project 
R Molloy, Department of Surgery, Gartnavel 
General Hospital, Glasgow; http: //www. update- 
software. com/national/); evaluate the bencfits of 
guided imagery and relaxation in cancer patients 
through a comparison of immune-targeted and 
non-specific imagery (ongoing project, M Spencer, 
Consultant in General Adult Psychiatry, Rydon 
House, Taunton (http: //www. update-software. - 
com/national/); assess the Psycho-neuroimmuno- 
logical effects of relaxation and guided imagery 
alone and in combination with other interventions 
in patients with colorectal cancer (ongoing project, 
P Mack and L Walker, Institute of Rehabilitation, 
Hull; http: //www. update-software. com/national/) 
and assess Quality of Life and psycho-neuroim- 
munological effects of reflexology, relaxation and 
guided imagery in patients with lung cancer 
(Lesley Walker). 
Only four of the included studies were published in their entirety. Two studies were published as 
abstracts only (Post-White, 1996; Kwekkeboom, 
1999). The authors were contacted but due to 
unpublished material the results from these studies 
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103 studies 
located that were 
relevant to guided 
imagery 
Imagery 
combined 
with other 
treatments 
(n=56) 
Uncontrolled trials 
(n=12) 
Non-randomised 
trial 
(n=2) 
Imagery case 
studies 
(n=27) 
6 studies 
included 
Figure 1. Flowchart of excluded studies including cancer patients. 
were not available and could therefore not 
be 
evaluated. These studies are discussed narratively 
only. The extracted data from all included trials 
are presented in Table 1. 
Five included studies were carried out in the 
USA between 1990 and 1999 and one was under- 
taken in Israel in 2002. All six studies were 
randomised controlled clinical trials, 
but none 
were outcome assessor blinded. 
All six trials 
adopted a parallel group design. 
In all trials 
patients in the experimental group received an 
imagery intervention additional to standard cancer 
care or palliative care. Patients 
in the control 
groups received standard care only, except 
in one 
study (Sloman, 2002), 
in which all patients 
received palliative care and the control condition 
was an 'attention' control where a nurse or 
practitioner spent an equivalent amount of 
time 
with patients but provided no specific 
therapeutic 
intervention. Three studies compared the guided 
imagery intervention with a standard care control 
only (Troesch et aL, 1993; 
Kolcaba and Fox, 1999; 
Kwekkeboom, 1999), whereas three studies 
included other intervention groups such as pro- 
gressive muscle relaxation, hypnosis, support or a 
combination of guided imagery and one of the 
above named interventions (Feldman and Salz- 
berg, 1990; Post-White, 1996; Sloman, 2002). 
Sample sizes ranged from 30 to 75 cancer 
patients. Dropouts and withdrawals were men- 
tioned in three studies (Troesch el al., 1993; 
Kolcaba and Fox, 1999; Kwekkeboom, 1999). 
All participants had previously been diagnosed 
with cancer and cancer types included newly 
diagnosed cancer, advanced primary or metastatic 
cancer, and early stage I or 11 breast cancer 
(Table 1). The ages of participants were reported 
in three studies (Troesch et al., 1993; Kolcaba and 
Fox, 1999; Sloman, 2002) and varied across the 
studies from 27 to 81 years. Gender was specified 
in all but one study (Trocsch et al., 1993); two 
studies included both males and females, and in 
three studies participants were all female. 
A variety of self-report measures were used to 
assess the effect of guided imagery, including 
anxiety, depression, quality of life, comfort, pain, 
nausea and vomiting, and overall chemotherapy 
experience. These outcomes were assessed using 
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validated questionnaires, such as the State Trait 
Anxiety Inventory (STAI), the Hospital Anxiety 
and Depression Scale (HADS), the Functional 
Living Index Cancer Scale (FLICS), Post-che- 
motherapy State Anxiety Scale (PCSTAS), and the 
Rhodes Index of Nausea and Vomiting Form 2, 
and non-validated tools such as the Chemotherapy 
Experience survey, and the Radiation Therapy 
Comfort questionnaire. One abstract only study 
additionally measured immune function (Post- 
White, 1996). Two studies investigated physiolo- 
gical outcomes such as heart rate and occurrence 
of nausea and vomiting (Feldman and Salzberg, 
1990; Troesch et al., 1993). In three studies, 
patients were undergoing chcmo- or radiotherapy; 
in one study patients were undergoing surgery and 
in another trial patients were receiving palliative 
care but had no other intervention. Additional 
cancer treatments included pain medication such 
as morphine and other antiemetic medication. In 
one study, published as an abstract only, patients 
had completed treatment; thus, imagery was 
strictly a supportive rather than an adjuvant 
therapy. This study was included as it met all 
other inclusion criteria but results were not 
available, and therefore it was not included in 
the evaluation (Post-White, 1996). All four studies 
published in full state that guided imagery training 
sessions were held either once or up to three times 
during duration of the trial, and duration of 
sessions varied from 12 to 60min (Feldman and 
Salzberg, 1990; Troesch et al., 1993; Post-White, 
1996; Sloman, 2002). No adverse effects of guided 
imagery were reported in any of the studies. The 
included studies are narratively described in the 
following section. 
SUMMARIES OF INCLUDED STUDIES 
Feldman and Salzberg assessed the effects of 
guided imagery on adverse reactions to cancer 
therapy in a randomised clinical study (Feldman 
and Salzberg, 1990). Sixty cancer outpatients who 
had recently received at least one cycle of 
chemotherapy were randomiscd into one of the 
following groups (a) guided imagery, (b) hypnosis, 
(c) hypnosis-imagery or (d) standard care. The 
intervention groups received training sessions, in 
which an experimenter briefly introduced the 
intervention before inducing a trance by describing 
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structured images before administering che- 
motherapy. Measurements were taken before, 
after and 24h following each administration of 
chemotherapy using the STAI and self-reports of 
anxiety, nausea and emesis. Results showed a 
significant group by time interaction for all groups 
for the post-chemotherapy STAI, F (6,112) = 2.40, 
P=0.03. Additionally, significant group differ- 
ences between the three intervention groups and 
the control group for the STAI were detected, 
F (1,78) = 7.14, P=0.008. No significant differ- 
ences were shown between the three different 
interventions or between the control group and 
hypnosis-imagery group, the guided imagery 
group or the hypnosis group alone. This study 
achieved one out of five Jadad points. No blinding 
of the outcome assessor or method of randomisa- 
tion was reported. 
Kolcaba and Fox studied the effects of GI on 
comfort in a randomised clinical study of 53 
women with early stage breast cancer who were 
about to undergo radiation therapy (Kolcaba and 
Fox, 1999). The State Anxiety Inventory was used 
as a baseline measure of anxiety. The primary 
outcome measure was the Radiation Therapy 
Comfort questionnaire. This instrument together 
with the guided imagery script was developed for 
the study by the authors to address all aspects of 
comfort. The script included references to the 
machinery and physical environment involved in 
the treatment, and to a healing white light. 
Measurements were taken three times: (1) at 
baseline, (2) three weeks after radiation therapy 
commenced and (3) three weeks after radiation 
therapy ended. The results indicated that in both 
groups overall comfort increased over a 6-week 
time period. Significantly higher levels of comfort 
were reported in the guided imagery group 
compared to the control group, F (1,51)=4.33, 
p<0.05 over the three measurement points. The 
strongest effect occurred at measuring three weeks 
after radiation therapy commenced (D2=0.55, 
p< 0.05). This study received two points on the 
Jadad score for methodological quality of the 
study. No blinding of the outcome assessor was 
reported. 
Kwekkeboom carried out a randomised clinical 
trial to assess the role of imaging ability in the use 
of GI for cancer related pain (Kwekkeboom, 
1999). Seventy-five women undergoing surgery 
for breast or gynaecologic cancers were rando- 
mised to receive either a GI intervention addition- 
ally to standard cancer care or only standard care 
control. The standard care control also allowed 
the use of analgesic medication. The GI interven- 
tion consisted of a 12-min relaxation tape with 
nature and relaxation images. Pain severity, 
distress and interference were the primary outcome 
measures. No significant differences were reported 
regarding the therapeutic effect of GI. Full results 
for this study were not available, as it was 
published only as dissertation abstract. Therefore, 
results could not be evaluated and the Jadad 
scoring system could not be applied to this paper. 
Post-White et al. investigated the psycho-im- 
mune response to imagery and support in 73 
female breast cancer survivors who had completed 
treatment for breast cancer within the past two 
years (Post-White, 1996). Participants were ran- 
domly assigned to an imagery group ('guided' 
imagery not specified), a support group or a 
standard care control group. Intervention groups 
met weekly for one and a half hours over a period 
of 8 weeks. Emotional state, fatigue, quality of life 
and immune responses were measured, however, 
no statistical analysis was reported. Again, this 
study is currently only available as a dissertation 
abstract. Therefore, the results could not be 
evaluated and the Jadad scoring system could 
not be applied to this paper. 
In a randomised clinical trial, Sloman invcsti- 
gated the effect of guided imagery on quality of 
life, anxiety and depression in patients with 
advanced cancer (Sloman, 2002). All 56 partici- 
pants were receiving palliative care in their homes 
and were on pain medication. Participants were 
randomised into four groups (a) guided imagery, 
(b) progressive muscle relaxation (PMR), (c) PMR 
and guided imagery or (d) attention control 
whereby nurses endeavoured giving patients an 
equal amount of attention as patients in the 
intervention group. Participants initially received 
a 30min session with a trained practitioner or 
nurse, followed by practice with an audiotape 
twice per day (for the intervention groups) and 
follow up sessions with the practitioner twice per 
week. Pre-test versus post-test comparisons were 
carried out three weeks after the initial session 
with the practitioner. Outcome measures included 
the Hospital Anxiety and Depression Scale, and 
the Functional Living Index-Cancer Scale. There 
were no significant differences in the anxiety scores 
between any of the groups. Comparisons of mean 
depression and quality of life scores showed that 
none of the three treatment groups significantly 
differed from each other but that each treatment 
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group was significantly different from the control significant effects were found in emotional re- 
group for both depression and quality of life (no sponse to chemotherapy (Troesch et aL, 1993) and 
statistics available). A significant overall group comfort during radiotherapy (Kolcaba and Fox, 
effect of the three interventions was reported for 1999). Significant effects were also reported for all 
depression (F=4.639, p<0.01) and quality of life interventions in both the four-armed trials, in 
(F= 4.979, p<0.01). The methodological quality which treatment groups included hypnosis or 
of the study achieved one point on the Jadad score. relaxation techniques and combined interventions 
No blinding of the outcome assessor or method of in addition to guided imagery alone (Feldman and 
randomisation was reported. Salzberg, 1990; Sloman, 2002). These studies 
Troesch et al. investigated the influence of GI on showed positive group effects for all intervention 
chemotherapy-related nausea and vomiting in a groups on depression, quality of life and anxiety 
randomised clinical trial of 28 newly diagnosed over a control or attention control group, but 
cancer patients receiving the antineoplastic agent there were no significant differences between 
Cisplatin as a part of their chemotherapeutic interventions. One four-armed study also reported 
regimen (Troesch et al., 1993). Patients were significant differences between each intervention, 
randomised into the experimental group, which and the control in both depression and quality of 
received GI, or the control group, which received life, but no statistics were reported (Sloman, 2002). 
standard care alone. The experimental group was Guided imagery did not have a significant effect on 
given instructions on the GI intervention from the physical symptoms, such as nausea or vomiting. A 
researcher, followed by 20-min sessions using a low incidence of symptoms at baseline may 
positive experience GI audiotape. Participants provide a reason for this in one study (Feldman 
practised with the tape three times: 60min before and Salzberg, 1990). 
their chemotherapy session in the clinic, at home Collectively, these data suggest that guided 
the following morning before breakfast and in the imagery may be beneficial as a psycho-supportive 
Fvening of the same day at bedtime. The study adjuvant therapy for cancer patients. Several 
investigators assessed nausea and vomiting with caveats, however, apply. Certain aspects of report. 
the Rhodes Index of Nausea and Vomiting Form ing were inadequate in all trials. The often-low 
2, which measures patients' perceived duration, scores on the Jadad scale present a possible 
frequency and distress of dry heaves. Data from tendency toward bias. Details of the subject matter 
hospital records were collected using the Subject in the guided imagery scripts were only reported in 
Demographics and Emetic Response Tool. This three studies (Troesch et al., 1993; Kolcaba and 
included nurses' documentation of the frequency Fox, 1999; Kwekkeboom, 1999) and, with the 
and severity of nausea and vomiting. However, exception of one study (Kolcaba and Fox, 1999), 
complete results were not reported. Findings explicit descriptions of the intervention procedures 
showed no statistically significant differences and duration were lacking. The often poor 
between the groups at any of the five measured reporting of the studies available for review 
times during chemotherapy administration. The renders firm conclusions problematic. 
Chemotherapy Experience survey was used to The stages at which patients practised the 
evaluate participants' overall perceptions of the interventions in their treatment regimen varied, 
chemotherapy. The GI group expressed a signifi- as did the amount of time spent practising and the 
cantly more positive experience with chemother- timing of measurements. Two studies reported 
apy compared to the control group (P - 0.0326). time effects, for post chemotherapy anxiety and for 
Two points were given to this study on the Jadad comfort during radiotherapy (Feldman and Salz- 
scale. No blinding of the outcome assessor was berg, 1990; Kolcaba and Fox, 1999). A recent 
reported. meta-analysis suggested that the effect size of 
guided imagery increased over the first five to 
seven weeks but decreased at 18 weeks. (Van 
DISCUSSION 
Kuiken, 2004). The authors also found that more 
detailed reporting of imagery practise and out. 
come measures is needed in further trials. 
Results from both the two-armed trials showed Most studies presented here incorporated the 
benefits in the guided imagery intervention groups use of audiotapes with guidance by a nurse, 
compared to standard care control groups; practitioner or experimenter The use of audiotapcs 
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is often favoured over face-to-face sessions with a 
practitioner in order to reduced costs. From a 
research perspective, this also has the benefit of 
reducing any context effect or influence of a 
personal interaction on the perceived benefit of 
the guided imagery technique itself. However, 
adherence to the intervention may be harder to 
achieve or assess in this situation. Only one study 
(Kolcaba and Fox, 1999) described monitoring 
patients' compliance with carrying out the inter- 
ventions as required by the study. The use of a 
support group or attention control in one study 
(Sloman, 2002) is commended as an attempt to 
control for context effects. 
There were no adverse effects reported in any of 
the trials, but there was a lack of reporting in all 
but one study (Sloman, 2002) about whether any 
opportunities were given for comments or follow 
up discussions with a practitioner. It has been 
noted that ambiguous sensations can be evoked 
during guided imagery, which people may inter- 
pret very differently (Graham, 1990). The oppor- 
tunity for patients to discuss their feelings and the 
issues raised by guided imagery, may help people 
acknowledge and interpret their feelings (Post- 
White, 2002). This may also influence their 
perceptions of the therapy session and contribute 
to the effectiveness of the intervention. This, again, 
highlights the importance of careful planning, 
conducting and reporting of trials. 
Confounding variables such as sleep, diet and 
exercise together with imaging ability and expecta- 
tions about the intervention may influence the 
results of clinical trials (Kwekkeboom et al., 1988) 
and measuring feelings and perceptions is fraught 
with difficulty. Many studies that have investigated 
the effectiveness of imagery lack the scientific 
rigour of randomised controlled trials. Physiolo- 
gicaI measures provide objective and reliable 
measurements, which usually satisfy rigorous 
scientific enquiry, however, individuals' needs 
and reasons for using imagery may vary greatly 
from one another and cannot always be reflected 
by such measures. The impact of an intervention 
on quality of life issues such as the experience of 
treatment, perceived relaxation or anxiety, or a 
sense of control can only be assessed by sclf. 
reports. It is therefore important that outcome 
measures employed to quantify such effects are 
adequately validated. A social desirability effect, 
whereby patients report positive responses to 
please the experimenter may contribute to posi- 
tive results (Krosnick, 1999) particularly, when 
questionnaires are not validated, as in two of the 
included trials (Troesch et aL, 1993; Kolcaba and 
Fox, 1999). The sensitivity of frequently used 
diagnostic scales such as the HADS is also 
uncertain when employed in different clinical 
populations (Love et aL, 2002). The HADS has 
been found to be less accurate for those with 
progressive disease (lbbotson et aL, 1994), yet this 
is the population it was applied to in one study 
(Sloman, 2002). 
There is no single standard method or script for 
guided imagery treatment and there is currently no 
evidence to suggest that one form of guided 
imagery is more effective than another (Post- 
White, 2002). Techniques employed in the re- 
viewed studies were, where described, varied, and 
the nature of the therapy allows practitioners and 
participants to modify their practise to suit 
circumstances and individual requirements. Due 
to the highly personalised and experiential nature 
of the therapy, patients are currently faced with a 
'trial and error' approach to selecting a technique, 
and are dependent on the good judgment of a well- 
trained and experienced practitioner. 
In the two four-armed trials, no differences were found between the results of groups who received 
other interventions and those who received guided 
imagery as a sole adjuvant intervention; nor were 
there differences between the GI groups and those 
who received hypnosis or progressive muscle 
relaxation, in addition to GI. These results suggest 
there may be no differences between guided imagery as a sole intervention than when com- 
bined with other interventions such as relaxation 
or hypnosis for outcomes such as anxiety, depres- 
sion or quality of life. 
The relatively small number of studies that have 
investigated the effect of guided imagery as a sole 
adjuvant therapy may be a reflection of practice. 
Boundaries between the various types of mind 
body therapies are blurred and combinations of 
techniques are frequently employed according to 
the practitioner and the user. However, for a clear 
evaluation, individual therapies, (ideally individual 
techniques) also need to be assessed in isolation. 
Given the widespread use of guided imagery and 
its popularity, sample sizes were small and lacked 
sufficient power to produce widely applicable 
results. 
Questions regarding individual differences and 
the influence of imagery content on effect size and 
immune response, as raised by Post-White and 
Fitzgerald (2002) still remain to be answered. 
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Further research comparing different interven- 
tions, techniques (such as 'pleasant' imagery and 
'targeted' imagery) and procedures (such as the 
timing of practise and number of sessions) and 
accompanied by qualitative data may reveal richer 
data regarding the suitability of techniques. This 
will enable the practitioner to address the indivi- 
dual needs of cancer patients from general quality 
of life or to a more direct approach to dealing 
with, for example, treatment related anxiety or 
adverse effects. The use of more sensitive tools and 
a combination of qualitative and quantitative 
methods might reveal subtle but important differ- 
ences experienced by cancer patients. Limitations 
of this review include the difficulty involved in 
defining 'imagery' for the inclusion/exclusion 
criteria; and this was doubly problematic when 
the reporting of imagery techniques was unclear 
and lacked details regarding whether an interven- 
tion was adjuvant to standard oncological treat- 
ment. Even though our search strategy was 
thorough, we cannot be certain to have located 
all relevant trials. As the number of included 
studies is small, missing even one or two studies 
could alter the conclusion of this review. Further- 
more, one-third of the included studies were only 
available in abstract form, which prevented any 
evaluation of their results. 
In conclusion, guided imagery as a sole adjuvant 
cancer therapy may be psycho-supportive and 
increase comfort. There is, however, no significant 
evidence from trials to suggest positive effects on 
physical symptoms such as nausea and vomiting. 
The paucity and low methodological quality of the 
primary data allow only tentative conclusions. 
However, the evidence available to date seems 
sufficiently encouraging for the use of guided 
imagery and merits further study. 
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Abstract 
Aims. - This systematic review summarises the existing evidence on acupuncture for cancer-related pain. 
Methods: Literature searches were conducted in seven databases. All clinical studies of acupuncture, electroacupuncture and car 
acupuncture in cancer patients with the main outcome measure of pain were 
included. Data were extracted according to pre-defined 
criteria by two independent reviewers and methodological quality was assessed using the Jadad scale. 
Results. 7 Of the seven studies included, one high quality randomised clinical trial of ear acupuncture showed statistically significant 
pain relief in comparison with placebo ear acupuncture. All the other studies were either non-blinded (n = 2) or uncontrolled clinical 
trials (n = 4). Most investigations suffered from methodological flaws such as inadequate study design, poor reporting of results, 
small sample size and overestimation of the results. 
Conclusions. - The notion that acupuncture may be an effective analgesic adjunctive method for cancer patients is not supported by 
the data currently available from the majority of rigorous clinical trials. Because of its widespread acceptance, appropriately 
powered RCTs are needed. 
0 2004 European Federation of Chapters of the International Association for the Study of Pain. Published by Elsevier Ltd. All 
rights reserved. 
Keywords: Acupuncture; Cancer; Pain; Randomised clinical trial; Systematic review 
1. Introduction 
The use of complementary and alternative medicine 
(CAM) including acupuncture for chronic cancer- 
related pain control has become common and widespread 
(Ernst and Cassileth, 1998; Thompson and Filshie, 
1999). In the UK, about 85% of chronic pain services 
offer acupuncture (Woollarn and Jackson, 1998). Health 
care professionals in Ontario, Canada, working with 
cancer patients selected acupuncture as the top CAM 
modality that they would like to learn more about 
(Sellick and Zaza, 1998). 
Corresponding author. Tel.: +44 1392 439035, fax: +44 1392 
427562. 
E-mail address. erc633@hotmail. com (H. Lee). 
Acupuncture is a common treatment for many pain. 
ful and non-painful conditions in traditional Chinese 
medicine (Ernst et al., 2001). It involves inserting fine 
needles into the skin at precise locations (acupuncture 
points) to treat various diseases or symptoms and im- 
prove health. There is good evidence for the use of acu- 
puncture for low back pain (Ernst and White, 1998), 
acute dental pain (Ernst and Pittler, 1998), recurrent 
headache (Melchart et al., 1999) and for the prevention 
of nausea and vomiting associated with chemotherapy, 
pregnancy or post-surgery (Vickers, 1996; Lee and 
Done, 1999). 
The manipulation of acupuncture needles has been 
suggested to stimulate the release of endorphins and 
enkephalins (Andersson and Lundeberg, 1995). 
Acupuncture might also influence the production and 
1090-3801/S30 0 2004 European Federation of Chapters of the International Association for the Study of Pain. Published by Elsevier Ltd. All rights 
reserved. 
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distribution of many neurotransmitters and neuromodu- 
lators (Shen, 2001; Han, 2003). 
While the use of acupuncture in conjunction with 
standard antiemetics to control chemotherapy-related 
nausea and vomiting is supported by good evidence 
(Vickers, 1996), fewer data are available on its role in 
palliation of chronic cancer-related pain (Weiger et al., 
2002). Although several reviews of this topic are availa- 
ble (Filshie, 1988,2000; Filshie and White, 2002), no 
systematic review has been published. Hence, in this sys- 
tematic review, we aimed at critically evaluating the evi- 
dence for or against acupuncture as an adjunctive 
therapy for cancer-related pain. 
2. Methods 
Systematic literature searches were conducted in the 
following electronic literature databases all from their 
inceptions to February 2004: MEDLINE, EMBASE, 
CINAHL, AMED, PsycINFO, British Nursing Index 
and The Cochrane Library. In addition, two leading 
Korean journals (The Journal ofKorean Societyfor A cu- 
puncture and Moxibustion and the Journal of Korean 
Oriental Medicine) were searched for relevant studies. 
A combination of the following search terms was em- 
ployed: acupuncture, electroacupuncture, cancer, neo- 
plasm, tumor (tumour). Further handsearches were 
performed in our department's own files as well as in 
the reference lists of all located articles. The search at- 
tempted to identify all relevant studies irrespective of 
language. 
All prospective clinical studies of manual acupunc- 
ture, ear acupuncture and electroacupuncture for can- 
cer-related pain in human cancer patients were 
included. Other forms of acupuncture such as laser acu- 
puncture, acupressure and moxibustion and studies 
using transcutaneous electrical nerve stimulation or 
other co-interventions of CAM modalities were ex- 
cluded. Case series, case reports and abstracts with no 
details of intervention procedure were also excluded. 
Articles of acupuncture for postoperative pain in cancer 
patients were excluded, as the pain in this situation can 
be assumed to be due to surgery rather than cancer. 
All articles were read in full and data were extracted 
independently by two authors (Lee and Schmidt) on 
trial methods, study design, participants, interventions, 
type of pain, pain outcomes and adverse effects. Taking 
account of the fact that it is virtually impossible for an 
acupuncturist to be blinded to the treatment, we used 
a modification of the Jadad scale (Jadad et al., 1996; 
White and Ernst, 1999). Points were awarded as follows: 
study described as randomised, I point; additional point 
for appropriate randomisation method, I point; inap- 
propriate randomisation method, deduct I point; pa- 
tient blinded to intervention (i. e., control procedure 
was indistinguishable from real acupuncture), I point; 
evaluator blinded to intervention, I point; description 
of withdrawals and dropouts, I point. The maximum 
points available were 5. Patient blinding was assumed 
where the control intervention was indistinguishable 
from acupuncture, even if the word 'blinding'did not oc- 
cur in the report. Point for evaluator blinding was only 
given if specified in the text. Trials with 4 or 5 points 
were considered high quality. Uncontrolled studies can 
only achieve a maximum of one point on the modified 
Jadad scale, as randomisation and double-blinding are 
not applicable. The authors met to agree to a consensus 
and discrepancies were settled by discussion with the 
third author (Ernst). 
3. Results 
Seven studies meeting the inclusion criteria were in- 
cluded (Rico and Trudnowski, 1982; Xja et at., 1986; 
Xu et al., 1995; Filshie et al., 1996; Dang and Yang, 
1998; Alimi et al., 2000,2003): three of them were rand- 
omised clinical trials (RCTs) (Xia et al., 1986; Dang and 
Yang, 1998; Alimi ct al., 2003), and four of them were 
uncontrolled studies (Rico and Trudnowski, 1982; Xu 
et al., 1995; Filshie et al., 1996; Alimi et al., 2000). Orig. 
inally, 29 articles were located of which 22 were excluded 
for the reasons given in Table 1. Key data of included 
studies are surnmarised in Table 2. 
3.1. Description of studies 
The studies originated from China (Xia ct al., 1986; 
Xu et al., 1995; Dang and Yang, 1998), France (Alimi 
et al., 2000,2003), United Kingdom (Filshie et al., 
1996) and United States (Rico and Trudnowski, 1982). 
Of the seven studies included, body acupuncture was 
used in four studies (Xia et al., 1986; Xu et al., 1995; 
Filshie et al., 1996; Dang and Yang, 1998), car acupunc- 
turc in two (Alimi et al., 2000; Alimi et al., 2003) and 
clectroacupuncture in one (Rico and Trudnowski, 
1982), respectively. Cancer patient populations were het. 
erogeneous and painful symptoms also varied from radi- 
ating back pain to neuropathic pain. Control groups 
were conventional therapies (Xia et al., 1986; Dang 
and Yang, 1998) or placebo acupuncture (Alimi et al., 
2003). 
3.2. Quality of studies 
Of three RCTs included, one RCT with the highest 
methodological quality was given 5 points on the mod- 
ified Jadad scale (Alimi ct al., 2003) and the other two 
RCTs were given a point for randomisation (Xia 
et al., 1986; Dang and Yang, 1998). All uncontrolled 
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Table I 
Reports of excluded studies of acupuncture for cancer-related pain 
Author (year) Reason for exclusion Direction of pain-related outcome 
Mann et at. (1973) 
Peng et al. (1974) 
Wen (1977) 
Filshie (1984) 
Filshie and Redman (1985) 
Poulain et al. (1985/1997) 
Chen (1990) 
Yu (1992) 
Aung (1994) 
Bauer (1994) 
U ct al. (1994) 
Guo et al. (1995) 
Ding (1996) 
Filshie et al. (1997) 
Gadsby et al. (1997) 
Mose et al. (1998) 
Dillon and Lucas (1999) 
He et al. (1999) 
Lcng (1999) 
Balk and Gerszten (2003) 
Zhang et al. (2003) 
studies scored zero point as they failed to report with- 
drawals and dropouts (Rico and Trudnowski, 1982; 
Xu et al., 1995; Filshie et al., 1996; Alimi et al., 2000). 
3.3. outcomes 
Visual analog scale (VAS) (Filshie et al., 1996; Alimi 
et al., 2000,2003) and patient's verbal assessment (Rico 
and Trudnowski, 1982; Xia et al., 1986; Xu et al., 1995; 
Dang and Yang, 1998) were used as primary pain- 
related outcome measures. Also plasma leucine-enkeph- 
alin level was measured in one trial (Dang and Yang, 
1998). 
Alimi et al. conducted two studies; one uncontrolled 
study (Alimi et al., 2000) where a significant pain relief 
after ear acupuncture was reported (P < 0.00001), fol. 
lowed by a randomised, placebo-controlled trial which 
demonstrated a superior analgesic effect of car acupunc- 
ture to placebo car acupuncture (Alimi et al., 2003). 
Two-month body acupuncture treatment provided no 
significant analgesic effect in one RCr (Dang and Yang, 
1998), while another RCT reported chest pain relief by 
two-week body acupuncture treatment (Xia et al., 
1986). However, the authors mentioned patients' assess- 
Case series of heterogeneous patient 
population (n = 18) 
Case series (n = 4) 
Case series (n = 29) 
Retrospective audit and heterogeneous patient 
population (n = 156) 
Retrospective audit and heterogeneous patient 
population (n = 183) 
Duplicated RCT of acupuncture for postoperative 
pain in cancer patients (n = 250) 
No pain-related data or statistics provided (n = 34) 
No clinical study 
Combined therapy of acupuncture with Qi-Gong and 
meditation (n = 344) 
Case series of TENS (n = 3) 
Acupuncture for postoperative pain in cancer patients (n 16) 
Combined therapy of acupuncture with analgesic herbal decoction 
(n = 286) 
Case series (n = 2) 
Conference abstract with no details of 
intervention (n = 67) 
Acupuncture-like TENS (n = 14) 
Different form of acupuncture (n = 29) 
Heterogeneous patient population (n = 28) 
Acupuncture for range of movement of 
shoulder after ablation and axillary 
lymphadenectomy in breast cancer 
patients (n = 48) 
Heterogeneous patient population (n - 47) 
Historical control (n = 18) 
Retrospective study without pain-related 
outcome measure (n = 405) 
Positive 
Positive 
Positive 
Positive 
Positive 
Positive 
No pain-related outcome measure 
Positive 
Positive 
Negative 
Positive 
Not clear 
Positive 
Negative 
Negative 
Positive 
No pain-related outcome measure 
Positive 
Negative 
Positive 
ment of pain relief and did not provide adequate statis- 
tics (Xia et al., 1986). Two uncontrolled studies reported 
pain relief by body acupuncture (Xu et al., 1995) and 
electroacupuncture (Rico and Trudnowski, 1982), 
respectively, whereas one session of manual acupuncture 
showed no significant analgesic effect in Filshie's study 
(Filshie et al., 1996). Mild (Dang and Yang, 1998; Xia 
et al., 1986) or no adverse events (Xu et al., 1995) were 
reported but four studies did not mention them (Rico 
and Trudnowski, 1982; Xu et al.. 1995; Filshie et al., 
1996; Alimi et al., 2000). 
4. Discussion 
Perhaps the most important finding of this systematic 
review is that only regrettably few trials of acupuncture 
exist, a method often used for alleviating cancer-related 
pain conditions in clinical routine. 
Numerous drawbacks of the primary studies were 
noted. Of the seven studies in this review, four studies 
are uncontrolled (Rico and Trudnowski, 1982; Xu 
et al., 1995; Filshie et al., 1996; Alimi et al., 2000). 
Uncontrolled studies are open to bias often leading to 
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false-positive results. Absence of adequate statistical 
comparison, use of unreliable or subjective outcome 
measure such as verbal assessment of pain relief by pa- 
tients, variability of therapeutic protocols and poor 
quality of reporting further undermine the minimal evi- 
dence available. Of three RC7rs included in this system- 
atic review, only one trial scored 5 points on the 
modified Jadad scale (Alimi et al., 2003). The other 
two trials did not satisfy basic methodological criteria; 
i. e., patient and assessor blinding, describing of with- 
drawals and dropouts (Yja ct al., 1986; Dang and 
Yang, 1998). The positive effects reported in these stud- 
ies could thus be due to observer bias or patient-prac- 
titioner interaction (Xia et al., 1986). Failure to 
describe an appropriate randomisation method, using 
subjective outcome measures or inadequate statistics 
and poor reporting of intervention details cast further 
doubt on the credibility of the reported results (Xia 
et al., 1986; Dang and Yang, 1998). 
Our research question was whether acupuncture is 
effective for the relief of cancer-relatcd pain. Conse. 
quently, we evaluated only pain-related primary out- 
come measures, e. g., pain intensity on VAS. One 
might argue that there are other benefits from acupunc- 
ture treatment such as improving tolerance against con- 
vcntional therapies and anxiolytic/relaxing effects 
(Filshic et al., 1996; Johnstine et al., 2002). Acupuncture 
also alleviates chemotherapy-related nausea and vomit- 
ing (Vickers, 1996; Weiger et al., 2002). Judging from 
the results of the studies in our review, however, its 
usage for analgesic purposes is not evidence-based. Most 
patients in the primary studies had failed to respond to 
conventional analgesic therapies (Rico and Trudnowski, 
1982; Xu et al., 1995; Alimi et al., 2000,2003). Neverthe- 
less, patients in five studies continued conventional anal- 
gesic medication during acupuncture treatment (Xia 
et al., 1986; Filshie ct al., 1996; Alimi et al., 2000, 
2003), and it was not mentioned in one study whether 
the patients were given other analgesic treatments in 
addition to acupuncture (Rico and Trudnowski, 1982). 
Only in one study, no supplementary analgesics were 
given (Xu et al., 1995). 
One could argue that the effects of acupuncture 
should be differentiated according to the nature of pain. 
For instance, the previous evidence suggests that acu. 
puncture was not more effective than placebo in reliev- 
ing pain caused by IIIV-related peripheral neuropathy 
(Shlay et al.. 1998). Although data on types of pain were 
extracted in this review, poor reporting and a dearth of 
data precluded such analyses. In acupuncture practice, 
the precise details of therapy are usually determined 
by characteristic manifestations of pain, patients' physi- 
cal condition and other accompanying symptoms. By 
contrast, the underlying mechanism of pain is rarely a 
crucial factor. Nevertheless, it would certainly be a rele- 
vant research question to ask whether the nature of pain 
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correlates in any way with the therapeutic response to 
acupuncture. 
In spite of evidence from laboratory experiments 
reporting a biological basis of acupuncture analgesia 
(Ulett et al., 1998) and the clinical use of acupuncture 
by patients with painful conditions, the effectiveness of 
acupuncture remains controversial. One theory on how 
acupuncture modulates pain is that the effects of acu- 
puncture analgesia are partly mediated by activation 
of a cascade of endorphins and monoamines (Sims, 
1997). A recent systematic review of acupuncture for 
chronic pain syndromes such as low back pain, neck 
pain, fibrornyalgia and osteoarthritis, concluded that 
there is limited evidence that acupuncture is better than 
no treatment (waiting list) and inconclusive evidence 
that acupuncture is more cffective than placebo, sham 
acupuncture or standard care (Ezzo et al., 2000). The 
authors also found that low-quality trials are signifi- 
cantly more likely to yield positive results than high- 
quality studies (P = 0.05) (Ezzo et al., 2000). In our 
review, the methodologically best trial showed promis- 
ing results: ear acupuncture provided a superior analge- 
sic effect compared with placebo ear acupuncture and 
placebo ear seeds in cancer patients with neuropathic 
and/or nociceptive pain (Alimi et al., 2003). Another 
poor-quality RCT failed to show a significant difference 
in analgesic effect of acupuncture in stomach carcinoma 
patients when compared with conventional analgesics 
both in short and long-terms (Dang and Yang, 1998). 
This trial lacks detail in reporting of methodological fea- 
tures such as carcinoma staging and co-intervention of 
point injection with human transfer factor (Dang and 
Yang, 1998). Although Xia et al. (1986) showed in their 
RCT some advantages for chest pain in lung and 
oesophageal cancer patients receiving acupuncture treat- 
ment, the trial methodology was too weak to draw any 
meaningful conclusions. 
Our systematic review has several weaknesses. Due to 
a dearth of high-quality primary studies in this field, no 
informative conclusion could be drawn. One of the basic 
requirements for conducting a systematic review is a 
large body of original studies. Systematic reviews can 
only be as good as the clinical studies that it contains 
(Bigby and Williams, 2003). The message that our sys- 
tematic review delivers to readers is therefore limited. 
Many cancer patients continue to explore CAM not as 
an "adjunct" in support or palliation, but as a "cure" 
(Ernst, 2002). This may cause more serious harm to can- 
cer patients than to those with other diseases (Wilkinson 
ct al., 2002). Until more information is available, this re- 
view provides a useful evidence for healthcare profes. 
sionals to responsibly advise cancer patients on the 
uncertainty of the analgesic effect of acupuncture. 
To establish the role of acupuncture in the pain man- 
agement of cancer patients, we obviously need more 
clinical trials with adequate design and power. Consider- 
ing the logistical difficulties of doing a clinical trial with 
cancer patients (e. g. ethical issues, variability of symp- 
toms, loss to follow-up), a very large randomised, open 
study which addresses effects of acupuncture as an 
adjunctive on clinically relevant outcomes, especially 
any sparing effect of acupuncture on use of invasive, 
and potentially harmful conventional therapies, could 
be one of the realistic approaches. Utilising either an 
individualised or a standardised approach to interven- 
tion in an acupuncture trial is also an issue. Balancing 
the need for replicability and general isability in research 
with the acupuncture treatment in a manner that is com- 
patible with actual clinical practice to maximise its ther- 
apeutic effects is a continuing challenge (Smith, 2004). 
The research effort required is considerable and there- 
fore it seems unrealistic to expect convincing data to 
emerge in the near future. Several RCTs are in progress 
at present (http: //clinicaltrials. gov/show/NCT00034034; 
http: //clinicaltrials. gov/show/NCrOO060021). It is only 
after we obtained sound evidence that the widespread 
use and general acceptance of acupuncture among can- 
cer population can be justified. There is no convincing 
evidence that acupuncture prolongs survival or allevi- 
ates symptoms in patients with malignancy except chem- 
otherapy-related nausea and vomiting (Vickers, 1996). 
In certain circumstances it could be prudent to avoid 
acupuncture for cancer: e. g., thrombocytopaenia and 
anticoagulant therapy (Weigcr et al., 2002). 
S. Conclusion 
In conclusion, the notion that acupuncture may be an 
effective analgesic adjunctive method for cancer patients 
is not supported by the data currently available from the 
majority of rigorous clinical trials. Because of its wide- 
spread acceptance, appropriately powered RCTs are 
needed. 
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Abstract 
Background: Ukrain is an anticancer drug based on the extract of the plant Cheridoniurn majus L 
Numerous pre-clinical and clinical investigations seem to suggest that Ukrain Is pharmacologically 
active and clinically effective. We wanted therefore to critically evaluate the clinical trial data In the 
form of a systematic review. 
Methods: Seven electronic databases were searched for all relevant randomised clinical trials. 
Data were extracted and validated by both authors, tabulated and surnmarlsed narratively. The 
methodological quality was assessed with the jadad score. 
Results: Seven trials met our Inclusion criteria. Without exception, their findings suggest that 
Ukrain has curative effects on a range of cancers. However, the methodological quality of most 
studies was poor. In addition, the interpretation of several trials was Impeded by other problems. 
Conclusion: The data from randomised clinical trials suggest Ukrain to have potential as an 
anticancer drug. However, numerous caveats prevent a positive conclusion. and Independent 
rigorous studies are urgently needed. 
Background 
UkTain (NSC-631570) is a semi-synthetic compound 
derived from the common weed, greater celandine (Cheli- 
donium majus L). Ibis plant contains a range of alkaloids, 
most notably chelidonine, also known as benzophen- 
anthridine alkaloid. A leaflet distributed to patients at the 
Bristol Cancer Help Centre, United I(ingdom, describes 
Ukrain as ' the only known product, which at present 
does not also destroy healthy cells, and which reduces 
tumors and boosts the immune system... " 111. Ukrain is 
most commonly administered intravenously and consists 
of one molecule thiophosphoric acid conjugated to three 
molecules of chelidonine. It has drug licenses in several 
states of the former Soviet Union. 
Research on Ukrain started about 20 years ago. Mean- 
while, numerous in-vitro studies 12-371 animal experi- 
ments 138-831, case reports 184-971, and case series 198. 
1081 have emerged. Collectively, these data suggest that 
Ukrain has anticancer activity In a wide range of cell lines, 
which could be of clinical value. Whether or not this 
translates into clinical effectiveness and whether or not 
Ukrain does Indeed cure some type of cancer or Improves 
their prognosis can best be decided on the basis of ran- 
domiscd clinical trials (RCrs). Ibis systematic review Is 
aimed at summarising and critically evaluating all such 
studies. 
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Methods 
Electronic literature searches were conducted in the fol- 
lowing databases: MEDLINE (1966 to date, via Pubmed), 
EMBASE (1974 to date), CINAHL (Cumulative Index to 
Nursing and Allied Health Literature, 1982 to date), 
AMED (Allied and Complementary Medicine Database, 
1985 to date), PsycINFO (1987 to date), DIMDI (Deut- 
sches Institut für Medizinische Dokumentation und Infor- 
mation) and The Cochrane Central Register of Controlled 
Trials (CENTRAL). The following search terms were used: 
'Ukrain', 'chelidonium', 'greater celandine', 'cancer', 'neo- 
plasm' or'tumout'. Further handsearches were performed 
in our unit's own files as well as in the reference lists of all 
located articles. The producer of Ukrain was also con- 
tacted. No restrictions regarding the language of publica- 
tion were imposed. 
We included all RCrs of Ukrain as a treatment for any type 
of human cancer. Ukrain could be used as a sole treatment 
or as an adjunct to conventional therapy. Any type of 
intervention was permitted in the control groups. The 
clinical endpoints had to be survival or parameters indic- 
ative of turnour burden. Non-randomised studies or RCrs 
that did not quantify clinical endpoints were excluded 
[e. g. 1109-11711, as were duplicates [ 118]. 
All articles were read in full by both authors and data relat. 
ing to design, diagnosis, number of subjects, treatments 
for experimental and control groups, outcome measures 
and results were extracted independently by both authors. 
The methodological quality of each trial was assessed 
using the Jadad score, unless the study was only available 
in abstract form [ 119 ]. It evaluates methodological qual. 
ity using three items assessing random allocation, double- 
blinding and the reports of withdrawals and drop-outs 
and a maximum of 5 points can be given if all criteria are 
met. The authors agreed to a consensus on the assessed 
data and cases of discrepancy would be settled by discus- 
sion. Because of overt clinical heterogeneity, a meta-anal- 
ysis was deemed unreasonable. Descriptive summaries of 
the data are presented in the following text. 
Results 
Our search strategy identified 7 RCrs 1120-1261. The 
majority of these studies was published in two different 
journals between 1995 and 2002 by 4 different groups of 
authors from the Belarus and Germany. Key data from 
these studies are summarised in Table I and will be dis. 
cussed below. 
Susak et al published an RCr in which 108 colorectal can. 
cer patients received either Ukrain as a monotherapy or 5. 
fluororacil for an unspecified time duration 11261. The 
results suggest that this was followed by non-progression 
of the malignancy in 88.8% of the patients in the experi- 
http: /Avww. biomedcentral. com/1471-2407/5/69 
mental group compared to 27.7% in the control group. 
This study is only reported in abstract form. Numerous 
methodological details are therefore not accessible and its 
methodological quality cannot be reliably assessed. 
One year later, the same research group published a simi. 
lar clinical trial, this time including 96 colorectal cancer 
patients 11201. Forty-eight patients received UkTain as a 
monotherapy and 48 patients received 5-fluorouracil and 
radiation. The survival rate differed substantially between 
the two groups. TWo-year survival was 78.6% in the exper. 
imental group compared to 33.3% in the control group. 
This study was not blinded but applied an appropriate 
method of randomisation. 
Bondar et al treated 48 histologically verified rectal cancer 
patients either with X-ray radiotherapy, chemotherapy 
and surgery (control group) or with Ukrain and surgery 
(experimental group) 1121). Before and after these treat. 
ments, the authors measured 19 different laboratory 
parameters including two tumour markers. In addition, 
the Karnofsky Index, tumour dimensions, and recurrences 
were monitored. All of these variables strongly favoured 
Ukrain therapy over conventional treatment. This study 
has, however, numerous limitations. For instance, the 
method of randomisation was not explained; the authors 
merely stated that 'all patients were subdivided into two 
randomised groups*. Moreover, 'tumour dimensions' 
were mentioned as an outcome measure but neither the 
methodology of measurement nor the results were pro. 
vided, The recurrence rates are expressed as percentage fig. 
ures and no test statistics seem to have been applied. 
Uglyanitsa et al conducted a study with 28 patients suffer. 
ing from bladder cancer 11161 aiming "to evaluate the effi. 
cacy of Ukrain". Patients were allocated to three groups 
treated with a total dose of 100 (group 1), 200 (group 2), 
or 300 mg Ukrain (group 3). Two weeks later turnout 
regression was verified through cytoscopy and ultrasound. 
Complete and partial regression was noted In 0/4 patients 
of group 1,1/4 patients of group 2, and 2/6 patients of 
group 3. This study lacks many characteristics of a rigor. 
ous trial; its stated aims (to evaluate efficacy) cannot be 
achieved with the study design, which essentially was that 
of an equivalence or dose-finding study. 
Zemskov and colleagues published a apilotstudyo with 42 
patients suffering from pancreas cancer who had refused 
chemotherapy 11221.7bey were randomised to receive 
eitherVitamin C alone orwith Ukrain (total dose 100 mg/ 
patient). The primary endpoint (survival) strongly 
favoured the Ukrain group. The analysis seems to Include 
4 protocol violations (the description Is unclear). Even 
though the randomisation procedure is mentioned 
('dosed envelopes') it seems unusual that precisely 21 
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patients ended up in both groups. The results are surpris- 
ingly good - much better than with any other treatment 
for that condition. 
Uglyanitsa et al randomised ("by lottery") 75 breast can- 
cer patients into three groups of 25 patients each 11231. 
They received either no specific treatment, a total dose of 
50 or 100 ing Ukrain 5-7 days before mastectomy. The 
authors note that Ukrain rendered the primary tumour 
and the affected regional lymph nodes larger, harder and 
'more clearly defined". They interpret this as Ukrain- 
induced tumour sclerosis. According to the investigators' 
judgement, these changes facilitated surgery and the oper. 
ative success. In addition, Ukrain was associated with 
remarkable symptomatic improvements, e. g. better appe- 
tite, more sleep, less weakness. The report is unclear in 
several respects. For instance, no details about statistical 
analyses are provided, the outcome measures seem sub- 
jective, no information regarding investigator blinding is 
given, and the randomisation procedure seems suspect. 
Zemskov and colleagues randomised 42 patients with 
pancreatic cancer who had refused conventional therapy 
11241. They received either Ukrain (total dose 100 mg/ 
patient) with Vitamin C or Vitamin C alone. The results 
confirmed this group's earlier findings 11221. Survival was 
remarkable in the Ukrain treated patients and symptoms 
responded well to this treatment. There are, however, 
numerous puzzling details. Why do the authors call their 
second study a *pilot study"? Why did their ethics com. 
mittee consent to this "placebo *-controlled trial in the 
knowledge of the surprisingly positive earlier results? 
How could a proper randomisation again result in two 
equally sized groups of 2 17 In the discussion, the authors 
describe their earlier results as though this trial was con. 
ducted against 5-FU which, in fact, is not the case 11221. 
Cansauge et al reported a study of 90 patients with pan- 
creatic cancer treated either with 1000 mg gemcitabine/ 
M2 Or 100 ing Ukrain or the combination of both regi- 
mens [1251. Survival rates suggested thatUkrainwas supe- 
rior to gemcitabine alone. A direct comparison of the 12 
month survival rates revealed large differences compared 
to the data from Zemskov et al 11241 (29% vs 76% in the 
Ukrain-treated groups). The randomisation procedure 
was not explained and, again, the equal group sizes are 
remarkable. 
Conclusion 
Collectively, these RCI7s seem to suggest that Ukrain is an 
effective therapy for a range of cancers. In conjunction 
with the numerous encouraging case reports 184-971 case 
series [98-1081, and non-randomised clinical trials 1109. 
1211 these data look impressive at first glance. Yet several 
important caveats need to be considered. 
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None of the RCrs in this systematic review is without seri- 
ous methodological limitations. The Jadad score 11191 of 
most RCrs was low. Their sample size was usually small, 
and a sample size calculation to define the number of 
patients required was lacking in most cases. Even though 
most RCrs were non-inferiority studies by design and pur- 
pose, their statistical approach was that of a superiority 
trial. The majority of RCrs were conducted in Ukrainian 
research institutes and published in only two different 
journals. In several trials, there are clear signs of involve. 
ment of the manufacturer of Ukrain. Most RCrs have gen- 
erally been poorly evaluated and reported, which possibly 
reflects the poverty of clinical science in Eastern Europe. 
Independent replications are not available. The only Ger- 
man study 11251 has also been heavily criticised: Its sam. 
ple size (30 patients in each group) is minute, the report 
lacks statistical detail and there is an inequality of treat. 
ment cycles between groups 11271. It was also noted that 
this study (the only RCr not published in the same two 
journals as all the other RCr3) was published in a journal 
for which the senior author served as editor 11271. No 
RCrs were found showing negative or near neutral results; 
this might suggest the existence of publication bias for 
which we did, however, find no definite proof. 
Greater celandine (Chelidonium majus L), which forms the 
basis of Ukrain, was traditionally used for liver and gall. 
bladder complaints, loss of appetite and gastroenteritis. 
None of these indications is supported by trial evidence. 
The main alkaloid from this plant, chelidonine, has anti- 
spasmodic, weak central analgesic and papaverine-like 
effects. In animal experiments, an alcoholic extract of 
greater celandine Increased bile flow, caused non-specific 
immune stimulation and acted as a hepatoprotectant 
1128). The oral administration of greater celandine In 
humans has been associated with several cases of toxic 
hepatitis 11291. 
The mechanism of action of Ukrain as an anticancer drug 
(if any) remains elusive. Collectively, the preclinical stud. 
ies are suggestive of antineoplastic and Immunomodula. 
tory effects. It has been postulated that the antineoplastic 
effect is due to the alkaloids interfering with the metabo. 
lism of cancer cells, diminished synthesis of DNA, RNA 
and proteins, the inhibition of cellular oxygen consump. 
tion, and the induction of programmed cell death in 
malignant cells 11301. 
Several reports of adverse reactions after greater celandine 
have been published. Most notably, toxic hepatitis has 
been associated with its oral use 1129,131,1321. No case 
reports of adverse events have emerged of intravenous 
Ukrain therapy for cancer. The clinical trial data suggest 
that Ukrain might cause the following adverse effects: an 
increase in patients' body temperature (n - 26) 
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1120,123,1251, general burning sensations (n - 3) 11231 
and bleeding (n - 4) 11251. Levels between 0-2 according 
to World Health Organisation toxicity criteria were noted 
in two trials [122,1241 and toxicity criteria between 0-3 
were observed in one trial 11251. The costs of Ukrain ther- 
apy are high; one course costs C 700 for the medication 
alone, and the total treatment costs have been estimated 
at C 3000 per week 1133). 
In conclusion, Ukrain is a plant-based anticancer drug 
that is supported by clinical and pre-clinical evidence in a 
range of malignancies. The data are, however, not free 
from problems. Before positive recommendations can be 
issued, independent replications with definite trials and 
larger sample sizes seem mandatory. 
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summary 
Background and objectlo%ý It has been suggested that patients recovering from 
acute myocardial infarction and acute cardiac disease may benefit from music 
therapy. This review is aimed to assess whether adjunctive music therapy Is ef- 
fective in patients suffering from various cardiac conditions. . I. 
MethoAr Electronic literature searches were performed using Medline, the 
Cochrane Library, Embase, CISCOM, CINAHL, AMED, the British Nursing 
index and Psychinfo. References of identified articles were checked for further 
potential trials. Randomised clinical trials of adjunctive music therapy that in- 
volved patients with cardiac conditions were considered. Music therapy was de- 
fined as passively listening to music in addition to standard care. Data on study 
design, experimental intervention, control intervention, primary outcome para. 
meters, statistics and results were extracted In a standardised numner. To be In- 
cluded, studies had to quantify endpoints relevant for cardiac conditions. 
Results. - Twelve randomised clinical trials were included in the systematic re- 
view. Eight of these showed significant benefits in a range of endpointg of music 
therapy over no such treatment. Music therapy was seen as superior to no treat- 
ment in three studies measuring physiological outcomes. In six trials, music 
therapy was superior to the control condition for psychological outcome meas- 
ures. In three of the included studies music therapy was not superior t6 the con- 
trol condition in any of the outcome measures. 
Conclusion: Collectively, these date suggest that music therapy shows some 
promise to lower patient anxiety, heart rate and possibly blood pressure of pa- 
tients with cardiac conditions. The use of music therapy for cardiac patients 
warrants finiher rigorous investigation. 
Keywords: music therapy, alternative medicine, coronary heart disease 
Zusfunmenfassung 
Hintergrund und ZieL- Musiktherapie soll die Rehabilitationsdavier nach Myo. 
kardinfarkt und anderen akuten Herzkrankheiten verkürzen. Dieses Review 
soll bewerten, ob Musiktherapie als Zusatztherapie bei diversen Herzkrankhei. 
ten effektiv Ist. 
Methodik- Die elektronischen Datenbanken Medline, Cochrane Library, Ein- 
base, CISCOM, CINAHI, AMED, British Nursing Index und Psychinfo wur- 
den systematisch durchsucht. Die Bibliographien der so identifizierten Publika. 
tionen wurden zusätzlich nach weiteren Studien durchgesehen. Alle randomi- 
sierten klinische Studien, In denen Musiktlierapie bei Patienten mit 
Henkrank- 
beiten eingesetzt wurde, wurden eingeschlossen. Musiktherapie wurde dabei als 
passives Hören von Musik definiert. Daten zum Studiendesign, 
den experünen- 
teilen Interventionen, den Interventionen In der Kontrollgruppe, den primären 
Zielparametern, den statistischen Analysen und den Ergebnisse wurden in stan- 
dardisierter Form extrahiert. Um in das Review eingeschlossen zu werden, 
mussten für HerzlrauMeiten relevante Endpunkte quantifizlert worden sein. 
Ergebnisse: 12 randomisierte kradoche Studien wurden in das systematische Re- 
view eingeschlossen. Davon wiesen 8 Studien signifikante Vorteile der Musik. 
Each year, 1.5 million people in the 
US experience an acute myocardial 
infarction (AM), suffer from acute 
coronary syndrome (ACS) or acute 
cardiac disease (ACD) (1]. The an- 
nual incidence of ACS in France is 
greater than 280 per 100.000 men and 
60 per 100.000 women [2]. In the UK 
approximately 300.000 people expe- 
nence a myocardial infarction each 
year [3] and in Australia this figure 
amounts to an incidence rate of 605 
coronary events per 100.000 popula- 
tion aged 40-90 years [4]. Admission 
to coronary care units (CCU) is a 
psychological and physiological strain 
on the patient, which might affect ad- 
versel the prognosis and recovery 
time 
r5-8]. 
Anxiety is often observed 
in CCU patients, and known to cause 
increased blood pressure, heart and 
respiration rate, all of which lead to 
poor blood circulation and can 
cause fluctuation in skin temperature 
[9-111. 
One intervention, which may relieve 
patients with cardiovascular condi- 
tions of some of the stresses they are 
suffering at coronary care units is mu- 
sic therapy. Music therapy (MT) has 
been subjected to a great deal of re- 
search during the past three decades 
and several journals are devoted to it 
(e. g. the Nordic Journal of Music 
Therapy, the British Journal of Music 
Therapy, the Journal of the American 
Association for Music Therapy and 
the Harp Therapy Journal). A recent 
flurry of interest in the effects of mu- 
sic on the human body and psyche has 
been observed in the media. Music 
therapy has been mainly employed as 
k 
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therapie hn Vergleich zur Kontrollintervention In einer Reihe von Endpunkten 
auf. Musiktherapie erzielte in 3 Studien bessere Ergebnisse bezüglich verschie- 
dener physiologischer Messpunkte. In 6 Studien war Musiktherapie der Kon- 
troffintervention in psychologischen Messpunkten überlegen. In 3 Studien war 
die Musiktherapie der Kontrollintervention In keinem der Endpunkte überle- 
geAussfolgemg. 
- Dieses systematische Review liefert Hinweise daNr, dass'Mu. 
siktherspie bei Patienten mit Herzkrankheiten Ängstlichkeit vermindert sowie 
die Herzfrequenz und möglicherweise den Blutdruck senkt Musiktherapie W 
Patienten mit Herzkrankheiten sollte auch weitirhin intensiv beforscht werden. 
Schlilsselw6rter: Musiktherapie, Altemativmedizin, koronare Herzkrankheit 
methodological quality were perform- 
ed indýpendently by two reviewers. 
Discussions between the reviewers re- 
solved any discrepancies. 
Statistical pooling was originally envi- 
saged but proved to be impossible due 
to the heterogeneity of the data. Thus, 
a narrative synthesis was conducted 
with a separate focus on anxiety and 
the effect of Nff on physiological out- 
come measures. The criteria on which 
the'validity and quality of the studies 
were based involve randornisation, 
blinding, and dropouts. The judge- 
ments of validity and quality of the 
a distraction stimulus for uncomforta- 
ble procedures at hospitals [12-15]. 
MT has been shown in a number of 
studies, including randomised, con- 
trolled trials (RCTs), to have benefici- 
a] effects in a variety of conditions m- 
cluding Alzheimer's disease [16], de- 
mentia [17) as well as pain and anxiety 
in critical care patients [18]. it has 
been proposed that MT can be adopt- 
ed as a safe and inexpensive therapy 
for patients undergoing surgery, ýýn- 
tal procedures, invasive endoscopic in- 
terventions and hospitalisations 
[19-211. It has been suggested that pa- 
tients recovering from AMI may be. 
nefit from MT (22,23]. 
This systematic review is aimed at as- 
sessing the effectiveness of MT on cli. 
nically relevant outcome measures in 
cardiovascular patients by summaris. 
ing and critically evaluating the evi. 
dence from published randomised cli- 
nical trials. 
Methods 
The following electronic databases 
were searched from their inception 
until August 2003: Medline, the 
Cochrane Library, Embase, AMED, 
CISCOM, CINAHL, the British Nurs- 
ing Index and Psychinfo. The search 
terms varied for different databases. 
For Embase the search terms were 
, music', 'music therapy', 'coronary ar- 
tery disease'. 'heart infarction' and 
'heart muscle ischaemic disease'. The 
search terms for CISCOM were 'mu- 
sic and cardiology or cardiac'. 'music 
and coronary, 'music and myocardi- 
al,, 'music and heart'. 7te search 
terms for all other databases were 'cli- 
nical trial', 'music', 'music therapy', 
scardiacl, 'cardiology' and 'coronary'. 
All search terms were employed sin- 
gularly and in addition with each 
other as subject heading, key words 
and text words. Additionally, the de- 
partment's personal files were hand- 
searched. Bibliographies of identified 
articles were checked for further po- 
tential trials. No restrictions regarding 
language of publication were applied. 
For the purpose of this systematic re- 
view, MT was defined as the passive 
listening to music. Participants either 
chose themselves which music they 
wanted to listen to or had to chose 
from a pre-selected variety of musical 
tapeý provided by the investigators. 
For ? nclusion, trials had to be ran. 
domised and involve human patients 
with cardiac conditions. All studies 
were employing music therapy as an 
experimental intervention in addition 
to standard care. Only studies that 
quantified psychological or physical 
outcome measures relevant to cardio- 
vascular conditions were included. 
Trials on healthy volunteers, case stu- 
dies, traditional reviews, abstracts and 
studies involving solely the presence 
of background music were excluded. 
It was impossible to define one uni- 
form endpoint because of the diversity 
of outcome variables used in the pri- 
mary studies. However, two specific 
research questions. were asked: a) 
what is the therapeutic effect of MT 
on anxiety of coronary patients and b) 
what is the effect of MT on physiolo- 
gical variables, such as heart rate and 
blood pressure in coronary patients? 
Key data from all RCTs were extract- 
ed in a standardised manner accord- 
ing to the following pre-defined cri- 
teria: study design, number of patients 
and clinical condition, settings, treat- 
ment intervention, other interventions 
and control intervention, and results 
from various outcome measures. Both 
data extraction and the assessment of 
studies was made by employing Ja- 
dad's scoring system to measure the 
likelihood of bias, for which a total of 
5 points can be distributed [241. In 
Jadad's scoring system one point is gi- 
ven inter alia for the double-blinding 
procedure of the subjects. However, 
this is impossible for MT, as the pa- 
tients were able to detect whether 
they have been randomised to receive 
either MT, the control treatment, such 
as, for instance, white noise tapes or 
standard care. Thus, one point was gi- 
ven if single blinding of the clinician 
was assured. 
Results 
Twelve RCTs were included in the re- 
view (Table 1) 122,23,25-34]. Tile 
studies reported were published be- 
tween 1988 and 2002. One study was 
observer-blinded [26]. Only two stu- 
dies reported a sample size calculation 
[33,34]. Patients were recruited from 
community hospitals [23,25,26,30, 
31,34], cardiac care units [27-29,33] 
and intensive care units P]. Five tri- 
als reported dropouts (26,29-32). 
Four studies scored 3 out of 5 total 
points on the Jadad score [26,30-321, 
three studies scored 2 points [25,27, 
291, whilst the remainder scored 1 
point (22,23,28,33,34]. All studies 
differ in terms of treatment period, 
treatment modality, and study sample. 
The methodological quality of studies 
ranged from 3 points on the Jadad 
score to I point. Only 5 of all 12 in- 
cluded studies have described the 
method of randomisation and only 
one study has ap lied appropriate 
assessor-blinding [M]. 
The total sample size of patients from 
all 12 studies was 904. The individual 
study samples ranged from 35 to 140 
patients. Study patients suffered from 
a range of conditions or underwent 
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various procedures and included coro- 
pary bypass (25,26], acute myocardial 
infarction (22,23,29,31,33], and angi- 
na pectoris [281, patients after place- 
ment of intra-vascular sheaths or in- 
tra-aortic balloon pumps [27], patients 
waiting to undergo cardiac catheteri- 
sation [30,32] and a group of acute 
myocardial infarction and coronary 
bypass patients [341. In all RCTs, pa- 
tients received standard care as a base- 
line treatment and the experimental 
groups received MT in addition. The 
following control or other interven- 
tions were employed: watching a mu 
sical videocassette [25,34] (other in- 
tervention), a rest period without mu- 
sic (22,23] (control intervention), a 
yocational suggestion tape [26) (other 
intervention), a muscle relaxation 
tape (281 (other intervention), sensory 
information input (other intervention) 
[32] or a blank tape (33) (control in- 
tervention), Benson's orespiratory 
one-method, x relaxation technique 
[29] (other intervention) or no further 
therapy at all (control intervention) 
[27,30,321 Eight studies involved 
three groups [23,25,26,28,29,32-341 
in which the third group received 
either a rest enod or standard care 
(23,25,3' 2-3# or listened to a sugg s- 
r tion tape [2 ], a muscle relaxation 
tape (281 or practised a muscle relaxa- 
tion technique [291. 
The outcomes assessed in this review 
involved a wide range of physiological 
and psychological endpoints. The Sta- 
te Trait Anxiety Inventory (STAI) 
(351 was most frequently employed as 
main outcome measures (22,23,25, 
28,30-33]. Other outcome measures 
were heart rate, blood pressure, respi- 
ratory rate, skin temperature, pain 
perception, days of postoperative stay 
at hospital, the Daily Living Activity 
Scale (DLAS), the Linear Analogue 
Anxiety Scale (LAAS), the Numeric 
Rating Scale for mood and anxiety 
(NRS), the Cardiac Symptom Scale 
(CSS), the Profile of Mood States 
(POMS), and the H ital Anxiety 
and Depression Scale ý=S). 
Barnason et al carried out an RCT 
with a repeated measure design on 96 
artery bypass patients [25]. Patients 
who were randomly assigned to the 
experimental group had to chose one 
out of 5 musical tapes of their prefe- 
rFnce and received one 30-minute ses- 
sion of MT. Patients assigned to a se- 
cond intervention group watched a 
musical video and control patients re- 
ceived 30 minutes of scheduled rest. 
The music tapes were from the follow- 
ing selection: Country Western Instru- 
mental, Fresh Aire by Mannheim 
Steamroller, Winter into Spring by 
George Winston, and Prelude and 
Comfort Zone by Steven Halpern. 
Outcome measures were taken at 10- 
minute intervals and included the 
STAI, NRS for mood and anxiety, 
blood pressure and heart rate. The fi. 
nal measure was taken after 30 minu- 
tes of MT and the results indicate that 
there was a statistically significant dif- 
ference for the NRS (mood) for pa- 
tients in the MT group, F[2,87]=4.33, 
p=0.016. 
The methodological quality of this 
RC`r was fairly poor. The method of 
randomisation of participants was de. 
scribed and appropriate. However, no 
single-blinding of the investigator or 
mentioning of dropouts were report- 
ed. 
Blankfield et al were investigating the 
effect of taped therapeutic suggestion 
and taped music therapy as adjuncts 
in the care of 66 coronary bypass pa- 
tients [26]. In this RCr patients were 
randomly assigned to one of the three 
groups: I suggestion group. 2 music 
group and 3 control group. Patients in 
group 1 listened to a suggestion tape 
with background music (Drearnflight 
U by Herb Ernst). Patients in group 2 
listened only to this background music 
and patients in group 3 receiyed stan- 
dard care. One session of the inter. 
vention lasted 30 minutes and was car- 
ried out once intra-operatively and 
post-operatively twice daily for the 
whole duration of hospitalisation. Pa- 
tients were assessed in regard to their 
days of postoperative stay, morphine 
intake, and their scores on a 7-item 
depression scale, DLAS, and the CSS. 
Results showed that there were no 
significant differences between groups 
for any of the outcome measures and 
thus, the trial did not demonstrate any 
objective effect to any of the interven- 
tions. 
The assessment of methodology indi- 
cated a satisfactory quality with 3 
points for the Jadad score, as the RCr 
was randomised and single-blinded. 
One hundred forty-five cardiac pa. 
tients who were bed resting due to pro. 
cedural sheaths or intra-aortic balloon 
pumps were enrolled in a RC`r carried 
out by Cadigan et al [27]. Patients 
were randomly assigned to receive 
either a 30-minute music intervention 
or standard care. The music selection 
was a combination of symphonic mu- 
sic and nature sounds and had been 
selected by the researchers. Psycholo- 
gical outcome measures included the 
POMS, and pain perception; physical 
outcome measures that were assessed 
were heart rate, blood pressure, respi- 
ratory rate and peripheral skin tempe- 
rature. There were statistically signifi- 
cant differences between the two 
groups for the POMS (t-2.3, 
p-0.021), for systolic and dialostic 
blood pressure (t=-3.1, p=0.002 and 
t-2.2, p--0.028, respectively), and for 
respiratory rate (t=-3.0, p=0.003) as 
the intervention group had a greater 
decrease in all of those measures. 
The methodological quality of the tri- 
al was fairly poor, as there was no 
mentioning of single-blinding or drop. 
outs. 
Elliott et al investigated the effects of 
music and muscle relaxation on pa- 
tient anxiety in 56 CCU patients 128]. 
Patients were randomised into one of 
the following groups: 1) the muscle re- laxation group contained a verbal 
script us! ng a combination of autoge. 
nic heaviness and a technique for in. 
ducing the relaxation response, 2) the 
music group listened to fight classical 
music designed by Bonnie (Music Rx, 
Portland, Washington) [36] and 3) pa- 
tients in the control group received 
standard care. The number of sessions 
were two or three within a period of 24 hours, depending on C bed sup- 
p! Y and demand and the subject's cli. 
nical condition. Psychological and 
Ehysiological effects were measured 
efore and after the intervention with 
the STAI, HADS, LAAS, blood pres- 
sure and heart rate. Within-group 
analyses revealed that all groups had 
statistically significant differences in 
STAI anxiety scores from pre-test to 
post-test measurements. No between 
group analyses were carried out. Thus, 
we cannot draw any conclusions from 
this methodologically fairly poor 
RCT. 
In another RCT (28] 80 myocardial in- 
farction patients at a CCU were ran- 
domly assigned to one of the follow. 
ing groups: 1) patients assigned to 
the relaxation group practised Ben. 
son's 'respiratory one-method', 2) pa. 
tients assigned to the music group sel- 
ected to listen to music tapes contain- 
ing either soothing classical music, 
soothing popular music or non-tradi- 
tional music (defined as compositions 
having no vocalisation or metre, peri- 
ods of silence and an asymmetric 
rhythm) and 3) patients in the control 
Periusion 04rM CI 17. Jahrgang 0 Verlag PERFUSION GmbH, N(Lmberg/Exeter 
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group received standard care. All pa- 
tients from the muscle relaxation and 
music groups participated in an initial 
session and then again in two more 
following sessions the next day. Heart 
rate and peripheral skin temperature 
were measured at baseline and after 
each session. Analyses of outcome 
measures suggest that for both out- 
come measures there were statistical- 
ly significant differences between 
groups, Ilere was a statistically signi- 
ficant difference for heart rate when 
the relaxation group and music group 
were compared to the control group 
(F[2,76]=4&56, p<0.001). No differen- 
ce, however, was found between the 
relaxation and music group. Groups 
also differed significantly in peri- 
pheral skin temperature, as the diffe- 
rence between the two intervention 
groups and the control group was sta- 
t1stically significant (F[2,75]=42.61, 
p<0.001). Additionally, the music 
therapy was more effective in decreas- 
ing peripheral skin temperature com- 
pared to the relaxation group ýt(49)=2.99, p--0.004). 
The quality of the methodological de- 
sign of this study was fairly poor. No 
single-blinding of the outcome asses- 
sor was reported nor was the method 
of randomisation adequately describ- 
ed. 
The effects of a music intervention on 
anxiety were assessed in 101 patients 
waiting for cardiac cathederisation has 
been evaluated by Hamel [30). In this 
RCr patients either received one ses- 
sion of the intervention (Trance-Zen- 
dance by Halpern) or standard care 
alone. outcome measures such as 
STAI, heart rate and blood pressure 
were taken before and after the inter- 
vention and analyses revealed a sta- 
tistically significant difference for the 
STAI score between the two groups 
(p---0.002). Thus, the music interven- 
tion had significantly decreased pa- 
tients' anxiety. 
The methodological quality of the cli- 
nical trial was satisfactory - the only 
point of criticism is that the study was 
not assessor-blinded. 
The effects of relaxing music on state 
anxiety of 40 myocardial infarction 
patients was assessed by Lueders-Bol. 
v! erk [31]. Patients were randomly as- 
signed to receive either 3 sessions of 
music therapy (Largo by Bach, Largo 
by Beethoven and Prelude to the Af. 
ternoon of a Faun by Dubussy) or 
standard hospital care. Five patients 
dropped out of the study as they were 
Porfüsion 04a004 EI 17. JahrSang 
transferred to other hospitals. All pa- 
tients filled in the STAI at baseline 
and after the final intervention. Tle 
results showed that patients in the 
music group had statistically signifi- 
cant lower scores on the STAI com- 
pared to the control group (t=-2.87, 
p=0.07). 
This study is of satisfactory methodo- 
logical quality and received 3 points 
on the Jadad scale. 
Taylor-Piliae et al measured the ef- 
fects of nursing interventions utilising 
music therapy or sensory information, 
on patients' anxiety prior to cardiac 
cathederisation (32]. In this RCT pa- 
tients were randon-Ay assigned to either 
receive 1) music therapy, 2) a sensory 
information intervention or 3) stan- 
dard CCU care. Anxiety (STAI), un- 
certainty (Mishel's Uncertainty in 
Illness Scale), mood states (POMS), 
heart and respiratory rates were mea- 
sured at baseline, after the interven- 
tion session and post-cardiac catheteri- 
sation. Participants in the music inter- 
vention could chose to listen to either 
New Age music (Songs from a Secret 
Garden or Introduction to New World 
Music, Vol I). Chinese instrumental 
(Guzheng selections of Kwok Wai. 
Sze) or classical music (Symphony Nr 
8 by Beethoven or Canon in D by Pa- 
chelbel). Post-intervention results 
showed that baseline-dependent va- 
riable mean scores revealed no signifi- 
cant differences between the groups. 
The methodological quality of this tri- 
al is reasonably satisfactory, given that 
an appropriate method of randomisa- 
tion was applied and drop-outs were 
reported. 
White carried out two RCTs to study 
the effects of MT on anxiety and car- 
diac autonomic balance [22,231. In 
one study 40 myocardial infarction pa- 
tients were randomly assigned to 
either receive one session of music 
therapy (4 pre-selected Adagios) or 
standard care (22]. Outcome measures 
included the STAL heart and respira- 
tory rates. Statistically significant re- 
ductions in all of the outcome meas- 
ures were found for the intervention 
group (STAI: F=29.72, p<0.001; heart 
rate: F=0.21, p=0.653; res ratory rate. 
F--4.14, p=0.049). 7bus, 
Piti 
was found 
that the MT intervention helped to re- 
duce the autonomic nervous system 
indicators of heart and respiratory 
rate as well as elevate anxiety in pa- 
tients suffering from acute MI. 
7be quality of the study design was 
fairly poor, as the study was not 
single-blinded and the number of 
drop-outs and method of randomisa- 
tion were not described. 
Forty-rive acute MI patients in a later 
study were randomised into one of the 
following groups. 1) music interven- 
tion (pre-selected classical music), 2) 
attention control or 3) standard care 
[231. STAI, heart and respiratory rate, 
and systolic blood pressure were 
measured at baseline and after the in- 
tervention. Outcome measures were 
taken at baseline, immediately after 
and one hour after the intervention. 
Between-group analyses of the results 
indicate that immediately after the in- 
tervention reduction in heart rate 
F=3.46, p=0.04), respiratory rate 
F--4.62, p=0.02) and STAI scores 
F[4,8+10.09, p<0.001). 
Again, this study also lacked of me- 
thodological rigour, as no assessor. 
blinding, number of drop-outs or me- 
thod of randomisation were reported. 
Finally, in two RCTs Zimmerman et 
al investigated the effects of MT on 
patient anxiety, pain and sleep in 
CCUS (33,34]. In one of the trials 75 
suspected MI patients were randomly 
assigned to participate in one session 
of one of the three interventions: 1) 
MT (Halpern relaxation tape, classical 
music or Country Western music),, 2) 
patients listening to a 'synthetic silen- 
ce , tape, which contained recordings 
of ocean waves or 3) 30 minutes of 
scheduled rest (33). Outcome meas- 
ures including STAI, heart rate, blood 
pressure and skin temperature were 
taken at baseline, after 10,20 and 30 
minutes. There were no statistically 
significant differences between groups 
for any of the outcome measures ta. 
ken. This trial was of poor methodolo- 
gical quality. 
In the other study 96 coronary bypass 
patients who had undergone coronary 
artery 
. 
graftiq were i cluded 
[341. Pa ents were either receiving 1) 
MT ( un Western Instrumental 
by Coun Pops, Fresh Aire by 
Mannheim Steamroller, Winter into 
Spring by George Winston or Prelude 
and Comfort Zone by Steve Halpern), 
2) a 30-minute video cassette playing 
soft instrumental music combined 
with visual images or 3) scheduled 
rest. The Verbal Rating Scale (VRS) 
for pain scores, the McGill Pain Ques- 
tionnaire and the Richards-Campbell 
Sleep Questionnaire were the out- 
come measures that were obtained. 
The results of this study showed that 
for the evaluative component of pain, 
0 Vedog PERFUSION OmbH. Ntirnberg/Exater 
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as measured by the VRS there were 
no statistical significant differences 
between groups. However, on the 
MPQ pain intensity score after session 2 
the evaluative component pain showed a 
significant group effect (F[2,93]=4.74, 
p<0.05) for postoperative day 2 
though not for day 3. Post-hoe Tukey 
tests revealed that participants in the 
MT group had significantly lower pain 
scores than the resting group. There 
was a significant difference among 
groups for the total RSQ measuring 
sleep (F[2,92]= 3.18, p<0.05). Again, 
this trial showed to be of poor metho- 
dological quality. 
The overall results from all 12 in- 
cluded trials can be summarised as 
follows: 4 RCTs showed significant ef- 
fects of MT on STAI scores [22,23, 
30,31], two trials demonstrated signi- 
ficant reductions in heart rate (23,291, 
two RCTs Sh ed as. gnificant 
decrease of resýIoirwatory ratel[23,27], 
one RCT demonstrated significant 
drops of dialostic blood pressure [271 
and two studies showed a significant 
drop in systolic blood pressure [23, 
27], one RCT demonstrated signifi- 
cant changes for skin temperature 
[29), and two RM showed significant 
effects for subject's mood ratings [25, 
27). 
DisclwiOn 
A music therapy intervention is aimed 
at addressing the physical and emotio. 
nal needs of patients as an adjunct to 
pharmacological pain and symptom 
management. Music therapy is known 
to have healing and relaxing effects. 
Although these effects appear to be 
mediated by release of neurotransmit- 
ters and hormones, the specific hor- 
monal systems involved have not yet 
been My investigated. The mecha- 
nism of action of MT might be a rela- 
xation response, which can be induced 
by soothing music and has been sug- 
gested to alter the autonomic, immu- 
ne, endocrine and neuropeptide sys- 
tems [23,30]. 
This systematic review implies that 
MT can have desirable effects in pa- 
tients suffering from various cardiac 
symptoms. Some of the included stu- 
dies indicate an improvement of phy- 
siological outcome variables, such as blood pressure and respiratory rate af- 
ter MT intervention; others show an 
improvement for psychological out. 
come measures, such as mood and an- 
xiety. 
Several limitations complicate the in- 
terpretation of these results. The type 
of music employed in these studies 
differed greatly. In most of the trials 
the patients were supplied with pre- 
selected music. Music, however. is of- 
ten of very personal taste and thus, 
the same music may have different ef- 
fects in different people. 7be presence 
of a music therapist may increase the 
impact of MT yet none of the studies 
mentioned the employment of a music 
therapist [37). Moreover, some of the 
criteria used to define improvement 
are of debatable relevance. It is not 
generally accepted, for example, that 
the STAI is a measure of improve- 
ment in cardiac patients. The same 
may be said about some of the other 
outcome measures. In most of the stu- 
dies the duration of the effect is un- 
known. 'Mus, the longevity of any ob- 
served effect seems uncertaia. 
The low Jadad score for most of the 
studies reflects the overall poor quali. 
ty of research on MT. Only one study 
employed single blinding [26] but fails 
to describe the method of blinding. 
Only two studies describe the method 
of randomisation [25,31]. A further 
problem is that only few studies exist 
for any single cardiac condition or 
outcome measure. 7he conditions vary 
from acute MI to coronary bypass re- habilitation, angina pectoris and pa- 
tients undergoing invasive procedures. 
Obviously, different conditions could 
yield different physiological and psy- 
chological outcomes. What is needed 
to advance our knowledge is an ade- 
quately powered clinical trial of a ho- 
mogeneous group of patients exposed 
to. uniform (but individualised) MT 
measuring valid clinical rather than 
surrogate endpoints. 
The question arises whether MT is 
cost-effective. On the basis of the data 
provided by the primary studies, a for- 
mal cost analysis is not possible. How. 
ever, supplying an audio-tape is low. 
cost and does not demand much pro. 
fessional time. It therefore seems like. 
ly that a cost-benefit-analysis would 
reach positive conclusions provided 
that effectiveness of MT can be esta- 
blished. 
Dýspite these limitations some preli. 
minary implications seem to emerge 
from the data. MT does seem to have 
potential for coronary patients in that 
it can have positive effects on a range 
of clinically relevant endpoints. 
143 
Moreover, it is not associated with sig. 
nificant risks and is inexpensive. The 
fact that none of the included trials 
have reported adverse effects is some. 
what assuring. Loud music may cause 
hearing impairment [381, but adequa- 
tely applied MT seems to be a safe 
treatment. Tbus, one might be tempt- 
ed to advocate its inclusion in routine 
cardiovascular care. The present re- 
viewers, however, believe that this 
may be premature and suggest further 
research to define the optimal type of 
MT. dosage, length of therapy, dura- 
tioa of effect and type of condition. 
In conclusion, the trial data on MT for 
cardiac patients is encouraging. Due 
to a range of limitations they are, however, not convincing. Positive re- 
commendations seem warranted only 
after its benefits have been demon- 
strated beyond reasonable doubt. Cl 
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